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Abstract  
Comparisons of the incidence of blood stream infection (BSI) between neonatal 
intensive care units (NICUs) can promote sharing of potentially better practices for 
infection control. Comparisons should take into account differences in babies’ 
vulnerability and the invasive procedures which can introduce infection. I carried out a 
systematic review of methods reported in the literature, or used by regional monitoring 
systems, for comparing the incidence of BSI among NICUs. I found substantial 
variation, especially in the risk factors used to adjust incidence estimates. 
 
The use of routinely recorded administrative data would minimize and accelerate staff 
workload for BSI monitoring. I investigated which risk factors recorded in routine data 
should be adjusted for when comparing BSI incidence between NICUs. I linked 
microbiology laboratory records with administrative records collected over four years 
for three London NICUs. I analysed rates of BSI using various methods, including 
Poisson regression and logistic regression assuming a matched case control design. 
With both approaches, National Health Service level of care was the strongest predictor 
for BSI incidence. Using Poisson regression models, the rate ratio for BSI, adjusted for 
birth weight, inborn/outborn status and postnatal age, was 3.15 (95% confidence 
interval (CI) 2.01, 4.94) for intensive care and 6.58 (95% CI 4.18, 10.36) for high 
dependency care, relative to special care. The case control study gave slightly larger 
estimates of effect than the Poisson regression models. Total parenteral nutrition was 
significantly associated with BSI incidence but explained less of the variance among 
babies than level of care.  
 
 3
Using the results from the risk adjustment model, I demonstrated how routine data can 
be integrated into a method for prospective, risk adjusted monitoring. This method 
involved standardised infection ratios and a sequential probability ratio test. The method 
can evaluate changes in BSI rates over time and between NICUs. It could also be used 
to quantify improvements following infection control interventions. 
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1. Introduction and systematic literature review 
 
1.1 Summary 
Comparisons of the incidence of blood stream infection (BSI) between neonatal 
intensive care units (NICUs) can reveal important differences, which may be due to 
variation in infection control practices. Investigation of these differences can highlight 
NICUs with effective infection control, whose practices can be shared with other units. 
To examine variation in practice, infection incidence must be risk adjusted to control for 
differences between units in the vulnerability of babies and the intensity of invasive 
procedures which can introduce infection.  
 
I reviewed methods for risk adjusting comparisons of BSI incidence between NICUs, 
both in the published literature and in reports published by regional and national NICU 
infection monitoring systems. PubMed and Embase were searched for studies reporting 
risk adjusted BSI incidence in more than one NICU. An internet search found NICU 
infection monitoring systems in Western industrialised countries.  
 
In the ten studies that met the inclusion criteria, risk adjustment reduced but did not 
eliminate variation in BSI incidence between NICUs. In both the studies and the 
regional monitoring systems, adjustment for baby susceptibility generally involved 
stratification by factors measured at birth. Adjustment for length of stay and invasive 
procedures involved reporting incidence by days with a device, such as central venous 
catheter days.  
 15
 Current methods for monitoring NICU infection lack consistency. Adjustment for 
factors measured at birth fails to capture changes in susceptibility throughout the NICU 
stay and adjustment for device days does not adequately reflect risk to babies without a 
device. There is a requirement for methods which adjust for variation in risk for all 
babies throughout their NICU stay.  
 
1.2 The rise of neonatal intensive care units 
NICUs were developed in the 1950s and 1960s, and are hospital units specialising in the 
care of premature or acutely ill newborn babies. They provide acute intensive and high 
dependency care, including cardiovascular and respiratory support. They also provide 
less intensive ‘special care’, including monitoring and support for feeding and 
temperature maintainance, for babies not sufficiently mature or well enough to be cared 
for by their mothers on postnatal wards. NICUs are run and staffed by neonatologists 
and neonatal nurses. Common conditions cared for in the NICU include: prematurity, 
extreme low birth weight, major birth defects, perinatal asphyxia, jaundice, blood 
stream infection and respiratory distress syndrome. In England, about 10% of all births 
are admitted to NICUs.1 
 
In developed countries, NICUs have greatly increased the survival of extremely 
premature and very low birth weight babies. In the 1950s, most babies of less than 30 
weeks gestation or less than 1400g birth weight died, whereas in the UK today 96% of 
these babies survive.  The limit of viability has decreased to 22/23 weeks and 500g birth 
weight.  The Extremely Preterm Infants in Sweden Study (EXPRESS) was a 
2
3
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prospective observational study covering Sweden’s entire population, carried out during 
2004-2007. 1011 babies were born before 27 weeks of gestational age, and 707 of these 
were liveborn. Of the liveborn babies, 497 (70%) survived to one year of age (95% 
confidence interval (CI) 67%-73%).4 However, babies who survive at the limit of 
viability often have severe developmental difficulties.5-7 
 
Several differences between NICUs and other intensive care environments are relevant 
for this project. In contrast to adult and paediatric intensive care, babies are rarely 
admitted to the NICU from the community, coming instead from labour wards in the 
NICU’s neonatal network. Babies in NICUs can suffer from infections acquired from 
their mothers during delivery as well as infections from the NICU environment. These 
factors result in different colonising organisms and incidences of infection between 
NICUs and other intensive care units. Maternally transmitted infections will be 
discussed in more detail in Chapter 5. In addition, duration of stay in intensive care 
differs between adults, children and babies. In a prospective cohort study including 
2060 adults admitted to 22 intensive care units in Austria in 2006/2007, the median 
length of stay was four days.8 The UK Paediatric Intensive Care Audit Network 
(PICANet) estimated that in the south west of England in 2007/2008, children admitted 
to district general hospital intensive care units had a median length of stay of 13 hours 
and children admitted to paediatric high dependency units had a median length of stay 
of one day.9 In contrast, babies spend longer periods in the NICU: the median length of 
stay was between 7 and 13 days for the two NICUs described in this project (discussed 
in Chapter 3). This means that babies can be exposed for long periods to invasive 
procedures which may introduce infection.  
 1.3 Hospital-acquired infections in NICU 
Between 6% and 22% of babies who spend at least 48 hours in an NICU acquire a 
hospital-acquired infection (HAI).10,11 HAIs are rather loosely defined as infections 
occurring in hospital or shortly after discharge, with no evidence that the infection was 
present or incubating at the time of admission.12 In the United States (US), a national 
point prevalence survey carried out for one day in 1999 included 827 babies from 29 
NICUs. HAI prevalence, defined according to United States Centers for Disease Control 
and Prevention (CDC) criteria,13 was estimated at 11.4% of NICU inpatients. Blood 
stream infection (BSI) was the most common HAI, accounting for 53% of infections. 
This was followed by respiratory infections (13%), urinary tract infections (9%) and 
other infections (25%).14 This PhD project focused on BSI, as it forms the majority of 
the most serious NICU-acquired infections. 
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Case definitions for blood stream infection 
The US CDC established criteria to define hospital-acquired BSI in 1988 (updated in 
2008), these criteria are summarised in the box below: 
 
US Centers for Disease Control and Prevention (CDC) criteria to define hospital-acquired 
blood stream infection (abbreviated)12,13 
 
Laboratory-confirmed BSI 
 
At least one of the following criteria must be met: 
 
1. Patient of any age has a recognised pathogen cultured from one or more blood cultures.  
 
2. Patient of any age has at least one of the following signs or symptoms: fever (>38°C), chills, 
hypotension 
and 
a common skin contaminant is cultured from two or more blood cultures drawn on separate 
occasions.  
 
3. Patient ≤1 year of age has at least one of the following signs or symptoms: fever (>38°C 
rectal), hypothermia (<37°C rectal), apnea, bradycardia 
and 
a common skin contaminant is cultured from two or more blood cultures drawn on separate 
occasions. 
 
For 1, 2 and 3 signs and symptoms and positive laboratory results must not be related to an 
infection at another site. 
 
Common skin contaminants are listed as: diphtheroids (Corynebacterium), Bacillus (not B 
anthracis), Propionibacterium, coagulase-negative staphylococci (including S epidermidis), 
viridans group streptococci, Aerococcus, Micrococcus. 
 
Clinical sepsis 
 
Clinical sepsis may be used to report primary BSI in neonates and infants. 
 
The following criterion must be met: 
 
1. Patient ≤1 year of age has at least one of the following signs or symptoms with no other 
recognised cause: fever (>38°C rectal), hypothermia (<37°C rectal), apnea, bradycardia 
and 
blood culture not done or no organisms detected in blood 
and 
no apparent infection at another site 
and 
physician institutes treatment for sepsis 
 
For both laboratory-confirmed BSI and clinical sepsis, there must be no evidence that the 
infection was present or incubating at the time of admission to hospital. Infections in babies that 
result from passage through the birth canal are considered HAIs. 
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A systematic literature review of multicentre monitoring for BSI incidence in NICUs 
showed that about half of the studies reviewed based their case definitions for BSI on 
CDC criteria (five out of ten published studies and three out of seven regional 
monitoring systems). These criteria were not considered appropriate in every study. In 
particular, authors of the NEO-KISS infection monitoring system in Germany had 
reservations about classifying maternally-transmitted infections acquired from the birth 
canal as HAI. They instituted several modifications to the CDC case definition, the 
main one stipulating that only BSI occurring after 48 hours of life should be considered 
hospital-acquired.15  
 
The main obstacle to the use of CDC criteria in research and infection monitoring is 
their complexity. They include clinical observations of signs of infection to help 
differentiate between clinically-relevant BSI and subclinical infection or contaminated 
blood cultures. However such clinical data are not routinely recorded and therefore 
require skilled data collection, which may not be possible. The systematic review 
showed that some studies relied to a greater degree on blood culture results,16-18 which 
can be obtained from routine hospital laboratory data. The systematic review is 
described in Sections 1.5 to 1.8. The case definition used in this PhD project relied 
solely on blood culture results, it is described in Chapter 3, Section 3.3.2 and discussed 
in Chapter 5, Section 5.5. A method for differentiating between maternally-transmitted 
and hospital-acquired BSI is described in Chapter 5. Section 5.3.2. 
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Organisms giving rise to blood stream infection 
The organisms most commonly contributing to NICU-acquired infection are Coagulase-
negative staphylococci (CONS). In a surveillance study, Gaynes et al. (1996) evaluated 
13,179 HAIs conforming to CDC case definitions, including 3833 BSIs, reported by 99 
US NICUs from 1986 to 1994. CONS were implicated in 36% of all HAI and in 51% of 
BSI.19 Commensal organisms such as CONS, which in healthy individuals can colonise 
the skin and gastrointestinal tract without giving rise to infection, were recognised as 
important pathogens 30 years ago, and have increasingly been implicated in NICU-
acquired infection over the last 20 years. This is probably due to increased survival of 
very premature babies, who are vulnerable to otherwise harmless bacteria due to their 
immune immaturity and increased requirement for invasive procedures which can 
introduce infection.20 Other organisms giving rise to BSI in NICUs include 
Staphylococcus aureus, Group B streptococci, Enterococci, Candida species and 
Escherichia Coli. The frequent and widespread use of antibiotics in NICUs, hospitals 
and the community has led to the emergence of antibiotic-resistant organisms such as 
Methicillin-resistant S. aureus, and vancomycin-resistant enterococci. Although the vast 
majority of organisms giving rise to NICU-acquired BSI are susceptible to antibiotics, 
sporadic outbreaks of resistant BSI have occurred.21-23 
 
Mechanisms of blood stream infection 
Newborn babies are particularly vulnerable to infection compared with older age 
groups. Figure 1.1 shows that in relation to other hospital departments, NICUs have a 
higher rate of BSI.24 A newborn’s immune system is functionally inferior to that of an 
older child or an adult, and is more naïve to antigens. For example, a baby’s IgG levels 
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reach about 60% of adult levels by one year of age.25 Because much of the maternal IgG 
is transferred to the fetus during the last trimester of pregnancy, premature babies have 
even lower levels of serum IgG than their term counterparts.26 Colonisation with 
‘normal’ flora in the first few days of life can deter colonisation with pathogenic 
organisms and in the NICU, this process can be disrupted by antimicrobial agents.27 
Premature babies also have immature skin and mucous membrane barriers, particularly 
in the gut, and insufficiently acidic gastrointestinal tracts, which can admit pathogens or 
commensals. Invasive procedures used in the NICU can provide portals for the entry of 
organisms, either at their insertion sites, or internally by causing physical trauma. 
Invasive procedures can provide an environment for colonisation, for example at the 
catheter hub, and intravenous infusions can become contaminated. In particular, 
intralipids infused as part of parenteral nutrition provide a favourable medium for 
organismal growth. Other issues specific to parenteral nutrition include its direct effects 
on both the immune system, perhaps through inhibition of interleukin-2,28 and on the 
development of natural gastrointestinal defences. 
 
Risk factors for blood stream infection 
Throughout this thesis, I divide risk factors for BSI into those reflecting susceptibility to 
BSI at birth, and those reflecting susceptibility during the NICU stay, i.e. invasive 
procedure-related factors. In the paragraph above I described how the mechanisms for 
BSI involve multiple intrinsic factors and extrinsic exposures associated with the 
complexity of intensive care. Many of these risk factors act at the molecular or bacterial 
level, and most are not investigated or recorded on a routine basis. Population-based 
studies have tended to use markers for susceptibility to infection which are routinely 
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recorded, examples include gestational age and the use of invasive procedures, for 
example central venous catheters (CVCs) and parenteral nutrition. The results of these 
studies are summarised in the following three paragraphs.  
 
Risk factors reflecting susceptibility to infection at birth 
As shown in several studies, babies with low gestational ages and/or very low birth 
weights are at increased risk for BSI. In a prospective cohort study, Beck-Sague et al. 
(1994) evaluated 376 babies in 3 US NICUs from 1989 to 1991. The proportions of 
babies developing BSI according to CDC criteria were: 31 of 110 (28%) babies with a 
birth weight below 1500g, and 11 of 266 (4%) babies with a birth weight above 1500g 
(risk ratio 6.8, p<0.01, no CI available, adjusted for other factors related to babies’ 
susceptibility to infection, such as admission diagnosis).29 In another prospective cohort 
study, the National Institute of Child Health and Human Development Neonatal 
Research Network (2002) reported on babies of very low birth weight (below 1500g), 
admitted to 15 US NICUs between 1998 and 2000. BSI was defined as one or more 
positive blood cultures obtained after 72 hours of life, which were treated with 
antibiotics. Cultures positive for organisms generally considered to be contaminants 
were only included if they were found to indicate infection on clinical review. Of 6215 
babies, 1313 (21%) experienced BSI, and the incidence of infection was inversely 
related to birth weight and gestational age. Forty three percent of babies with birth 
weights between 401 and 750g experienced infection, in contrast to 7% of babies with 
birth weights between 1251 and 1500g. Similarly, 46% of babies born before 25 weeks 
of gestation experienced BSI, which decreased to 2% for babies born after 32 weeks of 
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gestation (p<0.001 in unadjusted logistic regression models for BSI incidence, fitted 
with birth weight or gestational age as a covariate. Risk ratios and CIs not available).30  
 
Many studies have shown associations between maternal risk factors and maternally-
transmitted BSI occurring in the first few days of life.31 The National Institute of Child 
Health and Human Development Neonatal Research Network carried out one of the 
largest of these studies, in which babies with very low birth weights (below 1500g), 
admitted to 12 US NICUs between 1991 and 1993, were enrolled in a prospective 
cohort. BSI was defined as one or more positive blood cultures obtained before 72 hours 
of life, accompanied by clinical signs of infection. Cultures positive for known 
contaminants were only included if they indicated infection on clinical review. Of 7861 
babies, 147 (1.9%) experienced early-onset BSI, of which 45 (31%) experienced 
infection with Group B streptococcus. The time from rupture of membranes (rupture of 
the amniotic sac) to birth was a strong risk factor for BSI, because this interval reflects 
the potential exposure of the foetus to pathogenic organisms. If rupture of membranes 
occurred more than 24 hours before birth, the risk of BSI was more than four times 
greater than if this interval was less than 6 hours (p<0.01 adjusted for gestational age at 
birth. CI not available). Babies born by vaginal delivery can be exposed to potentially 
pathogenic organisms in the birth canal. Babies born by caesarean delivery were less 
likely to experience BSI than babies born by vaginal delivery (odds ratio 0.69, 95% CI 
0.49, 0.96, p<0.05 adjusted for gestational age at birth).32 This thesis concentrates on 
hospital-acquired BSI, by excluding probable maternally-transmitted BSI occurring 
during the first 48 hours of life. The threshold used to differentiate maternally-
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transmitted BSI from hospital-acquired BSI is described in more detail in Chapter 5, 
Section 5.3.2. 
 
Procedure-related risk factors reflecting susceptibility to infection during the NICU 
stay 
Studies have shown associations between the use of invasive procedures and BSI.33 The 
three invasive procedures most often associated with BSI are the use of parenteral 
nutrition, central venous catheters and assisted ventilation, as described by the following 
three prospective cohort studies. Holmes et al. (2007) evaluated 1367 babies admitted to 
one UK NICU between 2001 and 2003. BSI was defined as a positive blood culture, 
with the additional requirement of clinical symptoms if the culture revealed more than 
one organism or a skin contaminant. The rate of BSI was higher in the three days 
following treatment with parenteral nutrition (22.65 per 1000 baby days), than on other 
days (1.37 per 1000 baby days). The rate ratio was 14.2 (95% CI 8.8-22.9).34 In another 
study, the Canadian Neonatal Network evaluated 19,507 babies admitted to 17 
Canadian NICUs in 1996/1997. BSI was defined as one or more positive single 
organism blood cultures in babies with clinical suspicion of infection. The rate of BSI 
was higher on days treated with a CVC (7.2 to 13.1 per 1000 CVC days, depending on 
the type of CVC used) than on days not treated with a CVC (2.9 per 1000 noncatheter 
days). The rate ratio was 2.0 (95% CI 1.7, 2.5) to 3.5 (95% CI 3.0, 4.0).35 In a subset of 
16,497 babies from the Canadian Neonatal Network study, assisted ventilation was 
estimated to increase the odds of BSI 1.5 times (95% CI 1.1-2.0) in babies with birth 
weight below 1500g, and 2.9 times (95% CI 1.9-4.6) in babies with birth weight above 
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1500g (crude odds not available).36 Risk ratio estimates for all three invasive procedures 
were adjusted for other factors related to babies’ susceptibility to infection. 
 
Outcomes of infection 
Babies with BSI are at increased risk for neurodevelopmental impairment. The National 
Institute of Child Health and Human Development Neonatal Research Network (2004) 
carried out a prospective cohort study, which followed up 6093 babies in US NICUs, 
with birth weights between 401 and 1000g. Infection was defined as a positive culture 
from blood or cerebrospinal fluid, with antibiotic therapy for five or more days. 
Cultures positive for organisms generally considered to be contaminants were excluded. 
Of surviving babies at 18 to 22 months of corrected gestational age, those who 
experienced infection were significantly more likely to have cerebral palsy, impaired 
head growth, vision impairment and low scores on the mental and psychomotor 
development indices of the Bayley Scales of Infant Development II, than those who 
were not infected.37  
 
Proposed mechanisms for neurodevelopmental impairment involve multiple, interacting 
prenatal, perinatal and postnatal insults, including intrauterine infections such as 
chorioamnionitis, hypoxic ischaemic events such as birth asphyxia, and postnatal 
infections such as BSI and meningitis. Periventricular leukomalacia, or lesions in white 
matter surrounding the cerebral ventricles, is the brain injury most commonly associated 
with both infection and adverse outcomes such as spastic diplegia, impaired vision, 
squints, sensorineural hearing loss and developmental delay.38,39 In a retrospective case 
control study, Graham et al. (2004) evaluated all babies born at 23 to 34 weeks’ 
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gestation, at a tertiary university hospital between 1994 and 2001. 150 babies with white 
matter lesions, diagnosed within the first six weeks of life, were matched for gestational 
age with controls without brain injury. The unadjusted odds of developing white matter 
injury was twice as high in babies with a positive blood culture, than in babies without a 
positive blood culture (43 cases had a positive blood culture versus 28 controls, 95% CI 
1.04, 4.00).40 One explanation for the association between infection and white matter 
lesions is that infection and inflammation may result in vascular compromise and 
cytotoxic injury to white matter. A possible mechanism suggests that the presence of 
pro-inflammatory cytokines inhibits proliferation of neuronal precursor cells, activates 
astrogliosis and stimulates oligodendrocyte death.38  
 
BSI is associated with an increased risk of mortality, which varies depending on the 
infecting organism. In a prospective cohort study, Orsi et al. (2008) evaluated 575 
babies admitted to an Italian NICU between 2003 and 2006. Thirty-five babies died 
(6.1%), and two of these deaths were attributable to HAI (attributable mortality 5.7% of 
35), which was defined according to CDC criteria. Babies infected with BSI were 
almost four times more likely to die than babies not infected with BSI (risk ratio 3.89, 
95% CI 1.76, 8.63), although this relationship was not adjusted for other factors related 
to babies’ vulnerability.41 The risk of death associated with BSI varies according to the 
infecting organism. In a prospective cohort study, Isaacs et al. (2003) evaluated 
admissions to 18 NICUs in Australia and New Zealand, between 1991 and 2000. BSI 
was defined as a positive blood culture accompanied by clinical symptoms. Of 1249 
babies infected with CONS, between 4 and 24 (0.3% and 1.6%) were judged to have 
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died because of their infection. In contrast, 289 babies developed Staphylococcus 
aureus infection, of whom 38 (13.1%) died.42  
 
Babies with BSI also tend to spend longer in hospital and have increased treatment 
costs. In a retrospective cohort study, the Vermont Oxford Network (2004) evaluated 
2809 babies surviving to discharge from 17 US NICUs in 1998/1999. BSI was defined 
as a positive blood culture, with the additional requirement of clinical symptoms and 
antibiotic treatment if the culture revealed a commensal. BSI significantly increased 
lengths of stay by 4 to 7 days in babies of birth weight 401 to 1500g, and increased 
treatment costs by 15% to 21%, or by $6276 to $12,480, in babies of birth weight 751 to 
1500g.43 
 
Organisational measures to reduce infections in NICUs 
Various intervention studies have shown that infection control practices implemented at 
the unit level have reduced the incidence of BSI in NICUs. Maas et al. (1998) evaluated 
the effect of a CVC care programme including aseptic techniques, such as the use of 
gloves and gowns when changing infusion sets, implemented in a Belgian NICU in 
1989. BSI was defined according to modified CDC criteria. In the four year follow-up 
period, the proportion of babies acquiring BSI while treated with a CVC fell from 11/26 
(42%) to 18/156 (12%) (adjusted risk ratio in the period before versus after the 
intervention, 2.96 95% CI 1.13, 7.79).44 Pessoa-Silva et al. (2007) evaluated the effect 
of a hand hygiene promotion programme, including education on hand washing 
techniques, implemented in a Swiss NICU in 2001. HAI was defined according to CDC 
criteria. In the 27 month follow-up period, the rate of HAI in babies with birth weight 
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below 1500g fell from 15.5 to 8.8 per 1000 baby days (adjusted odds ratio 0.40 95% CI 
0.19-0.85).45 Isolation of babies known to be infected is recommended for serious, 
easily transmissible or hard to treat infections such as Methicillin-resistant S. aureus.46 
Changes to NICU environments and staffing can also affect BSI. The UK Neonatal 
Staffing Study Group (2005) evaluated 13,334 babies admitted to 54 UK NICUs in 
1998/1999. 402 babies (2.97%) acquired BSIs, defined by a positive blood culture. The 
adjusted odds of BSI increased by 1.13 (95% CI 1.07, 1.20) for each additional special 
care cot per hand washbasin, and decreased by 0.53 (95% CI 0.35, 0.79) in units with an 
NICU infection control nurse compared with units without.16 
 
1.4 Surveillance of blood stream infection in NICU 
Surveillance can be defined as ‘a comprehensive method of measuring outcomes and 
related processes of care, analysing the data, and providing information to members of 
the health care team to assist in improving those outcomes’.47  
 
Surveillance of BSI in NICU could be used to: 
 Assess the burden of infection 
 Monitor changes in infection incidence over time and to trigger alarms if 
incidence increases significantly 
 Encourage sharing of improved infection control practices between NICUs 
 Monitor the outcome of interventions to improve infection control 
 
An example of how surveillance can be used to assess the burden of BSI and to monitor 
changes over time is provided by the neonatal Krankenhaus Infektions Surveillance 
 29
System (NEO-KISS). NEO-KISS monitors babies with birth weights below 1500g 
cared for in German NICUs, and BSI is defined according to modified CDC criteria. 
Between 2000 and 2005, 24 NICUs each participated in the system for a period of three 
years, and submitted data for a total of 3856 babies. The overall burden of BSI was 8.3 
per 1000 baby-days in the first year of participation, which for most units decreased 
over the study period to give a mean of 6.4 per 1000 baby-days (adjusted odds ratio 
0.73, 95% CI 0.60, 0.89).48 The programme includes biannual feedback to NICUs, 
including comparisons between hospitals and within hospitals over time. The authors 
inferred that taking part in surveillance may motivate NICU staff to reduce the risk of 
BSI. Further evidence for a positive effect of surveillance is provided by a systematic 
review of over 100 randomised controlled trials showing that audit and feedback alone 
produce small to moderate improvements in clinical practice.49,50 
 
When comparative monitoring has been used to trigger sharing of improved practices 
between units, substantial reductions in infection incidence appear to have been 
achieved. Six NICUs in the Vermont Oxford Network, and 52 NICUs in the Hospital 
Corporation of America collaborated in separate but similar projects, both involving the 
sharing of infection control practices, between NICUs with consistently low rates of 
BSI and those with higher rates. Practices shared between units included protocols to 
reduce the contamination of invasive procedures, and to improve the accuracy of BSI 
diagnosis, for example by recommending a minimum blood sample of 1ml. The 
Vermont Oxford Network analysed CONS BSI only, the case definition was a blood 
culture testing positive for this organism, which was accompanied by clinical symptoms 
and treated with antibiotics. For babies of birth weight below 1500g, the mean 
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proportion infected across the participating NICUs decreased from 24.6% to 16.4%, 
from 1997 to 2000 (crude risk ratio 0.67, 95% CI 0.51, 0.87).51,52 Across the Hospital 
Corporation of America network, the total incidence of all BSI, defined by positive 
blood culture, fell from 3.8 to 2.9 per 1000 baby-days, from 1997 to 1999. The average 
hospital cost per baby reduced from $60,826 to $48,916 (risk ratios and 95% CIs for 
decreases not available).53 Neither study could definitively link the observed decreases 
in BSI with their initiatives, or with specific practice changes. It is also unclear to what 
extent decreases in BSI were due to infection control practices, or reductions in false 
positive blood cultures due to improved sampling for BSI. However, the Vermont 
Oxford Network demonstrated that the decrease in BSI was consistent in all but one 
NICU, and that practice changes were widely adopted, suggesting that the collaboration 
succeeded in improving practice. 
 
A weakness of the Vermont Oxford Network and Hospital Corporation of America 
studies described above, is that some of the initial variation in BSI incidence observed 
between NICUs may have been attributable to factors other than quality of care, such as 
case mix, babies’ length of stay and the invasive procedures carried out, all of which 
can influence hospital-acquired infection.54 A robust multicentre monitoring system 
must adjust for these factors, in order to take into account variation in case mix. Any 
residual variation may be explained, at least in part, by factors amenable to change, such 
as hygiene practices. Developing a method for risk adjusting comparisons of BSI 
incidence between NICUs is a major challenge for infection monitoring, and is the 
focus of this thesis. 
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1.5 Aims of the systematic review 
I performed a systematic review to determine: 
 Methods used for risk adjustment in studies that compared infection incidence 
between NICUs 
 How much infection incidence varied before and after risk adjustment 
 The extent to which these approaches for risk adjustment are being used by 
regional surveillance systems for NICU-acquired infection around the world 
 
I discuss different approaches for risk adjustment and suggest ways to improve 
robustness of comparisons. 
 
1.6 Methods of the systematic review 
 
1.6.1 Systematic review of studies reporting risk adjustment 
Studies were included if they reported any measure of the frequency of BSI at more 
than one NICU and comparative results that were risk adjusted. I accepted any approach 
for risk adjustment, including stratification for risk factors, for example reporting 
infections as rates per catheter days, as well as the inclusion of risk factors in a 
statistical risk adjustment model. I accepted any definition for hospital-acquired BSI, 
but excluded studies concentrating on maternally-transmitted BSI in the first few days 
of life.  
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I combined three sets of search synonyms relating to NICU, BSI, and monitoring or risk 
adjustment to search PubMed and Embase databases (with Embase thesaurus mapping) 
in any language until October 2009. All titles and abstracts for potentially eligible 
articles were reviewed. Studies meeting the inclusion criteria were reviewed by myself 
and my primary supervisor. I also searched reference lists and ‘related articles’ of all 
included studies (using PubMed). Abstracts from relevant conferences were reviewed 
from January 2005 to October 2009. The Appendix to Chapter 1 contains details of the 
search strategies. 
 
1.6.2 Review of regional monitoring systems 
As both infections and organisational structures vary greatly among NICUs in 
developing countries, I included only monitoring systems from Europe, North America 
and Australasia to ensure generalisability. The search was performed in Google in 2007 
and updated in October 2009, using short phrases and the region of interest, this is 
described in the Appendix to Chapter 1. 
 
1.7 Results  
 
1.7.1 Systematic review of studies reporting risk adjustment 
 
Case definition  
Ten studies met the inclusion criteria (Figure 1.2).16,18,30,35,36,55-59 Case definitions for 
BSI varied in complexity from a first positive blood culture,16,18 to hospital-acquired 
BSI defined by US CDC criteria.13,56-59 Two studies excluded BSI acquired before 
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NICU admission as they were restricted to blood cultures taken at least 48 hours after 
admission.36,55 CDC criteria state that ‘there must be no evidence that the infection was 
present or incubating at the time of hospital admission’, but give no time threshold.13 
All but two studies57,59 distinguished hospital-acquired from maternally-transmitted 
BSI, using thresholds ranging from 48 to 72 hours after birth.  
 
Risk adjustment 
The third column of Table 1.1 shows that most studies took into account the duration of 
exposure, by reporting incidence per baby days of stay or per CVC days,35,57-59 
sometimes with Cox proportional hazards regression models or Kaplan-Meier analyses 
of time to infection.55,56 Four studies did not take into account length of stay, reporting 
the proportion of babies experiencing one or more BSI.16,18,30,36 Only three studies took 
recurrent infections into account, by reporting rates of BSI per baby or catheter 
days.35,57,59 
 
The fourth to the sixth columns of Table 1.1 summarise adjustment for potential risk 
factors. Adjustment for factors reflecting susceptibility at birth was performed by 
stratifying BSI incidence by birth weight,19,36,59 or by including factors in a risk 
adjustment model.16,18,30,36,55,56,58 Adjustment for procedure-related factors was 
performed by reporting BSI per days with a CVC.35,57,59 Other studies included invasive 
procedures in a risk adjustment model: some factors were included as binary variables 
(eg. CVC: yes/no),56,58 some as durations censored at the onset of BSI or removal of the 
CVC or ventilator,56,58 and others as daily variables which were updated continuously 
during a baby’s stay.55 Adjustment for organisational factors was performed by 
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including factors such as the provision of infection control nurses in a risk adjustment 
model.16,18  
 
Two studies addressed the possibility that differences in blood sampling frequency 
between hospitals could influence comparisons, as the more samples taken the greater 
the risk of detecting asymptomatic BSI or a contaminated sample. The UK Neonatal 
Staffing Study Group (2005) found no association between the ratio of positive to all 
blood cultures and the incidence of BSI or any of their risk adjustment variables. Brodie 
et al. (2000) measured a two-fold variation in the frequency of blood sampling among 
NICUs, but reported that differences in BSI incidence between NICUs remained 
significant when results for the commonest contaminant, CONS, were removed from 
the analysis.  
 
Five studies reported a reduction in the variation between NICUs after risk adjustment 
(third column of Table 1.2). All ten studies showed residual variation in BSI incidence 
between NICUs after risk adjustment. Perlman et al. (2007) also showed variation 
between two NICUs in the adjusted incidence of BSI with gram-positive organisms. In 
contrast, two subgroup analyses by Perlman et al. (2007) showed no significant 
variation in the adjusted incidence of BSI in babies who had at least one CVC placed 
during their NICU stay or in BSI occurring in the presence of a CVC (fourth column of 
Table 1.2).  
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1.7.2 Review of regional monitoring systems  
 
Case definition 
Table 1.3 summarises risk adjustment methods used by the seven regional monitoring 
systems included in the review.17,60-65 Case definitions varied in complexity from a 
positive bacterial culture (excluding cultures for CONS)17 to CDC case definitions,63,64 
while NEO-KISS modified the CDC case definition for use in neonates.15 Four systems 
excluded BSI acquired before NICU admission by including only diagnostic blood 
cultures taken at least 48 hours after admission,60,62 or rejecting infections with evidence 
that they were acquired elsewhere.63,64 Two systems differentiated between maternally-
transmitted and hospital-acquired BSI, using thresholds of 4860 or 7265 hours after birth. 
 
Risk adjustment 
Five systems provided some adjustment for duration of exposure, by reporting 
incidence by catheter days,60,61,63 or by catheter days and baby days of stay.62,64 (third 
column of Table 1.3) 
 
The UK-based NeonIN was the only system not using any method of risk-adjustment. 
As the remaining six systems were based on the original US CDC surveillance system, 
they were remarkably similar. Adjustment for factors reflecting susceptibility at birth 
was performed by stratification into birth weight groups. Adjustment for procedure-
related factors was performed by reporting incidence by catheter days. NEO-CAT 
incorporated several factors in a multivariable risk adjustment model (fourth column of 
Table 1.3). 
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 While most systems did not directly adjust for differences in blood sampling frequency 
between NICUs, their case definitions attempted to control for differences in blood 
sample contamination by, for example, requiring that a positive blood culture be 
associated with clinical symptoms or a CVC.61 The Vermont Oxford Network went 
further in proposing practices to standardise sampling techniques between participating 
NICUs, for example by recommending a minimum blood sample of 1ml.51 
 
Most case definitions combined clinical evidence of infection with blood culture results 
and consequently required active reporting by clinicians. I found no evidence that any 
system exclusively used electronic hospital administrative data.  
 
1.8 Discussion  
Overall, risk adjustment attenuated but did not remove differences in infection incidence 
between NICUs. Residual variation could indicate differences in data quality, 
inadequate adjustment for case mix or procedure-related factors, or true differences in 
incidence. For example, Perlman et al. (2007) showed a significant difference between 
NICUs in overall BSI incidence adjusted for CVC use, but not for the subset of CVC-
related BSI. This suggests that CVC use and study site were linked, and that probably 
the overall analysis was inadequately adjusted for CVC use. The UK Neonatal Staffing 
Study Group suggested that residual variation resulted from differences in quality of 
care. Measures of risk adjusted BSI showed statistically significant associations with 
NICU organisational factors, such as the provision of neonatal consultants and infection 
control nurses, and the availability of hand washbasins. Differences in quality of care 
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may have contributed to the localised outbreak of Staphylococcus epidermidis, which 
Perlman et al. (2007) suggested gave rise to the varying Gram-positive BSI incidences 
between NICUs. There is a consensus that risk adjustment is necessary, feasible and 
effective, but there is no agreement regarding the best method for carrying it out. 
 
This review highlights the need for more consistent outcome measures and risk 
adjustment methods. A Europe-wide survey of hospital infection control physicians 
revealed that their strongest consensus research priority is standardisation of 
surveillance systems for international comparison of hospital-acquired infection 
incidence.66 Consistency in the denominator used is the minimum requirement. Most 
studies and regional monitoring systems reported incidence by baby days or catheter 
days, controlling for variations between NICUs in duration of exposure to infections. 
Incidence rates also capture recurrent infections within the same baby, which is not 
possible if reporting consists of proportions of babies experiencing one or more BSI.  
   
Meaningful comparisons also require consistency in the risk factors adjusted for, and in 
how these are measured and analysed. Most studies and regional monitoring systems 
adjusted for factors measured at birth, such as birth weight, however this does not adjust 
for changes in a baby’s susceptibility throughout his or her NICU stay. Days with a 
CVC can provide such a continuous measure, but they exclude the 80% of NICU babies 
not treated with a CVC,35 who may have widely differing risks of infection. The 
Canadian Neonatal Network Study (2002) (Table 1.1) suggested that only about 40% of 
BSI are CVC-related.35 Holmes et al. questioned the use of CVC days for risk 
adjustment, as their multivariable analysis found parenteral nutrition to be a stronger 
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predictor of BSI than CVC use alone.34 However again, parenteral nutrition is used to 
treat a minority, 24%, of babies in the NICU.67 Continuous composite risk adjustment 
variables may be preferable, capturing multiple risk factors and all babies throughout 
their NICU stay. An example is days of stay at each level of care, which in some 
countries is updated daily and allocated to all babies according to clinical status. Levels 
of care used in the UK National Health Service (NHS) are described in the box below 
and in the Appendix to Chapter 3. The following chapters will examine level of care, as 
well as specific invasive procedures, as risk adjustment factors for comparisons of BSI 
between NICUs. 
 
 
British Association of Perinatal Medicine, Categories of Neonatal Care 
(abbreviated)68 
 
Intensive care 
For babies: receiving any respiratory support via a tracheal tube, less than 29 weeks 
gestational age and less than 48 hours old, requiring complex clinical procedures or 
major surgery. 
Recommended nurse to baby ratio 1:1. 
 
High dependency care 
For babies: receiving parenteral nutrition, requiring care of an intra-arterial catheter, 
with apneoa requiring stimulation. 
Recommended nurse to baby ratio 1:2 
 
Special care 
For babies: requiring continuous monitoring of respiration or heart rate, receiving 
phototherapy, recovering from more specialist care. 
Recommended nurse to baby ratio 1:4 
 
The only regional monitoring system which did not perform risk adjustment was 
NeonIN, which aimed to provide simple, rapid determination of the patterns of 
organisms in NICUs, with data entry by busy clinicians. NeonIN highlights dual 
requirements for NICU monitoring: rapid data collection and feedback and more time-
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consuming comparisons of risk adjusted rates. Both approaches are useful; the former 
can alert clinicians to sudden changes, the latter is essential for quality of care 
benchmarking. For both approaches, the use of routine electronic clinical records would 
accelerate data collection and minimise staff workload, but must be balanced against the 
use of case definitions that include clinical observations, which can require skilled data 
collection and stand-alone data systems. 
 
This systematic literature review was published in the ‘Journal of Hospital Infection’ 
(included in the Publications Appendix).69 The paper does not include the study by 
Perlman et al. (2007), which appeared on PubMed after its acceptance for publication. 
  
Key conclusions of Chapter 1 
Findings 
 Risk adjustment is widely recognised as necessary for meaningful 
comparisons of BSI incidence between NICUs, however there is a lack of 
consistency in the methods used. 
 Most regional monitoring systems agreed that adjustment for duration of 
exposure and susceptibility at birth is a minimum requirement. 
Conclusions 
 Further research should investigate the possibility of adjustment for 
continuous, composite measures of risk from invasive procedures. 
 The use of routine electronic data would accelerate data collection and 
minimise staff workload. 
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Figure 1.1 Number of hospital-acquired BSIs per 1000 patient-days, by 
specialty, in the UK 1997-2002 
 
Nosocomial Infection National Surveillance Service (2002) ‘Surveillance of Hospital-Acquired 
Bacteraemia in English Hospitals 1997-2002’ Public Health Laboratory Service, London, UK. 
Permission to reproduce this graph was confirmed by the Health Protection Agency in January 
2011. 
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Figure 1.2 Flow diagram of the process and results of the systematic 
literature review 
 
 
 
 
 
 
 
 
 
 
 
 
 
4193 rejected after 
scanning titles and 
abstracts 
79 rejected after full 
text review 
10 studies included 0 from conference proceedings 
10 studies 
0 from bibliographies 0 from PubMed 
‘related articles’ 
searches 
6021 studies found 
PubMed: 2373 
Embase: 3648 
Total (minus overlap): 4282 
89 full papers reviewed 
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Table 1.1 Studies comparing risk adjusted BSI incidence between NICUsa 
 
 Outcome measures adjusted for: 
Authors and setting 
(study period) 
Population Outcome measure Birth susceptibility 
factors 
Procedure-related 
factors 
Organisational factors 
Brodie et al, 200055 
6 US NICUs 
(1994-1996,1996-1997) 
 
1354 babies  
with birth weight <1500g 
Time to first BSI after 
admission 
 
Birth weight, SGA Duration of  
Broviac catheter 
parenteral nutrition  
(Daily variables) 
 
No 
1) 19,507 babies35 
 
1) Incidence per CVC days 
 
1) Gestational age, 
outborn status, SNAP-II 
 
1) Duration of CVC  
(by CVC type) 
 
1) No 
 
The Canadian Neonatal     
Network, 2002, 2005 
17 Canadian NICUs 
(1996-1997) 
 
2) 16,497 babies36 
 
2) Proportion of babies 
with ≥1 BSI 
 
2) Birth weight, gestational 
age, outborn status, 
SNAP-II 
 
2) No 
 
2) No 
 
1) Time to first BSI after 
admission 
 
 
1) 3-10 day model: birth 
weight, sex, apgar score, 
respiratory distress 
syndrome, patent ductus 
arteriosus, intraventricular 
haemorrhage 
 
1) 3-10 days:  
       CVC  
       ventilation 
(yes/no variables) 
 
 
1) No 
 
 
 
Carrieri et al, 200356 
21 Italian NICUs 
(1996-1997) 
2160 babies  
with birth weight  
≤1750g 
 
Babies with 15 defined 
‘minor’ conditions excluded 
2) Time to first BSI after 
admission 
2) 10-35 day model: birth 
weight, maximum base 
excess, NEC 
2) 10-35 days:  
Duration of  
CVC 
ventilation 
(censored at onset of BSI) 
 
2) No 
Gaynes et al, 199157 
35 US NICUs 
(1986-1990) 
 
24,480 babies 
 
Incidence per CVC days 
 
Birth weight Duration of CVC No 
The National Institute of 
Child Health and Human 
Development Neonatal 
Research Network 
(NICHD), 200230 
15 US NICUs 
6215 babies 
with birth weight  
401-1500g 
Proportion of babies ≥1 
BSI  
 
 
Birth weight, gestational 
age, sex, ethnicity  
No No 
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(1998–2000) 
  
1) Number of first 
BSI/baby-days before first 
BSI 
1) Birth weight 1) CVC  
Surgery 
Ventilation 
NC-CPAP 
(yes/no variables) 
 
1) No 
2) Among babies treated 
with a CVC at any point:  
 
Number of first BSI/baby-
days before first BSI 
 
2) Birth weight 2) CVC  
Surgery 
Ventilation 
NC-CPAP 
(yes/no variables) 
2) No 
3) Ratio of CVC-related 
BSI vs. non CVC-related 
BSI: 
 
Number of first BSI (CVC-
related)/CVC days before 
first BSI 
 
Number of first BSI (non-
CVC-related)/baby-days 
before first BSI 
 
3) Birth weight 3) Surgery 
Ventilation 
NC-CPAP 
(yes/no variables) 
 
Duration of CVC 
(censored at onset of BSI) 
3) No 
Perlman et al, 200758 
2 US NICUs 
(2001-2003) 
 
2,935 babies 
4) Ratio of BSI with gram-
positive pathogens vs. BSI 
with gram-negative 
pathogens: 
 
Number of first BSI/baby-
days before first BSI 
 
4) Birth weight 4) CVC  
Surgery 
Ventilation 
NC-CPAP 
(yes/no variables) 
4) No 
Stover et al, 200159 
41 US NICUS 
(1997) 
 
No number given Incidence per CVC days 
 
Birth weight Duration of CVC No 
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1) Proportion of babies ≥1 
BSI16 
 
1) Gestational age, SGA, 
sex, mode of delivery, 
diagnostic category, 
antenatal steroids 
1) No 
 
1) Provision of handwash 
basins and infection 
control nurse 
2) Proportion of babies ≥1 
BSI18 
2) Birth model: Gestational 
age, SGA, sex, mode of 
delivery, diagnostic 
category, antenatal 
steroids 
2) No 
 
 
 
2) Low birth weight patient 
volume, provision of 
consultants and nurses 
The UK Neonatal Staffing 
Study Group, 2002, 2005 
54 UK NICUs 
(1998-1999) 
13,334 babies  
<1 month old corrected for 
gestation 
 
3) Proportion of babies ≥1 
BSI18 
 
3) 12hr model: admission 
temperature, blood 
analysis: most extreme 
PaCO2, mean appropriate 
FiO2 and lowest base 
excess 
3) No  
 
 
3) Low birth weight patient 
volume, provision of 
consultants and nurses 
 
a – SGA - small for gestational age, CVC - central venous catheter, SNAP II - Score for Neonatal Acute Physiology II, NEC - necrotising enterocolitis, NC-CPAP - nasal cannula 
continuous positive airway pressure, CVC-related BSI - BSI in the presence of a CVC, with no other identifiable site of infection, non CVC-related BSI - BSI occurring without a 
CVC present, or with another identifiable site of infection. 
Table 1.2 Variation in BSI incidence between NICUs before and after risk adjustment 
Authors Outcome measure Between NICU variation reduced by risk 
adjustment? 
How much residual variation between 
NICUs? 
Brodie et al, 2000 Time to BSI after admission Yes Statistically significant variation between 3/6 
NICUs 
 
1) Incidence per CVC days 1) Yes 1) Statistically significant variation for all CVC 
strata 
The Canadian 
Neonatal Network, 
2002, 2005 
2) Proportion of babies with ≥1 BSI 
 
2) Yes 2) Statistically significant variation for babies 
with birth weight <1500g 
   
1) Time to BSI after admission 1) Unable to determine: no crude measures 
provided 
1) BSI 3-10 days: statistically significant 
variation 
Carrieri et al, 2003 
2) Time to BSI after admission 
 
2) Unable to determine: no crude measures 
provided 
2) BSI 11-35 days: statistically significant 
variation 
Gaynes et al, 1991 Incidence per CVC days 
 
Unable to determine: no crude measures 
provided 
‘Significant between centre differences’, but no 
risk adjusted figures provided 
 
NICHD, 2002 Proportion of babies ≥1 BSI  
 
Unable to determine: no risk adjusted figures 
provided 
‘Statistically significant variation’, but no risk 
adjusted figures provided 
 
1) Number of first BSI/baby-days before first BSI 
 
1) Unable to determine: no crude measures 
provided 
1) Statistically significant variation in the overall 
rate of BSI 
 
2) Among babies treated with a CVC at any 
point:  
 
Number of first BSI/baby-days before first BSI 
 
2) Unable to determine: no crude measures 
provided 
2) No statistically significant variation in the rate 
of BSI among babies treated with a CVC 
Perlman et al, 2007 
 
 
 
3) Ratio of CVC-related BSI vs. non CVC-
related BSI  
 
Number of first BSI (CVC-related)/CVC days 
before first BSI 
 
Number of first BSI (non-CVC-related)/baby-
days before first BSI 
3) Unable to determine: no crude measures 
provided 
3) No statistically significant variation in the ratio 
of CVC-related BSI vs. non CVC-related BSI 
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4)  Ratio of BSI with gram-positive pathogens 
vs. BSI with gram-negative pathogens: 
 
Number of first BSI/baby-days before first BSI 
 
4) Unable to determine: no crude measures 
provided 
4) Statistically significant variation in the ratio of 
BSI with gram-positive pathogens vs. BSI with 
gram-negative pathogens 
Stover et al, 2001 Incidence per CVC days 
 
Yes for babies with birth weight 1501-2500g Variation remained, no information concerning 
statistical significance 
 
1) Proportion of babies with ≥1 BSI 1) Yes 1) Statistically significant variation in odds ratios 
between NICUs with >1 level 1 cot per 
handwash basin and NICUs with <1. More 
handwash basins led to lower outcomes 
 
Statistically significant variation in odds ratios 
between units with an infection control nurse 
and units without. Presence of an infection 
control nurse led to lower outcomes. 
 
2) Proportion of babies ≥1 BSI 2) Birth model: Yes 
 
2) Statistically significant variation for NICUs 
allocated to different strata of consultant 
provision. Lower consultant availability led to 
lower odds ratios. 
 
The UK Neonatal 
Staffing Study 
Group, 2002, 2005 
3) Proportion of babies ≥1 BSI 3) 12hr model: Yes 3) Statistically significant variation for NICUs 
allocated to different strata of consultant 
provision. Lower consultant availability led to 
lower odds ratios. 
 
 
 
 
 
 
Table 1.3 Risk adjustment in regional monitoring systems 
 System and setting (year established) Population Outcome measure Outcome measures adjusted for: 
The Canadian Nosocomial Infection 
Surveillance Program (CNISP)62 
Canada (2006) 
21 hospitals  
 
Babies with a CVC inserted 
Incidence of BSI per 
CVC days 
days of NICU stay  
 
 
Birth weight 
Duration of 
CVC 
NICU stay 
 
National Healthcare Safety Network 
(NHSN), previously the National 
Nosocomial Infections Surveillance 
System (NNIS)64 
USA 
NNIS (1970) 
NHSN (2005) 
 
140 NICUs 
 
Babies with a CVC inserted, or on a 
ventilator 
Incidence per  
CVC days  
days of NICU stayb 
Birth weight 
Duration of  
CVC 
NICU stay 
 
NEOCAT of CCLIN (Centre de 
Coordination de la Lutte contre les 
Infections Nosocomiales)61 
Paris and Western region, France (2006) 
 
9 NICUs 
 
Babies with a CVC inserted for >48hrs 
Incidence per  
CVC days 
 
 
Baby susceptibility factors 
Procedure-related factorsc  
Duration of CVC 
 
NEO-KISS (Krankenhaus Infektions 
Surveillance System)60 
Germany (1997) 
66 NICUs 
 
Babies with birth weight <1500g  
Incidence per  
CVC days,   
peripheral VC daysd,e 
 
Birth weight 
Duration of  
CVC 
peripheral VC 
 
Neonatal Infection Network (NeonIN) 
surveillance database17 
UK (2007) 
 
12 NICUs  
(pending further expansion) 
Frequency of BSI episodesf   None 
Vermont Oxford Network65 
USA, UK (1998) 
700 hospitals  
Babies with birth weight 501-1500g 
Proportion of babies ≥ 1 BSIf Birth weight 
 
VICNISS Hospital Acquired Infection 
Surveillance System63 
Victoria, Australia (2002) 
 
29 hospitals  
 
Incidence per  
CVC days 
peripheral VC days 
 
Birth weight 
Duration of  
CVC 
peripheral VC 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
b - Incidence of pneumonia also reported per ventilator days and days of NICU stay, and stratified by birth weight 
c - Risk adjustment factors summarised for brevity  
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d - Peripheral venous catheter days 
e - Incidence of pneumonia also reported per ventilator days and continuous positive airway pressure days. Incidence of necrotising enterocolitis reported by days of NICU stay 
f - Outcome measures also reported for bacterial infection in cerebrospinal fluid and urine 
 
2. Overview of areas addressed in this thesis 
The main aim of this thesis was to establish risk factors for BSI incidence in NICUs, 
which could be adjusted for in order to give fair and meaningful comparisons of BSI 
incidence between hospitals. The results of various analytic approaches are compared 
and assembled to show a method of risk adjusted BSI monitoring that could be used in 
practice. 
 
The study population comprised all babies admitted to three inner London NICUs from 
2001 to 2005 (the precise months included varied according to the analysis). NICUs 1 
and 2 are level 3 units, with approximately 260 (NICU 1) and 430 (NICU 2) admissions 
each year. NICU 3 is a level 1 to 2 unit, with approximately 250 admissions each year 
(Level 1, 2 and 3 NICUs are defined in the Appendix to Chapter 2).62 All three units 
admit inborn babies and referrals. 
 
All of the surveillance studies and regional monitoring systems reviewed in Chapter 1 
relied on hospital staff entering the required information into a dedicated dataset. This 
study employed electronic, routine clinical records, which could accelerate data 
collection, minimise staff workload and cut costs in monitoring. 
 
I analysed BSI episodes recorded in routine microbiology laboratory data, in relation to 
potential risk factors recorded in NICU administrative data. The potential risk factors 
analysed fell into the following categories: factors reflecting susceptibility to infection 
at birth (for example gestational age, birth weight and inborn/outborn status) and 
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procedure-related factors reflecting susceptibility during the NICU stay (for example 
level of care, total parenteral nutrition and ventilation). 
 
I chose to present a range of analytic approaches for determining risk factors, for two 
reasons. Firstly, methods of data collection varied between NICUs. For example, for 
each baby, procedure-related factors could be recorded for each day of NICU stay, or as 
the sum of days treated with the procedure. This demanded a variety of corresponding 
statistical analyses. Secondly, I found that the most robust methods for determining risk 
factors were not appropriate in the context of routine monitoring, which demanded a 
simpler, more pragmatic approach. I present both simple and more complex methods, to 
assess consistency in their results. Table 2.1 gives a summary of the analytic approaches 
used. Wherever possible, analyses were performed for the hospitals separately and 
combined. This was to assess consistency in the effect of risk factors for BSI between 
NICUs, as well as to profit from a larger sample size with more explanatory power 
when the centres were combined. 
 
I also discuss issues related to monitoring, such as the potential provided by routine 
hospital data, data requirements for monitoring, the establishment of a case definition 
for BSI, and difficulties in differentiating between: true BSI and contaminated blood 
culture results, and maternally-transmitted and hospital-acquired BSI.  
 
Table 2.1 Summary of the analytic approaches used in this thesis  
Chapter and 
analysis 
Dataset BSI episodes 
linked to 
individual 
babies? 
Dates of BSI 
episodes 
analysed? 
Birth 
susceptibility 
factors 
analysed? 
Procedure-
related factors 
analysed? 
Outcome Analytic 
approach 
Relevance to 
NICU monitoring 
Chapter 3 
Aggregated 
analyses 
 
Aggregated 
dataset 
containing 
monthly totals of 
BSI episodes 
and baby-days 
 
No Yes  
(by month only) 
Yes Yes  All BSI episodes 
 
Recurrent BSI 
episodes included 
Analysed monthly 
rates of BSI 
 
Poisson 
generalised linear 
models 
 
Simple risk 
adjusted analyses 
suitable for routine 
monitoring 
Chapter 5 
1) Analyses of 
procedure-
related factors 
recorded as the 
sum of days 
treated  
 
 
1) Babies 
categorised 
according to 
baby 
susceptibility 
factors and the 
number of days 
treated with 
each invasive 
procedure 
 
 
1) Yes 
 
1) No 
 
1) Yes 
 
1) Yes 
 
1) All BSI episodes 
occurring >48 
hours after birth 
 
Recurrent BSI 
episodes included 
 
1) Analysed rates 
of BSI by baby 
 
Poisson 
generalised linear 
models 
 
1) An approach for 
analysing 
procedure-related 
factors recorded 
as the sum of days 
treated (as in the 
British Association 
of Perinatal 
Medicine minimum 
dataset prior to 
2004)  
 
2) Analyses of 
time to the 
development of 
BSI 
2) As above 2) Yes 2) Yes 2) Yes 2) No 2) Number of days 
before first BSI 
episode occurring 
>48 hours after 
birth 
2) Analysed time 
to first BSI episode 
 
Cox regression 
models 
Kaplan-Meier plots 
 
2) Not appropriate 
for monitoring as 
cannot assess risk 
from procedure-
related factors 
Chapter 6 
Analyses of 
factors 
predicting 
infection: 
poisson 
regression 
Dataset with 
each baby-day 
labelled 
according to 
procedure-
related 
exposures in 
Yes Yes Yes Yes, in the three 
days preceding 
a BSI episode 
The first BSI 
episode occurring 
>48 hours after 
birth 
Days with onset of 
a first BSI episode 
divided by total 
days of NICU stay. 
Baby-days 
censored at the 
first BSI episode. 
A robust method to 
determine factors 
predicting BSI. 
Required data 
structure too 
complex for 
monitoring on a 
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the previous 
three days 
 
Poisson 
generalised linear 
models with 
generalised 
estimating 
equations 
 
routine basis 
Chapter 7 
Analyses of 
factors 
predicting 
infection: case 
control study 
Case control 
dataset, with 
censoring ages 
labelled 
according to 
procedure-
related 
exposures in 
the previous 
three days 
 
Yes Yes Yes Yes, in the three 
days preceding 
a BSI episode 
The first BSI 
episode occurring 
>48 hours after 
birth 
Ratio of the odds 
of BSI in cases 
and controls 
 
Conditional logistic 
regression 
As above 
Chapter 8  
1) Method for 
prospective 
monitoring: 
yearly 
standardised 
infection ratios  
 
 
1) Aggregated 
dataset 
containing 
monthly totals of 
BSI episodes 
and baby-days 
 
1) No 
 
1) Yes  
(by year only) 
 
1) Yes 
 
1) Yes 
 
1) All BSI episodes 
occurring >48 
hours after birth 
 
Recurrent BSI 
episodes included 
 
1) Observed 
number of BSI 
episodes/expected 
number of BSI 
episodes 
 
 
 
1) Robust method 
for routine 
monitoring 
2) Method for 
prospective 
monitoring:  
quarterly 
sequential 
probability ratio 
test 
 
2) As above 2) No 2) Yes  
(by quarter only) 
2) Yes 2) Yes 2) As above 2) Observed 
number of BSI 
episodes/expected 
number of BSI 
episodes 
 
Thresholds to 
determine when 
observed deviates 
unacceptably from 
expected 
 
2) As above 
 
3. Simple risk adjusted analyses in electronic 
routine data 
 
3.1 Summary 
Hospital laboratory and administrative data were analysed for admissions over four 
years at two of the inner London NICUs. A dataset was generated of aggregated 
monthly totals of blood cultures, BSI episodes and baby-days for strata of level of care, 
gestational age at birth and hospital. The outcome was BSI episodes per 1000 baby-
days. Level of care, and to a lesser extent, gestational age, were strong risk factors for 
BSI. The rate ratio for BSI, adjusted for gestational age and sampling frequency and 
relative to the baseline, special care, was 3.37 (95% CI 2.38, 4.77) in intensive care and 
4.40 (95% CI 3.15, 6.15) in high dependency care.  
 
I demonstrate how electronic routine National Health Service data could be aggregated 
for BSI monitoring in NICUs. Adjustment of BSI incidence by level of care and 
gestational age could produce risk adjusted rates for meaningful comparisons between 
NICUs. I present simple risk adjusted analyses that could be carried out by routine 
prospective monitoring systems. 
 
3.2 Introduction 
Hospital laboratory and administrative data were analysed for admissions over four 
years at two of the inner London NICUs. As NICUs participating in monitoring have 
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limited time and resources, a dataset was generated which would permit the analysis of 
BSI incidence with minimal data manipulation. This consisted of aggregated monthly 
totals of blood cultures, BSI episodes and baby-days, stratified by potential risk factors 
for BSI. The outcome was BSI episodes per 1000 baby-days at each stratum. 
 
Potential risk factors were analysed in view of their suitability for risk adjusting 
between unit comparisons of BSI incidence. Gestational age at birth and NHS level of 
care were chosen for their existence and reliability in routine administrative records, and 
their likely association with BSI. Data concerning gestational age and level of care are 
routinely recorded and relatively complete because they are used for costing purposes.1 
The association between gestational age and BSI is well-known.30,36 As a standardised 
measure of the intensity of care in NICUs, level of care68 is likely to be associated with 
BSI and has not previously been evaluated in risk adjusted analyses. UK NHS levels of 
care are defined in detail in the Appendix to Chapter 3. I present simple risk adjusted 
analyses that could be carried out by routine prospective monitoring systems. 
 
3.3 Methods 
 
3.3.1 Study population 
Data were analysed for babies who were inpatients at NICU 1 and NICU 2, from the 1st 
of May 2001 to the 28th of February 2005. 
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Records for NICU 3 could not be used in this analysis because they did not contain 
information on level of care for each day of NICU stay (this is explained further in 
Chapters 4 and 5). 
 
3.3.2 Case definition 
An episode of BSI was defined as one or more blood cultures in which the same 
bacterial organism was isolated within a seven day period. For a given baby, multiple 
positive cultures could relate to the same BSI episode. If this was the case, within the 
seven day period, the date of the first blood sample was taken as the date of the episode. 
In neonates, a proportion of blood cultures positive for CONS may reflect 
contamination by skin commensals. Huang et al. (2003) carried out a prospective cohort 
study in a Taiwanese hospital between 1998 and 2001. Of the babies and children 
admitted to the hospital’s neonatal and paediatric intensive care units, 60 experienced a 
total of 67 episodes of CONS-positive blood cultures. Thirty (45%) of these episodes 
reflected contamination, if true BSI was defined as: the same strain of CONS in 
‘sequential’ blood cultures or a positive blood culture accompanied by clinical 
symptoms. ‘Sequential’ blood cultures were not defined, and no information was given 
regarding the reasons for blood sampling. Patients with a blood culture result revealing 
more than one organism were excluded from the analysis.70 To explore BSI potentially 
due to culture contamination, I performed separate analyses for total BSI, CONS, and 
non-CONS BSI. I also adjusted for differences in blood sampling frequency between 
hospitals as I expected that this could influence comparisons. The more cultures taken 
the greater the risk of detecting asymptomatic BSI or a contaminated culture. 
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3.3.3 Creating an aggregated dataset from electronic routine data  
Linkage of administrative records with blood culture records is not routinely performed 
in NICUs. Chapter 4 proposes that records could be linked automatically within the 
hospital to facilitate BSI monitoring. For this chapter, a data manager performed data 
linkage and prepared the data for analysis. Microbiology laboratory records, and records 
from the Patient Administration System (PAS) were extracted from 2/10/1995 to 
19/5/2005 for NICU 1, and from 1/1/2000 to 9/9/2005 for NICU 2. Blood cultures in the 
laboratory records were matched with PAS daily records using baby identity numbers 
and dates. Some blood sample dates fell just outside the corresponding baby’s 
admission period. For these discrepancies in data entry, the rules in Figure 3.1 were 
applied. These rules applied to few blood cultures, 53 (1.18%) of the total 4482 blood 
cultures from NICU 1 and 28 of the 3151 (0.89%) blood cultures from NICU 2. 385 
(8.6%) blood cultures from NICU 1 and 255 (8.1%) blood cultures from NICU 2 did not 
match baby identity numbers or admission periods in PAS records, and were excluded.  
 
17 babies in NICU 1 and 3 babies in NICU 2 had missing gestational ages. For NICU 1, 
gestational ages were recovered for 305 babies from the unit’s separate neonatal dataset. 
Daily records for each baby were aggregated to give monthly totals of blood cultures, 
infection episodes for CONS, non-CONS and total BSI and baby-days at each level of 
care and gestational age group. Datasets for the two hospitals were combined for the 
months for which they both supplied data; Jan 2000 to May 2005 inclusive. Within this 
period, an error in data extraction from the laboratories meant that blood culture data 
were missing for the months of: March to May 2005 for NICU 1; and January 2000 to 
April 2001 for NICU 2, so the data used for the analysis covered the complete months 
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of May 2001 to February 2005. The structure of this aggregated dataset is demonstrated 
in Figure 3.2.  
 
3.3.4 Statistical analyses 
Differences between NICUs were assessed for proportions of babies experiencing one 
or more BSI, proportions of BSI that were recurrent or repeat infections within babies 
(using two-sample Z-tests for proportions), and median length of NICU stay (using the 
Pearson chi-squared test of the equality of medians). 
 
I calculated the rate of BSI per baby days of stay. Poisson generalised linear models 
were fitted to investigate relationships between BSI and level of care, gestational age at 
birth, NICU and the number of blood samples taken. I also examined the relationship 
between BSI and month, in order to detect changes over time. Adjusted models were 
constructed using a forward stepwise model selection strategy, that fitted covariates 
which showed statistically significant relationships (p<0.01) with BSI in crude analyses.  
Goodness of fit was compared between models using Akaike’s information criterion 
(AIC, defined below).71 When the optimal combination of covariates had been defined, 
the AIC was compared between models fitted with and without interactions between 
level of care and gestational age. I also fitted a Poisson generalised linear model to 
examine differences in the number of blood samples taken between NICUs. 
 
The AIC is a parsimonious measure of goodness of fit for an estimated statistical model, 
which describes a trade-off between model precision (a greater log likelihood) and 
complexity (a higher number of parameters). Within a given dataset, competing models 
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may be ranked according to their AIC, with the one having the lowest AIC being 
considered as the best, ie. the model with the fewest parameters that still provides an 
adequate fit to the data. The AIC is defined as: 
 
AIC = - 2ln(L) + 2k 
k = number of parameters in the model 
L = maximised value of the likelihood function71 
 
The analyses were repeated for total, CONS and non-CONS BSI, and for each of the 
hospitals separately and combined. 
 
Monthly rates of total BSI were plotted by level of care for each NICU. Rates were 
aggregated for high dependency and intensive care because they were similar and 
because high dependency care had small numbers of babies for some months. 
 
All analyses for this thesis were carried out using R 2.7.072, Stata 10.073 and Microsoft 
Office Excel 200374 in a Windows environment. 
 
3.4 Results 
There were 208 BSI episodes at NICU 1 and 225 BSI episodes at NICU 2. Table 3.1 
shows the rates of BSI episodes for different organism classes. Similar distributions of 
organisms were found in both NICUs, with CONS predominating. In contrast to all 
subsequent chapters, results for statistical analyses in this chapter included probable 
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maternally-transmitted BSI occurring during the first 48 hours of life. Maternally-
transmitted BSI will be discussed in Chapter 5. 
 
I made a crude comparison between NICUs based on the proportion of babies who had 
one or more BSI episodes during their NICU stay. These proportions differed slightly, 
but non-significantly at the 1% level, for CONS BSI (10.9% for NICU 1 and 8.5% for 
NICU 2, two-sample Z-test p=0.04), and were similar for non-CONS BSI (3.4% for 
NICU 1 and 3.5% for NICU 2, p=0.86). Slightly more recurrent BSI occurred in NICU 
1 compared with NICU 2, but this difference was not statistically significant:  20.8% of 
CONS episodes were recurrences in NICU 1 versus 13.3% in NICU 2 (p=0.07); 1.7% of 
non-CONS episodes were recurrences in NICU 1 versus 1.3% in NICU 2 (p=0.82). The 
median length of stay differed between NICUs (13 days in NICU 1 and 7 days in NICU 
2 (Pearson chi-squared test p<0.001)). Tables 3.3, 3.4 and 3.5 show that crude and 
adjusted rates of BSI did not differ between NICUs and remained stable over time, 
whether measured as total BSI, CONS or non-CONS organisms.  
 
In terms of the AIC, level of care was the strongest single risk factor for BSI, with those 
in high dependency and intensive care being most at risk. Table 3.2 shows how the best 
adjusted model was selected using the AIC. This model included both level of care and 
gestational age at birth. These findings did not change when CONS and non-CONS BSI 
were analysed separately (Tables 3.3, 3.4 and 3.5). No significant interactions were 
found between level of care and gestational age. 
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As expected, gestational age was significantly associated with the rate of BSI in 
adjusted analyses, and this finding remained when CONS and non-CONS BSI were 
analysed separately (Tables 3.3, 3.4 and 3.5). As the last column shows, BSI risk was 
highest in the most premature and in term babies. In comparison, premature babies born 
in the third trimester, between 32 and 37 weeks, had the lowest risk. 
 
The rate of blood sampling per 1000 baby days was significantly higher in NICU 2 
(78.71) than in NICU 1 (61.85); the crude rate ratio was 1.27, (95% CI 1.20-1.35, 
p<0.001). Sampling rate was also significantly associated with the rate of BSI (CONS 
and non-CONS) in crude analyses. These findings suggest that differences in sampling 
rate could confound comparisons of BSI rates between NICUs, so sampling rate was 
included in the adjusted analyses. However, in the final models, its effect was no longer 
statistically significant after adjustment for level of care and gestational age (Tables 3.3, 
3.4 and 3.5). 
 
Most of the above findings remained unchanged when the NICUs were analysed 
separately. However, gestational age was a weaker risk factor for BSI in NICU 1, as its 
relationship with CONS BSI diminished in adjusted analyses. The sampling rate in 
NICU 1 was also significantly associated with CONS BSI in adjusted analyses 
(Appendix to Chapter 3, Tables 3.6 to 3.11).  
 
Figure 3.3 shows monthly rates of total BSI, by level of care for each NICU. 
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3.5 Discussion: the potential of electronic routine data for 
blood stream infection monitoring 
Both hospitals used electronic, rather than paper-based records, which has several 
advantages. Electronic platforms can carry large amounts of information whilst using 
minimal storage space, and can be easily backed-up to prevent loss of data. They can be 
accessed remotely, admit several users simultaneously, and can be accessed in a 
controlled and secure way for data protection, for example by requiring passwords. 
They can also be continuously modified and updated, and exported in electronic format 
ready for analysis. Since 2005, in view of the advantages of electronic data, an NHS 
web platform called Neonatal.net was developed by Clevermed Ltd, and is currently 
used in 70% of UK NICUs.1 Neonatal.net enables real-time electronic entry of patient 
data,75 and was designed to be incorporated into the NHS National Programme for IT 
when this is rolled out nationally.1 
 
In comparison with study-specific data collection, the use of routine hospital data may 
accelerate, facilitate and cut costs in NICU BSI monitoring. Because of this, it may also 
ensure that monitoring is sustainable over the long term. This chapter demonstrates a 
dataset that could be produced by hospital data managers relying exclusively on 
electronic routine data, and it demonstrates how this dataset could be used for risk 
adjusted monitoring of BSI in NICUs. Although the dataset would be suitable for 
monitoring once risk factors for BSI have been established, it had drawbacks for the 
initial identification of risk factors. A structure incorporating more variables was needed 
to evaluate more potential risk factors for BSI. In addition, the dataset could not reveal 
predictive  associations between risk factors and BSI. For example, the association 
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found between level of care and BSI may be due to increased intensities of care 
contributing to  BSI, but increased intensities of care may also be the consequence of 
infections causing babies’ conditions to deteriorate. It would be useful to determine 
predictive factors for BSI, so that clinicians can identify high risk groups who could 
benefit from preventive action or close monitoring. To examine predictive associations, 
analyses must focus on potential risk factors in the days preceding the onset of BSI. 
Chapter 4 describes the preparation of a dataset suited to further exploratory analyses of 
risk factors for BSI and predictive associations. It also describes alternative strategies 
for data linkage, as this chapter revealed that around 8% of blood culture records did not 
match baby identity numbers or admission periods in PAS records. Chapter 4 also 
highlights further aspects of electronic routine data that are necessary if it is to be used 
for BSI monitoring. 
 
The fact that NHS level of care was the strongest risk factor for BSI is not surprising as 
it is by definition a measure of vulnerability. The key implication is that adjustment of 
BSI incidence by level of care may be a simple method to give meaningful comparisons 
between NICUs. More specifically, the results suggest that BSI incidence could be 
stratified by both level of care and gestational age at birth as gestational age was also an 
independent risk factor for BSI in NICU 2. Data on gestational age and level of care is 
standardised across the NHS, routinely recorded and relatively complete and accurate 
because it is used for costing purposes.1 In Chapter 9 I will explain how appropriate 
methods of risk adjustment may change as the availability of data expands. 
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The findings highlight the importance of taking into account length of stay. Median 
length of stay in NICU 1 was nearly twice as long as for NICU 2, so although NICU 1 
may have had a slightly higher proportion of babies experiencing CONS BSI, the two 
units had similar numbers of CONS BSI episodes per days of stay. Despite these 
discrepancies, proportions of babies experiencing one or more infections are used in 
many studies reporting between-NICU comparisons.30,36,52 Incidence rates based on the 
number of BSI episodes divided by the total days of NICU stay may be preferable. 
These take into account differences in length of stay and capture recurrent infections. 
An awareness of length of NICU stay and recurrent BSI would increase clinicians’ 
understanding of reasons for variation between NICUs, in order to target infection 
control more effectively. Recurrent infections represented up to 20% of CONS episodes 
and up to 2% of non-CONS episodes. An increased length of stay may increase the risk 
of BSI, and may be amenable to reduction.  
  
In most analyses, blood sampling rate in the unit was not a significant risk factor for 
BSI, but it was weakly and significantly associated with CONS BSI in NICU 1. This 
suggests that a proportion of the ‘CONS episodes’ recorded for NICU 1 may have been 
an artefact of sampling itself, reflecting contaminated blood cultures. Monitoring 
systems should be aware that differences in sampling frequency can confound 
associations with BSI. A disadvantage of routine data is the lack of clinical symptoms 
which help to differentiate between true BSI and contamination. Reporting rates by 
broad organism groupings, as in this analysis for CONS and non-CONS, may be the 
only way to differentiate between infections more or less likely to represent 
contamination. Reporting rates by finer organism classes would not be practical, as 
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numbers of BSI episodes by year or month would be sparse (as shown in Table 3.1). 
The case definition for BSI, adjustment for sampling frequency and a method for 
differentiating maternally-transmitted from hospital-acquired BSI are discussed further 
in Chapter 5.  
 
Aspects of this analysis have been published in two letters to the ‘Journal of Hospital 
Infection’ (included in the Publications Appendix).76,77 
 
Key conclusions of Chapter 3 
Findings 
 I demonstrated how a dataset relying exclusively on electronic routine data 
could be used for risk adjusted analyses of BSI incidence in NICUs. 
 NHS level of care and gestational age at birth were the strongest independent 
risk factors for BSI. 
Conclusions 
 Electronic routine hospital data has the potential to facilitate long-term 
monitoring of BSI in NICUs. 
 Adjustment of BSI rates by level of care and a factor reflecting susceptibility 
to BSI at birth, such as gestational age, may produce meaningful 
comparisons between NICUs. 
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Figure 3.1 Rules for assigning blood cultures to PAS admission days 
 
 
 
 
 
 
 
 
 
A blood culture can be matched to a PAS admission day if: 
 
1. PAS admission date < Blood sample date < PAS discharge date 
OR 
2. Blood sample date = PAS date of birth & PAS admission date = PAS date of 
birth + 1 
OR 
3. Blood sample date = PAS discharge date + 1 
 
For condition 1, the blood sample date was not altered 
For condition 2, the blood sample was assigned to the PAS admission date 
For condition 3, the blood sample was assigned to the PAS discharge date 
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Figure 3.2 Diagram to describe stays in the NICU for three hypothetical babies over one month, and how these stays would be 
translated into the aggregated dataset 
 
 
Days of May 2001 
at NICU 1 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 … 31 
Baby 1 
Gestational age:  
25 weeks 
Admitted 5/5/01 
Died 12/5/01 
      C 
S 
  NC
S  
 
            
Baby 2 
Gestational age:  
36 weeks 
Admitted 16/5/01 
Discharged 20/05/01 
               C 
S  
 
      
Baby 3 
Gestational age:  
37 weeks 
Admitted 3/5/01 
Discharged 7/5/01 
  C 
S  
 
  
S 
 
                 
Special care  
High dependency  
Intensive care  
CONS infection 
episode 
C 
Non-CONS infection 
episode 
NC 
Blood sample taken 
 
S 
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Figure 3.2 (continued) Aggregated dataset 
    Totals of: 
Hospital Month Level of care Gestational age group 
CONS 
infection 
episodes 
Non-
CONS 
infection 
episodes 
All BSI 
infection 
episodes 
Baby-days 
(denominator) 
Blood 
samples 
takena 
1 May 2001 Special care <26 0 0 0 0 0 
1 May 2001 Special care 26-<28 0 0 0 0 0 
1 May 2001 Special care 28-<32 0 0 0 0 0 
1 May 2001 Special care 32-<37 0 0 0 2 0 
1 May 2001 Special care ≥37 0 0 0 1 0 
1 May 2001 Special care Missing 0 0 0 0 0 
1 May 2001 High dependency care <26 0 0 0 0 0 
1 May 2001 High dependency care 26-<28 0 0 0 0 0 
1 May 2001 High dependency care 28-<32 0 0 0 0 0 
1 May 2001 High dependency care 32-<37 1 0 1 3 1 
1 May 2001 High dependency care ≥37 0 0 0 1 0 
1 May 2001 High dependency care Missing 0 0 0 0 0 
1 May 2001 Intensive care <26 1 1 2 8 2 
1 May 2001 Intensive care 26-<28 0 0 0 0 0 
1 May 2001 Intensive care 28-<32 0 0 0 0 0 
1 May 2001 Intensive care 32-<37 0 0 0 0 0 
1 May 2001 Intensive care ≥37 1 0 1 3 2 
1 May 2001 Intensive care Missing 0 0 0 0 0 
a - Blood samples only stratified by level of care, not by gestational age 
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Figure 3.3 Monthly rates of total BSI and 95% confidence intervals, by level of care for each NICU  
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Table 3.1 Rates of BSI per 1000 baby days (numbers) according to organism groupingsb 
NICU 1 NICU 2 
Year Total 
baby-days 
CONS Group 
B strep 
Other 
GPos 
Gneg Yeasts Total Total 
baby-days 
CONS Group 
B strep 
Other 
GPos 
Gneg Yeasts Total 
2001 4865 4.52(22) 0.41(2) 0(0) 1.03(5) 0(0) 5.96(29) 4843 4.54(22) 0(0) 1.45(7) 1.03(5) 0(0) 7.02(34) 
2002 6838 6.43(44) 0.44(3) 0.88(6) 0.73(5) 0.15(1) 8.63(59) 7723 5.57(43) 0.26(2) 1.68(13) 0.65(5) 0.13(1) 8.29(64) 
2003 7370 4.61(34) 0.27(2) 1.22(9) 0.54(4) 0(0) 6.65(49) 8086 5.44(44) 0.25(2) 0.62(5) 0.87(7) 0.12(1) 7.30(59) 
2004 7315 5.47(40) 0.27(2) 1.09(8) 1.23(9) 0(0) 8.07(59) 8475 5.19(44) 0.59(5) 1.06(9) 0.35(3) 0(0) 7.20(61) 
2005 1292 6.19(8) 0(0) 0.77(1) 1.55(2) 0(0) 8.51(11) 1389 4.32(6) 0(0) 0.72(1) 0(0) 0(0) 5.04(7) 
b - Columns from left to right in each NICU refer to total baby-days, Coagulase-negative staphylococcus, Group B streptococcus, Gram-positive organisms 
other than Group B streptococcus, Gram-negative organisms, Yeasts, total 
 
 
.
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Table 3.2 NICU 1 and NICU 2 combined: forward model selection strategy 
for choosing the best adjusted model for total BSI 
Potential risk factors included in model 
(factors were included if they showed statistically 
significant relationships (p<0.01) with total BSI in 
crude analyses) 
AIC 
Level of care 1524.9 
Gestational age 1636.1 
Number of blood samples taken 1636.7 
Level of care and gestational age 1499.5 
Level of care, gestational age and number of 
blood samples taken 
1498 – lowest AIC indicates the best model 
Level of care interacting with gestational age, 
and number of blood samples taken 
1503.3 
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Table 3.3 NICU 1 and NICU 2 combined: crude and adjusted rate ratios for total BSI 
Potential risk factor 
BSI episodes/baby-days 
(Rate per 1000 baby-days) 
Crude rate ratios 
(95% CI) p-value 
Adjusted rate ratios 
(95% CI) p-value 
         
NHS level of care         
Intensive care 279/23,018 (12.12) 4.16 (3.27, 5.29) <0.001 3.37 (2.38, 4.77)  <0.001 
High dependency care 67/5177 (12.94) 4.11 (2.99, 5.65) <0.001 4.40 (3.15- 6.15)  <0.001 
Special care 87/30,001 (2.90)  1   1  
Total 433/58,196 (7.44)       
         
Gestational age (weeks)         
<26  136/11,977 (11.36) 1.29 (0.99, 1.67) 0.057 0.68 (0.51, 0.92)  0.011 
26-<28 72/7698 (9.35) 1.05 (0.77, 1.42) 0.762 0.62 (0.45, 0.86)  0.004 
28-<32 84/14,604 (5.75) 0.66 (0.49, 0.88) 0.005 0.51 (0.38, 0.69)  <0.001 
32-<37 45/13,038 (3.45) 0.39 (0.28, 0.56) <0.001 0.43 (0.30, 0.61)  <0.001 
≥37 96/10,871 (8.83)  1   1  
Missingc 0/8        
         
Hospital         
NICU 2 225/30,516 (7.37) 0.98  (0.81, 1.19) 0.866    
NICU 1 208/27,680 (7.51)  1     
         
Number of blood samples taken         
Linear increase   1.03 (1.03, 1.04) <0.001 1.01 (1.00, 1.03)  0.062 
         
Month         
Linear increase   1.00 (0.99, 1.01) 0.881    
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Table 3.4 NICU 1 and NICU 2 combined: crude and adjusted rate ratios for CONS BSI 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Potential risk factor 
CONS episodes/baby-days 
(Rate per 1000 baby-days) 
Crude rate ratios 
(95% CI) p-value 
Adjusted rate ratios 
(95% CI) p-value 
         
NHS level of care         
Intensive care 202/23,018 (8.78) 4.36  (3.27, 5.82) <0.001 3.14  (2.07, 4.74) <0.001 
High dependency care 45/5177 (8.69) 4.00  (2.72,  5.89) <0.001 4.39  (2.93, 6.57) <0.001 
Special care 60/30,001 (2.00)  1   1  
Total 307/58,196 (5.28)       
         
Gestational age (weeks)         
<26  96/11,977 (8.02) 1.51  (1.09, 2.09) 0.014 0.80  (0.56, 1.15) 0.222 
26-<28 57/7698 (7.40) 1.37  (0.95, 1.98) 0.089 0.81  (0.55, 1.20) 0.298 
28-<32 65/14,604 (4.45) 0.84  (0.59, 1.20) 0.333 0.65  (0.45, 0.94) 0.021 
32-<37 31/13,038 (2.38) 0.45  (0.29, 0.69) <0.001 0.49  (0.31, 0.75) 0.001 
≥37 58/10,871 (5.34)  1   1  
Missingc 0/8        
         
Hospital         
NICU 2 159/30,516 (5.21) 0.98  (0.78, 1.22) 0.839    
NICU 1 148/27,680 (5.35)  1     
         
Number of blood samples taken         
Linear increase   1.04  (1.03, 1.05) <0.001 1.02  (1.00, 1.03) 0.044 
         
Month         
Linear increase   1.00  (0.99, 1.01) 0.878    
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Table 3.5 NICU 1 and NICU 2 combined: crude and adjusted rate ratios for non-CONS BSI 
Potential risk factor 
Non-CONS episodes/baby-days 
(Rate per 1000 baby-days) 
Crude rate ratios 
(95% CI) p-value 
Adjusted rate ratios 
(95% CI) p-value 
         
NHS level of care         
Intensive care 77/23,018 (3.35) 3.70  (2.38, 5.73) <0.001 4.01  (2.12, 7.60) <0.001 
High dependency care 22/5177 (4.25) 4.34  (2.47,  7.63) <0.001 4.39  (2.43, 7.95) <0.001 
Special care 27/30,001 (0.90)  1   1  
Total 126/58,196 (2.17)       
         
Gestational age (weeks)         
<26  40/11,977 (3.34) 0.96  (0.61, 1.49) 0.848 0.51  (0.31, 0.85) 0.009 
26-<28 15/7698 (1.95) 0.55  (0.30, 1.00) 0.051 0.32  (0.17, 0.61) <0.001 
28-<32 19/14,604 (1.30) 0.37  (0.22, 0.65) <0.001 0.29  (0.17, 0.51) <0.001 
32-<37 14/13,038 (1.07) 0.31  (0.17, 0.57) <0.001 0.34  (0.18, 0.63) 0.001 
≥37 38/10,871 (3.50)  1   1  
Missingc 0/8        
         
Hospital         
NICU 2 66/30,516 (2.16) 1.00  (0.71, 1.42) 0.998    
NICU 1 60/27,680 (2.17)  1     
         
Number of blood samples taken         
Linear increase   1.03  (1.01, 1.04) 0.001 1.00  (0.98, 1.03) 0.763 
         
Month         
Linear increase   1.00  (0.98, 1.01) 0.606    
         
c - Babies with missing variables were few and experienced few episodes of BSI. For this reason I considered it acceptable to remove them from the analyses. 
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4. Methods of data linkage and data 
requirements for monitoring 
 
4.1 Summary 
Further analyses of potential risk factors for BSI required the preparation of a dataset 
with a more complex structure to that described in Chapter 3, including the timing of 
potential risk factors occurring before infection. This chapter describes how I generated 
the more complex dataset, and how I employed various matching strategies to improve 
the linkage of laboratory blood culture records with administrative records. 
 
Using the raw datasets for NICUs 1, 2 and 3, I linked blood culture records with 
administrative records using baby identity number and blood sample date. Records with 
no matches in this first step were linked using other identifiers such as date of birth and 
sex. Between 6% and 18% of blood culture records found no matches in administrative 
data. Datasets were prepared with records for each baby-day, including precise dates of 
BSI episodes and invasive procedures. 
 
The data management was laborious, and it revealed aspects of electronic routine 
hospital data that could be improved to facilitate BSI monitoring. These include a 
common data system for all participating NICUs, automatic linkage of microbiology 
laboratory blood culture records with this common system, and the use of daily patient 
care records.  
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 4.2 Introduction 
As described in Chapter 3, after demonstrating the structure of a dataset suitable for 
routine monitoring, it was necessary to build a more complex dataset to determine risk 
factors for BSI and predictive associations. Factors predicting infection are useful for 
identifying high risk groups that may benefit from close monitoring or infection control 
interventions. To identify potentially predictive relationships, invasive procedures can 
be examined in the few days prior to the development of a BSI episode. The analyses in 
Chapter 3 relied on a dataset of aggregated monthly totals of infections and baby-days, 
for strata of potential risk factors. An analysis of predictive relationships required a 
dataset with a record for each baby-day, including precise dates of procedure-related 
factors and BSI episodes. In addition, as our data manager was unable to match 
approximately 8% of blood culture records with PAS records, I wanted to assess 
whether non-matches on baby identity number, possibly due to data entry errors, could 
be matched using other information, for example name, date of birth and sex. 
 
In this chapter I describe the the development and structure of the raw datasets for 
NICUs 1, 2 and 3, before explaining the procedures I used for data linkage and data 
management at each NICU. The Discussion section relates the structure of the raw 
NICU patient data to requirements for BSI monitoring. Current developments in 
regional shared, electronic routine medical record systems form a background to this 
discussion. 
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4.3 Development and structure of the raw datasets 
Raw datasets for all three NICUs were extracted by hospital data managers in 2005, 
before I started this PhD project in October 2006, except for the separate neonatal 
dataset from NICU 1, which was extracted in December 2006. I wrote to clinicians, a 
microbiologist and a data manager at the three NICUs to enquire about the development 
of the datasets, their responses form the basis of this section (personal communication, 
Dr Paul Ostro, University College London Hospitals NHS Trust, Dr Stephen Kempley 
and Dr Mike Millar, both at Barts and The London NHS Trust and Mayank Patel, Royal 
Free Hampstead NHS Trust). I also visited NICU 1 to learn about its clinical activities 
and data collection processes. 
 
Two types of data systems were used to store administrative and care information: 
Patient Administration Systems (PAS) (NICUs 1 and 2), and separate neonatal data 
systems (NICUs 1 and 3). PAS were used primarily to organise administrative activities 
within the hospital: ordering blood tests and x-rays, organising appointments in clinic, 
producing annual statistics and providing information for costing. PAS data were 
mainly entered by trained ward clerks, using information provided by medical and 
nursing staff. PAS were descended from computerised hospital records installed in the 
1970s, and had been updated in the 1980s at NICU 1 and in the 1990s at NICU 2.  
 
In more recent years separate neonatal data systems were developed specifically for the 
NICU environment at NICUs 1 and 3 to help organise neonatal care, with information 
entered by clinical staff, often by junior doctors. Information concerning blood cultures 
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was stored separately in microbiology laboratory data systems, whose main function 
was to communicate the results of blood cultures to clinical staff. 
 
Table 4.1 shows the structure and content of the raw datasets for all three NICUs. PAS 
data at NICU 1 were structured as a record for each NICU admission with dates and 
times of entry and exit to: the NICU, each level of care and other hospital specialties to 
which babies were admitted. The more modern PAS at NICU 2 incorporated a record 
for each baby-day and recorded procedure-related factors as either present or absent. 
The separate neonatal data systems at NICUs 1 and 3 contained a record for each baby 
including the sum of days treated with procedure-related factors. Microbiology 
laboratory data had a similar structure at all three NICUs, storing the date and result for 
each blood culture.  
 
As PAS had hospital-wide applications, datasets extracted from these systems contained 
dates of discharge to other hospital specialties including surgery. No other information 
was recorded concerning care outside the NICU, so it was unclear how many of these 
periods involved transfer to another hospital. Because NICU 1 provides specialist 
surgical care, we can assume that most babies remained within the hospital. At NICUs 2 
and 3, babies requiring specialist care would mostly have been discharged to a tertiary 
paediatric surgical unit nearby. 
 
 
 
 
 78
4.4 Data linkage for NICU 1 
 
4.4.1 Data linkage 
 
Conversion of Patient Administration System records to daily records 
To match blood culture records with PAS admission days, PAS data had to be expanded 
to contain a record for each baby-day. Entry and exit to each level of care was denoted 
by a date and time, and some levels converged on the same day. For example, baby 
1001 may have exited high dependency care and entered special care on the 11th July 
2002 at midday. To expand the data into baby-days, such days had to be assigned a 
single level of care for simplicity, and I chose to assign the level of care to which the 
baby was entering. For the example above, for baby 1001, the 11th July 2002 would be 
assigned to special care. Another approach would have been to assign the highest level 
of care which the baby experienced that day. For the example above, the 11th July 2002 
would be assigned to high dependency care. However this would have resulted in the 
more intensive levels of care being overrepresented in the dataset. Of the 66,491 baby-
days in the raw PAS data, 64,192 (96.5%) were assigned to NICU levels of care, 1667 
(2.5%) were assigned to other hospital specialties such as paediatrics or the maternity 
ward, and 632 (0.95%) were assigned to surgery.  
 
Linking blood culture records with Patient Administration System records 
Laboratory blood culture records were first linked to admission days in PAS using baby 
identity numbers and blood sample dates (using the rules for assigning blood cultures to 
PAS admission days described in Figure 3.1, Chapter 3). Blood culture records not 
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matching PAS admission days in this first step were matched using date of birth and sex 
(the only identifying information available in the laboratory data) and blood sample 
date. As date of birth and sex did not uniquely identify babies, hospital specialty 
information was also required to match. Of the remaining 264 blood cultures which 
could not be linked to PAS records, 27 tested positive for BSI and only 58 had hospital 
specialty recorded as NICU (either special care, high dependency or intensive care). 
Figure 4.1 summarises the linkage of blood culture records with PAS records, showing 
the numbers matched at each step. 
 
Linking separate neonatal data system records with Patient Administration System 
records  
The separate neonatal data system consisted of an admission dataset and a ventilation 
dataset. The admission dataset consisted of 2570 records (2570 babies). 2458 records 
were matched with babies in PAS records using baby identity number. A further 11 
records were matched using date of birth, sex and date of admission. This left 101 
records unmatched (4.1% of the total separate neonatal admission records). The 
ventilation dataset consisted of records for 1294 babies receiving ventilation, and 971 
could be matched with babies in PAS records using baby identity number. Most of the 
remaining 323 records (25% of the total ventilation records) probably referred to babies 
admitted outside the time period for which PAS records were provided. This cannot be 
assessed as the ventilation records did not contain dates of birth or admission. This also 
meant that these remaining records could not be matched on other identifiers. 
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4.4.2 Data cleaning 
For data fields included in both the PAS records and the separate neonatal data system, 
the PAS information was used for analysis unless variables were found to be missing. 
325 babies had missing gestational ages at birth in PAS records, of which 304 had this 
information recovered from the separate neonatal records. Similarly, 350 babies had 
missing delivery method information in PAS records, of which 299 had this information 
recovered from the separate neonatal data. Data entry errors resulted in three babies 
with years of birth prior to 1980. These were corrected to correspond with the year of 
admission. Four babies had negative numbers recorded for their days with ventilation, 
and these were corrected by calculating the duration of ventilation by subtracting the 
admission date from the extubation date.  
 
4.5 Data linkage for NICU 2 
 
4.5.1 Data linkage 
 
Preparation of Patient Administration System records 
The version of PAS employed by NICU 2 consisted of baby, admission and daily care 
records, which matched up exactly using baby identity numbers. These three datasets 
matched exactly because they formed an integrated system. Baby and daily care 
information could not be entered without an admission record. Unlike data from NICU 
1, data from NICU 2 did not include days spent in other hospital specialties or in 
surgery. These days could be inferred however, if a baby had been discharged from 
NICU then readmitted, using the field concerning where the baby was discharged to. 
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Calculating the days between discharge and readmission I was able to input and label 
these missing days. Of the resulting total 45,727 baby-days, 44,450 (97.21%) were 
assigned to NICU levels of care, 230 (0.50%) were assigned to other hospital 
specialties, 1,025 (2.24%) were assigned to surgery and 22 (0.05%) were missing a 
specialty.  
 
Linking blood culture records with Patient Administration System records  
Laboratory blood culture records were linked to admission days in PAS using baby 
identity numbers and blood sample dates (using the rules described in Figure 3.1, 
Chapter 3). 266 records (8.44% of the total blood culture records) found no matches, of 
which 32 tested positive for BSI. As the laboratory records contained no identifiers 
other than baby identity number, further matching was not possible, as shown in Figure 
4.2. 
 
4.5.2 Data cleaning 
Four babies had dates of birth recorded as occurring after their admission dates. Either 
the date of birth or the admission date was corrected, by checking when babies were 
born and admitted to NICU in the daily care record. 
 
Comparison with the data management described in Chapter 3 for NICUs 1 and 2 
In comparison with the data linkage performed by a data manager for Chapter 3, there 
were discrepancies in the numbers of blood culture records linked by baby identity 
number and sample date for NICU 1 (4097 linked previously versus 4171) and NICU 2 
(2896 versus 2885). There were two reasons for this, firstly our data manager took 
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account of the time of admission or discharge when assigning blood culture records. 
The data providers stated that these times were not reliable so I simply used admission 
and discharge dates. Secondly, I was interested in characterising time spent outside the 
NICU and in surgery, to investigate the BSI risk associated with these phases, and I was 
able to match more blood culture records to these periods, particularly for NICU 1.  
 
4.6 Data linkage for NICU 3 
 
4.6.1 Data linkage  
 
Conversion of neonatal data system records to daily records 
Neonatal data system records for NICU 3 contained admission and discharge dates, but 
did not contain any information concerning days spent in hospital specialties outside the 
NICU or in surgery. The records were expanded to contain a record for each baby day, 
giving 22,480 baby-days.  
 
Linking blood culture records with neonatal data system records  
Figure 4.3 summarises the linkage of blood culture records with neonatal data system 
days. Blood culture records were first linked to admission days using baby identity 
numbers and blood sample dates (using the rules for assigning blood cultures to 
admission days described in Figure 3.1, Chapter 3). Blood culture records not matching 
admission days in this first step were matched using surname, date of birth and sample 
date. As the blood culture and neonatal data system records had many discrepancies in 
the spelling of surnames, babies who could not be matched by name were matched by 
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date of birth and sample date. Further enquiries at NICU 3 revealed that many of the 
microbiology laboratory records were duplicates, existing simply to give further 
information regarding sample bottle type, rather than representing blood cultures 
themselves (personal communication, Mayank Patel, Royal Free Hampstead NHS 
Trust). These duplicates were removed from the matched and unmatched datasets. 333 
records (18.03% of the total remaining blood culture records) found no matches, of 
which 12 tested positive for BSI. 
 
4.6.2 Data cleaning 
One baby had a gestational age recorded as one week, this was changed to missing. 
Thirty-six babies had no admission date, 20 babies had no discharge date and 12 had 
neither. For 19 of those missing an admission date only, this information could be 
imputed from dates of birth. The remaining babies were excluded as their total number 
of admission days could not be calculated for further analyses. Errors in the entry of 
year of admission or discharge resulted in seven babies with lengths of NICU stay 
longer than one year. Errors in year of admission were corrected using year of birth as a 
guide, errors in year of discharge were corrected by summing days at each level of care 
to calculate the length of NICU stay. Three babies had admission or discharge dates 
recorded as occurring before their dates of birth. The erroneous admission or discharge 
dates were changed to the date of birth. 
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4.7 Time coverage, quality and completeness of the final 
datasets for NICUs 1, 2 and 3  
To ensure that datasets for NICU 1 and 2 covered the same time period as the analyses 
in Chapter 3, they were truncated to cover the complete months of May 2001 to 
February 2005. The dataset for NICU 3 was truncated to cover as much of this time 
period as possible, the complete months of May 2001 to July 2004. In contrast to the 
data management in Chapter 3, all complete admissions between the cut-off dates were 
included, rather than all baby-days. For example, consider a baby admitted before the 
cut-off date, on the 26th February 2005, and discharged after it, on the 2nd of March 
2005. The data management process described in Chapter 3 would have excluded the 
last two days of the baby’s NICU stay, whereas the dataset in this chapter would 
exclude the baby’s entire stay. This enabled analyses in which potential risk factors 
were recorded per baby, rather than aggregated per month as in Chapter 3. The structure 
of the resulting datasets, which each contain a record for each baby-day, is shown in 
Figure 4.4. These datasets formed the basis for the statistical analyses in all subsequent 
chapters. 
 
Table 4.2 compares data quality and completeness for various data fields, for the final 
datasets of the three NICUs. In terms of completeness, NICU 3 had the most missing 
data whereas NICU 2 had the least. Numbers of babies with unusual values for 
quantitative data can give an idea of data quality. In particular, 10 of the 1011 babies at 
NICU 1 (0.99%)  had recorded gestational ages above 42 weeks, including one with a 
gestational age of 48 weeks. Seventeen of the 1612 babies at NICU 2 (1.05%) had 
recorded birth weights above 4500g, including one with a reported birth weight of 
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8913g. It is unclear how many of these extreme values represent errors in data entry, so 
they were left unchanged. In the analyses described in following chapters, gestational 
age and birth weight were analysed as categorical variables. For example, the baby with 
a birth weight recorded as 8913g would be categorised in the highest birth weight 
category. This tempered the potential bias presented by such outliers. 
 
4.8 Discussion: further data requirements for blood stream 
infection monitoring in NICUs 
Following the recommendations from Chapter 3 for electronic routine hospital data, the 
data linkage and data management processes in this chapter revealed further aspects of 
data that are necessary or could be improved if they are to be used for BSI monitoring.  
 
It is essential that NICUs participating in monitoring use the same definitions and a 
common system for data capture and storage, to provide fair comparisons between each 
other. Although the three NICUs used similar definitions for most data fields, they 
differed in the extent of information stored concerning time spent away from the NICU. 
This could hinder fair comparisons, for example, of the effect of surgery on BSI. They 
also differed in data completeness and quality, as shown in Table 4.2. Data entry 
systems at NICU 2 incorporated automatic quality checks and mandatory fields, which 
explains the lower proportion of missing data when compared with the other two 
NICUs. Since 1997, the British Association of Perinatal Medicine (BAPM) has 
recommended a ‘minimum dataset’ of baby and unit level information, using common 
definitions, to standardise audits of activity and outcomes.78 In addition, two common 
systems for capture and storage of neonatal data have been developed, which comply 
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with the BAPM minimum dataset and run on the Neonatal.net platform. The 
Standardised Electronic Neonatal Database (SEND) was established in 2004, and is 
currently used in most neonatal units in England, including the NICUs featured in this 
thesis.75,79 The Maternal and Neonatal Electronic Recording System (MANNERS) was 
launched in 2007, and is used by several NICUs in the West Midlands.80 Both systems 
support the day-to-day running of the NICU, for example by producing discharge 
summaries, and enabling patient transfers by locating suitable cots and sharing 
information with other hospitals. They also collect data for audits, such as the National 
Neonatal Audit Programme,81 and for health service commissioning, such as the 
Payment by Results system.82 Thus both SEND and MANNERS are able to support the 
daily activity of units, whilst providing data suitable for fair comparisons between units, 
using common definitions and data entry protocols. Recognising the potential of a 
common, routine administrative data system, the non-risk adjusted NeonIN surveillance 
system17 reviewed in Chapter 1 intends to use SEND for its data capture in the future 
(personal communication, Dr. Paul Heath, St George’s Healthcare NHS Trust).  
 
To support infection monitoring, common data systems must automatically incorporate 
information concerning BSI, to reduce effort, maintain consistency between NICUs and 
improve data completeness and quality. Crude or unadjusted between-NICU 
comparisons of BSI incidence would be feasible without linking administrative and 
blood culture records by baby. Rates could be calculated using aggregated or total BSI 
episodes and baby-days from each data source respectively and separately. However, to 
provide risk adjusted comparisons, blood culture results must be linked to babies’ 
characteristics and invasive procedures recorded in administrative records. Linking 
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blood culture and administrative records for the three NICUs was labour intensive, 
particularly for records not matching on baby identity number and sample date. These 
were linked on identifiers which varied in availability between NICUs, giving 
inconsistencies in the proportion of records matched at each unit. Between 6% and 18% 
of blood culture records found no matches with administrative data and were excluded, 
which may have affected data completeness. At NICU 1, 78% of non-matching blood 
cultures were recorded as having originated from other hospital specialties such as 
‘Well babies’, indicating that they did not actually belong in data extraction for the 
NICU. This may also have been the case for non-matching blood cultures at NICU 2 
and NICU 3 (personal communication, Dr Mike Millar, Barts and The London NHS 
Trust). Unlike identity numbers, names, dates of birth and sex do not uniquely identify 
babies, so matching records on these identifiers has potential for error and consequences 
for data quality. To avoid the pitfalls of data linkage, common data systems could 
incorporate blood culture information as patient records are created. Neonatal staff 
participating in the MANNERS system enter infection and pathogen details in daily 
patient care records. For participation in a monitoring system, the details required would 
depend on the agreed case definition for BSI. The case definition used in this project, 
described in Chapter 3 and justified in detail in Chapter 5, relies solely on blood culture 
results from the laboratory. These could be automatically linked with the common data 
system on a daily basis, to reduce the burden of data entry for neonatal staff and the 
potential for error associated with manual data entry.  
 
Finally, daily patient records provide the best data format for infection monitoring, as 
they record precise dates for factors which change during the NICU stay and they can 
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improve data quality. In the three NICUs, factors which changed during the NICU stay, 
for example level of care and total parenteral nutrition, were recorded in three ways: the 
sum of days treated with the particular factor (NICU 1 and NICU 3), start and end dates 
for treatment (NICU 1) and in daily records (treatment with the factor on each day, 
yes/no) (NICU 2). To provide risk adjusted BSI rates for monitoring, the timing of BSI 
episodes in relation to potential risk factors must be known, to assess their association. 
The sum of days treated with a factor does not convey if treatment coincided with BSI. 
Start and end dates convey more timing information, but do not easily record, for 
example, if treatment was suspended for single days. Daily records precisely convey the 
timing of procedures in relation to BSI episodes, and provide a versatile format which is 
suited to data analysis software. BSI episodes and baby-days can be summed by month 
(as in Chapter 3), by quarter or year, or by days with potential risk factors, depending on 
the requirements of the monitoring system. Daily rather than retrospective data entry 
probably improves data quality, as events are fresh in the minds of staff. There is also a 
stronger incentive to maintain the quality of daily records, as they can provide a ‘live’ 
system for NICU management and neonatal network-wide cot-sharing. Both SEND and 
MANNERS use daily patient records in this way.  
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 Key conclusions of Chapter 4 
 I created datasets for the three London NICUs, suitable for more complex 
analyses of various potential risk factors for BSI and predictive 
associations. 
 The data management process highlighted aspects of data collection that 
differed between NICUs. 
 Retrospective data linkage was time-consuming and between 6% and 18% 
of blood culture records found no matches in administrative data. 
 Daily patient care records conveyed the timing of procedures and BSI 
episodes with the greatest precision.  
 
Conclusions 
Aspects of electronic routine hospital data that are necessary if they are to be used 
for BSI monitoring include: 
 a common data system for all participating NICUs 
 automatic linkage of laboratory blood culture results with this common 
system, avoiding workload and error associated with manual data entry 
 the use of daily patient care records 
 
These recommendations are feasible, as shown by newly developed data systems 
such as SEND and MANNERS. 
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Figure 4.1 NICU 1: linking blood culture records with Patient 
Administration System records 
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3.1) 
264 blood cultures 
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4218 blood cultures (1875 babies) 
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Figure 4.2 NICU 2: linking blood culture records with Patient 
Administration System records 
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Figure 4.3 NICU 3: linking blood culture records with administrative 
records 
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using name, date of birth and 
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rules in Figure 3.1) 1189 blood 
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remaining  
388 blood cultures matched 
using date of birth and sample 
date  
(according to rules in Figure 
3.1) 
3407 blood cultures matched  
 1893 records removed 
from matched category 
and 468 records 
removed from 
unmatched category as 
they were not genuine 
blood culture records 
(refer to section 4.6.1) 1514 blood cultures (126 babies) matched  
 
801 blood 
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Figure 4.4 Diagram to describe stays in the NICU for three hypothetical babies, and how these stays would be translated into a 
dataset with a record for each baby-day 
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Figure 4.4 (continued) Dataset with a record for each baby-day 
Baby Date Gestational age (wks) 
Birth 
weight (g) Sex 
Inborn/ 
Outborn 
Delivery 
method Level of care 
Total 
parenteral 
nutrition 
Ventilation CONS episode 
Non-CONS 
episode 
Blood 
sample 
taken 
1 5/5/2001 <26 700-<1200 Male Inborn Vaginal Intensive care Yes Yes 0 0 0 
1 6/5/2001 <26 700-<1200 Male Inborn Vaginal Intensive care Yes Yes 0 0 0 
1 7/5/2001 <26 700-<1200 Male Inborn Vaginal Intensive care Yes Yes 1 0 1 
1 8/5/2001 <26 700-<1200 Male Inborn Vaginal Intensive care Yes Yes 0 0 0 
1 9/5/2002 <26 700-<1200 Male Inborn Vaginal Intensive care Yes Yes 0 0 0 
1 10/5/2001 <26 700-<1200 Male Inborn Vaginal Intensive care Yes Yes 0 1 1 
1 11/5/2001 <26 700-<1200 Male Inborn Vaginal Intensive care Yes Yes 0 0 0 
1 12/5/2001 <26 700-<1200 Male Inborn Vaginal Intensive care Yes Yes 0 0 0 
2 16/5/2001 32-<37 ≥1200 Female Inborn Vaginal High dependency care No No 1 0 1 
2 17/5/2001 32-<37 ≥1200 Female Inborn Vaginal High dependency care No No 0 0 0 
2 18/5/2001 32-<37 ≥1200 Female Inborn Vaginal High dependency care  No No 0 0 0 
2 19/5/2001 32-<37 ≥1200 Female Inborn Vaginal Special care No No 0 0 0 
2 20/5/2001 32-<37 ≥1200 Female Inborn Vaginal Special care No No 0 0 0 
3 3/5/2001 ≥37 ≥1200 Male Inborn Vaginal Intensive care No No 1 0 1 
3 4/5/2001 ≥37 ≥1200 Male Inborn Vaginal Intensive care No No 0 0 0 
3 5/5/2001 ≥37 ≥1200 Male Inborn Vaginal Intensive care No No 0 0 1 
3 6/5/2001 ≥37 ≥1200 Male Inborn Vaginal High dependency care No No 0 0 0 
3 7/5/2001 ≥37 ≥1200 Male Inborn Vaginal Special care No No 0 0 0 
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Table 4.1 Structure of the raw datasets for NICUs 1, 2 and 3 
Dataset Time period covered Structure 
One record for each: 
Data fields 
NICU 1 
PAS NICU admission Baby identity number, date of birth, name, sex, gestational age at birth, delivery 
method, inborn/outborn status, dates and times of admission and discharge to the 
NICU, dates and times of admission and discharge to each level of care or other 
hospital specialty to which the baby was admitted 
 
Microbiology laboratory Blood culture Baby identity number, date of birth, sex, date the sample was taken, hospital 
specialty where the sample was taken, organism class and genus cultured 
 
Separate neonatal data 
system: admission 
Baby identity number, date of birth, sex, gestational age at birth, birth weight, 
delivery method, date of admission to the NICU 
 
Separate neonatal data 
system: ventilation 
1/1/1996 to 6/3/2005 
Datasets covered various time 
periods. They were truncated 
to cover the minimum period 
for which reliable data was 
received from the microbiology 
laboratory. 
Baby 
Baby identity number,  date of extubation, sum of days treated with: ventilation, 
nasal continuous positive airway pressure  
 
NICU 2 
PAS: baby Baby Baby identity number, date of birth, sex, gestational age at birth, birth weight, 
delivery method, inborn/outborn status 
 
PAS: admission NICU admission Baby identity number, where the baby was discharged to, dates and times of 
admission and discharge 
 
PAS: daily care Day of NICU stay Baby identity number, date, level of care, treatment with: ventilation, total parenteral 
nutrition (yes/no variables) 
 
Microbiology laboratory 
1/1/2000 to 9/9/2005 
Blood culture Baby identity number, date the sample was taken, organism class and genus 
cultured 
 
NICU 3 
Neonatal data system Baby Baby identity number, date of birth, name, sex, gestational age at birth, birth weight, 
delivery method, dates of admission and discharge, sum of days cared for in: 
special care, high dependency care, intensive care, sum of days treated with: nasal 
continuous positive airway pressure, total parenteral nutrition, long line, umbilical 
arterial catheter, umbilical venous catheter 
 
Microbiology laboratory:  
2/3/2001 to 30/7/2004 
Blood culture Baby identity number, date of birth, name, date the sample was taken, organism 
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positive blood cultures class and genus cultured 
 
Microbiology laboratory:  
negative blood cultures 
Blood culture Baby identity number, date of birth, name, date the sample was taken 
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Table 4.2 Data quality and completeness in the final datasets 
 NICU 1 NICU 2 NICU 3 
Time period covered 01/05/2001 to 28/02/2005 01/05/2001 to 28/02/2005 01/05/2001 to 31/07/2004 
Number of babies included 1011 1612 762 
Data completeness: 
Number of babies missing the following data fields (% of babies at each NICU): 
Gestational age at birth 16 (1.58) 0 10 (1.31) 
Birth weight 20 (1.98) 0 9 (1.18) 
Inborn/outborn status 31 (3.07) 0 36 (4.72) 
Sex 0 0 23 (3.02) 
Delivery method 17 (1.68) 5 (0.31) 62 (8.14) 
Data quality: 
Number of babies with gestational age at birth (range in weeks):  
<25 weeks 37 (21, 24) 42 (22-24) 11 (23, 24) 
>42 weeks 10 (43, 48) 3 (43) 0 
Number of babies with birth weight (range in g): 
<500g 6 (376, 493) 6 (356, 485) 3 (458, 480) 
>4500g 4 (4550, 4600) 17 (4576, 8913) 17 (4570, 5294) 
 
 
5. Exploring crude associations between 
potential risk factors and blood stream infection 
 
5.1 Summary 
This chapter explores associations between BSI and potential risk factors reflecting 
susceptibility at birth and between BSI and procedure-related factors which change 
during the NICU stay. The analysis made use of procedure-related factors which were 
recorded as the sum of days treated, and treatment periods of varying length were 
analysed in relation to the development of BSI. 
 
Birth weight and inborn/outborn status were significant independent risk factors for 
NICU-acquired BSI. When compared with babies weighing 1200g or more at birth, the 
rate ratio for BSI adjusted for inborn/outborn status was 2.00 (95% CI 1.54, 2.60) in 
babies weighing 700g to 1200g, and 3.43 (95% CI 2.60, 4.53) in babies weighing less 
than 700g. Babies with lower birth weights and outborn babies also contracted BSI 
earlier upon entry to the NICU. Days of stay in each of the NHS levels of care and days 
of treatment with total parenteral nutrition and ventilation were all significantly 
associated with BSI, however as these factors were correlated they could not be 
analysed together in multivariable models. 
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Birth weight and inborn/outborn status could be used to adjust BSI rates to give risk 
adjusted comparisons between NICUs. More complex analyses are required to explore 
associations between BSI and procedure-related factors.  
 
5.2 Introduction 
This chapter examines crude associations between BSI and procedure-related factors 
which change during the NICU stay, such as level of care and total parenteral nutrition. 
Chapters 6 and 7 will focus on associations which predict infection, by restricting 
analyses to procedure-related factors that preceded BSI episodes. This chapter provides 
a preliminary analysis, by analysing associations between varying durations of 
treatment with invasive procedures, and the development of BSI at any time during the 
NICU stay. This analysis was required to investigate certain procedures which were 
only recorded as the sum of days treated, which would otherwise be lost to the study. 
 
I also included an analysis of associations between BSI and factors reflecting 
susceptibility to infection at birth, such as birth weight and gestational age at birth. This 
analysis included Cox regression models to describe the effects of potential risk factors 
on how quickly babies were infected with BSI upon entering the NICU. 
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5.3 Methods 
 
5.3.1 Study population 
The datasets with records for each baby-day, described in Chapter 4, were used for the 
analysis. Because the dataset for NICU 3 included babies who were admitted on or after 
1st May 2001 and discharged up to and including 31st July 2004, the analyses for the 
other two NICUs were restricted to this time period to enable comparisons between all 
three NICUs. 
 
5.3.2 Case definition and a method to differentiate maternally-transmitted 
from hospital-acquired blood stream infection 
As in Chapter 3, an episode of BSI was defined as one or more blood cultures in which 
the same bacterial organism was isolated within a 7-day period.  
 
A method to differentiate maternally-transmitted from hospital-acquired blood stream 
infection 
The focus of this and the following chapters is on comparing rates of hospital-acquired 
infection between NICUs, to inform infection control practices. There is no easy way to 
differentiate maternally-transmitted from hospital-acquired BSI, apart from using timing 
of infection. Previous studies have used arbitrary thresholds between two and three days 
of age.16,30 I derived a threshold, by exploring age at first BSI episode using finite 
mixture latent class regression models with normally distributed components.83 I used 
the R library flexmix to fit models in this class.84 Because this threshold was to be 
used for the rest of this study, which concentrates mainly on NICUs 1 and 2, only data 
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for these two hospitals were used for its calculation, for the period 1st May 2001 to 28th 
February 2005.  
 
For these analyses I based my model selection strategy on the Bayesian information 
criterion (BIC). Like the AIC described in Chapter 3, Section 3.3.4, the BIC is another 
parsimonious measure of goodness of fit for an estimated statistical model, which 
describes the trade-off between model precision and complexity. Within a given dataset, 
competing models may be ranked according to their BIC values, with the one having the 
lowest BIC being the best. The BIC differs from the AIC in that the penalty for 
additional parameters is larger, thus it is more robust against over-parametrisation. This 
is an important aspect when fitting latent class mixture models, which may have many 
parameters. The BIC is given by: 
 
BIC = -2ln(L) + kln(n)  
L = maximised value of the likelihood function 
k = number of parameters in the model 
n = the number of independent observations used to fit the model, or the sample size85 
 
The optimal model had four components, and I calculated pairwise maximal differences 
in the empirical cumulative probability functions of these components. One of the 
maximal differences was at 2.23 days, indicating that the frequency of first BSI 
episodes drops sharply at this age. I hypothesised that this is due to a shift in the 
aetiology of BSI from maternally-transmitted to hospital-acquired at around day two of 
life. Figure 5.1 shows how this threshold was derived.  
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Figure 5.2 shows the organisms giving rise to BSI episodes by day of life. It also 
indicates a shift in the aetiology of BSI at around day two of life, as CONS, Group B 
streptococcus and Gram positive organisms other than Group B streptococcus show 
marked decreases. The importance of Group B streptococcal infections in the first two 
to three days of life has been described previously.32,86 CONS is less frequently a 
pathogen during this period,86 so the early spike in the number of CONS episodes may 
be partly the result of a high blood sampling frequency. In the first few days of life, 
blood samples may be taken more frequently as part of standard care as babies are often 
in an emergency situation. The blood sampling rate in days 1 and 2 of life (445.07 per 
1000 baby-days, 95% CI 424.32, 466.58) was significantly greater than the rate in days 
3 and 4 of life (70.67 per 1000 baby-days, 95% CI 62.54, 79.57). As described in 
Chapter 3 (Section 3.3.2 and Section 3.5), the more blood samples taken the greater the 
risk of detecting asymptomatic BSI or a blood culture contaminated with a commensal 
organism such as CONS.  
 
To concentrate on hospital-acquired BSI and to reduce blood sampling bias, I excluded 
BSI episodes from the first 48 hours of life. All further analyses in this thesis are based 
on BSI episodes occurring after the first 48 hours of life.  
 
5.3.3 Factors reflecting baby susceptibility at birth 
Babies were divided into categories of gestational age at birth in weeks (<26, 26-<28, 
28-<32, 32-<37, ≥37) and birth weight in grams (<700, 700-<1200, ≥1200). These strata 
were chosen to be comparable with a study by Holmes et al. (2008), which is described 
in Chapter 6.34 I modified this study’s categories by dividing babies with gestational 
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ages above 27 weeks into three categories rather than one, as variability in gestational 
age within this group was found to have a statistically significant relationship with BSI. 
 
Poisson generalised linear models 
I fitted Poisson generalised linear models to investigate relationships between BSI and 
gestational age, birth weight, inborn/outborn status, hospital, sex and delivery method. 
Adjusted models were constructed using forward fitting of covariates which showed 
statistically significant relationships (p<0.01) with BSI in crude analyses. As gestational 
age at birth and birth weight were correlated, separate adjusted models were built for 
each of these variables. Goodness of fit was compared between models using the AIC.  
 
Analyses of time to the development of blood stream infection 
Cox regression models were fitted to investigate relationships between potential risk 
factors reflecting susceptibility at birth, and the time to infection with a first BSI 
episode. Babies entered this analysis at the latest date of either their NICU admission or 
day three of life, and exited it at the earliest date of their first BSI episode or discharge 
from the NICU. The construction of multivariable models proceeded as for the Poisson 
generalised linear models described above. Kaplan-Meier plots were used to display 
time to BSI, for strata of risk factors shown to have a statistically significant effect on 
BSI in the Cox regression multivariable models. 
 
5.3.4 Procedure-related factors which change during the NICU stay 
This analysis made use of procedure-related potential risk factors which were recorded 
as the sum of days of treated (refer to Chapter 4, ‘Data fields’ section of Table 4.1), 
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rather than dates starting and stopping treatment, or daily records. These comprised all 
of the procedure-related variables for NICU 3 (level of care, total parenteral nutrition, 
ventilation, nasal continuous positive airway pressure (CPAP), long line, umbilical 
arterial catheter, umbilical venous catheter), and two for NICU 1 (total parenteral 
nutrition and ventilation). For this analysis, the remaining procedure-related variables 
(level of care at NICU 1 and all procedure-related variables at NICU 2) were converted 
to this format, by summing days of treatment using the records for each baby-day in the 
three datasets created in Chapter 4. Babies were categorised according to their number 
of days treated with each procedure-related factor (0, 1-3, 4-6 and ≥7 days). Again, 
these strata were chosen to be comparable with Holmes et al. (2008), who judged that 
the maximum time from BSI to the manifestation of clinical symptoms was about three 
days.34 Babies were also categorised according to number of blood samples taken (0-3, 
4-6, ≥7). By definition, babies with no blood samples taken had no BSI episodes, so 
they were grouped with babies with one to three blood samples. The structure of the 
datasets used, with babies categorised according to the sum of days treated with each 
invasive procedure, is demonstrated in Figure 5.3. 
 
Poisson generalised linear models 
I fitted Poisson generalised linear models to investigate relationships between BSI and 
procedure-related factors, which varied in availability between NICUs. Procedure-
related factors were not combined in multivariable models, as they were highly 
correlated.  
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It was not possible to analyse time to the development of BSI with procedure-related 
factors. As procedure-related factors were recorded as the sum of days treated for this 
analysis, their timing was not recorded in relation to BSI episodes. 
 
All analyses were repeated for total BSI, CONS and non-CONS BSI. Poisson regression 
analyses were repeated for the NICUs separately as well as combined. 
 
5.4 Results 
 
5.4.1 Factors reflecting baby susceptibility at birth 
 
Poisson generalised linear models 
There were no significant differences between NICUs in BSI rates per 1000 baby-days, 
whether measured as total BSI (6.14 at NICU 1, 6.29 at NICU 2 and 5.24 at NICU 3), 
CONS (4.42 at NICU 1, 4.53 at NICU 2 and 4.41 at NICU 3) or non-CONS (1.72 at 
NICU 1, 1.77 at NICU 2 and 0.83 at NICU 3) infection episodes (refer to Tables 5.1, 
5.2 and 5.3). It is important to note that, despite the relatively large sample size (2562 
babies and 58,046 baby-days), these rate ratios are underpowered. A power of 80% or 
above is desirable, but for the analysis of total BSI,  this would have required between 
double and triple the sample size obtained (between about 5000 and 8000 babies, or 
between 115,000 and 180,000 baby-days), which was not feasible for this study. Figure 
5.4 demonstrates this for total BSI rate ratios at NICU 1 and NICU 2. It shows that even 
with twice the sample size studied, the power to detect a rate ratio of two for NICU 2 
compared with NICU 1 would still only be about 45%.  
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 Gestational age at birth, birth weight and inborn/outborn status were significantly 
associated with total BSI in crude analyses. As in the analyses for Chapter 3, BSI risk 
was highest in the most premature and in term babies. Preterm babies born in the third 
trimester, between 32 and 37 weeks, had the lowest risk. Babies with birth weights 
below 1200g were at increased risk for BSI, as were babies transferred to the NICU 
from another hospital after birth. Birth weight increased with gestational age (Figure 
5.5). As these two factors were correlated they could not be combined in the same 
multivariable model. In terms of the AIC, the optimal adjusted model included birth 
weight and inborn/outborn status (Table 5.1).  
 
These findings broadly remained when CONS and non-CONS BSI were analysed 
separately, except that non-CONS BSI was not significantly associated with 
inborn/outborn status (Tables 5.2, 5.3). When the NICUs were analysed separately, 
gestational age was a weaker risk factor for BSI in NICU 1 and NICU 2. Inborn/outborn 
status had no significant effect on non-CONS BSI at either NICU 1 or NICU 2, or on 
any BSI at NICU 3. As the study population at NICU 3 was relatively small, it 
contained too few non-CONS BSI episodes to permit some stratified analyses (Tables 
5.10 to 5.18, Appendix to Chapter 5). 
 
Neither sex nor delivery method had significant effects on total BSI, CONS or non-
CONS infection episodes. 
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 Analyses of time to the development of blood stream infection 
The results shown in Table 5.4 are based on hazard rates, which for any point in time, 
describe the rate of first BSI episodes in the group of babies currently being observed. 
The hazard ratios compare rates at which babies are experiencing first BSI episodes, for 
different strata of various potential risk factors. For example, a hazard ratio of 2 
indicates twice the instantaneous rate of first BSI episodes in relation to the baseline 
comparison group. Hazard ratios can be interpreted as comparisons of the time to first 
BSI episode between strata. There were no significant differences between NICUs in 
the time to first BSI episode after admission to the NICU, whether measured as total 
BSI, CONS or non-CONS infection episodes. 
 
Gestational age, birth weight and inborn/outborn status were significantly associated 
with total BSI in crude analyses. In terms of the AIC, the optimal adjusted model 
included birth weight and inborn/outborn status (Table 5.4). Again, these findings 
remained when CONS and non-CONS BSI were analysed separately, except that non-
CONS BSI was not significantly associated with inborn/outborn status in crude analyses 
(Tables 5.5, 5.6). Figures 5.5 to 5.9 illustrate differential time to infection in strata of 
birth weight and inborn/outborn status for all BSI and CONS BSI, and in strata of birth 
weight for non-CONS BSI. The proportion of babies without BSI decreased over time. 
This decline was steeper for the more common CONS BSI than for non-CONS BSI. 
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5.4.2 Procedure-related factors which change during the NICU stay 
Procedure-related factors were highly positively correlated (p<0.001), an increase in 
one was significantly associated with increases in the others (Figure 5.5), so these 
factors could not be combined in multivariable models. 
 
Poisson generalised linear models 
Throughout this section, days of stay at each level of care and days of treatment with 
each invasive procedure are referred to as ‘short’ (1 to 3 days), ‘medium’ (4 to 6 days) 
or ‘long’ (7 or more days) periods. Risk ratios are expressed in relation to the baseline 
of 0 days, or no exposure to the procedure-related factor. 
 
Each level of care was strongly associated with total BSI, and BSI rates increased with 
the intensity of care. Any time spent in special care was associated with a halving in the 
risk of BSI. Long stays in high dependency care were associated with an increase in the 
risk of BSI by 50%. For intensive care, the risk of BSI increased between two-fold for 
short stays and four-fold for long stays (Table 5.7). These findings broadly remained 
when CONS and non-CONS BSI were analysed separately. However for non-CONS 
BSI, short and medium stays in special care were associated with a weaker protective 
effect and long stays in intensive care were associated with a greater risk (Tables 5.8 
and 5.9). When the NICUs were analysed separately, special care had no significant 
effect on any BSI at NICU 1. Intensive care had no significant effect on non-CONS BSI 
at NICU 2. The effect of intensive care appeared to be particularly strong at NICU 3. 
Compared with no days spent in this level, long stays were associated with an eleven-
fold increase in the risk of total BSI (Tables 5.19 to 5.27, Appendix to Chapter 5). As 
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the study population at NICU 3 was relatively small, the high rate ratios observed for 
some potential risk factors were accompanied by large confidence intervals. 
 
Information concerning specific procedure-related factors varied in availability between 
NICUs. Total parenteral nutrition was strongly associated with both CONS and non-
CONS BSI at the two NICUs where its use was recorded. At NICU 2, long periods of 
treatment with total parenteral nutrition were associated with a four-fold increase in the 
risk of total BSI. This association appeared to be stronger at NICU 3, where risk 
increased between eight and eleven-fold, depending on the length of treatment. Long 
periods of ventilation were associated with a three-fold increase in the risk of total BSI 
at all three NICUs. When the NICUs were analysed separately, ventilation was not 
significantly associated with CONS BSI at NICU 1, nor with non-CONS BSI at NICU 
2. Again associations with ventilation appeared to be stronger at NICU 3, with between 
three and seven-fold increases in BSI risk, depending on the length of treatment (Tables 
5.7 to 5.9 and Tables 5.19 to 5.27, Appendix to Chapter 5). 
 
Nasal continuous positive airway pressure was recorded at NICUs 1 and 3. It was not 
associated with any BSI at NICU 1, but long periods of treatment were associated with 
a three-fold increase in total BSI at NICU 3. Treatment with a long line, an umbilical 
arterial catheter or an umbilical venous catheter was recorded at NICU 3 and all three 
procedures were associated with increased risks of BSI. Surgery was recorded for 
NICUs 1 and 2 and was associated with a two-fold increase in the risk of total BSI, 
compared with no surgery (Tables 5.19 to 5.27, Appendix to Chapter 5). The number of 
blood samples taken was strongly associated with the risk of total BSI; in relation to 0 
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to 3 blood samples, 4 or more blood samples were associated with a four to five-fold 
increase in the risk of total BSI (Table 5.7).  
 
5.5 Discussion 
Of the factors reflecting baby susceptibility at birth, birth weight and inborn/outborn 
status were the strongest risk factors for BSI in both Poisson and Cox regression 
multivariable analyses. Babies with lower birth weights and outborn babies were at 
greater risk of developing BSI, and they also developed BSI earlier upon entering the 
NICU. This indicates that BSI rates could be adjusted for these two risk factors to 
compare rates between NICUs. I found no significant differences between NICUs in 
either total BSI, CONS or non-CONS infection rates. In contrast to Chapter 3, the 
analyses in this chapter included more potential risk factors reflecting baby 
susceptibility at birth, and found birth weight to be a stronger risk factor for BSI than 
gestational age at birth. In crude analyses for both chapters, babies born in the third 
trimester but before term (28-<32 or 32-<37 weeks gestation), were at lowest risk for 
BSI. This has not previously been reported but is plausible, as these babies are usually 
admitted to NICU for observation and help with feeding, but are otherwise healthy and 
not requiring invasive procedures. In contrast, more premature and term babies may be 
more prone to infection, either from extreme prematurity, or in term babies, from other 
serious complications such as congenital anomalies which may require invasive surgical 
care.  
 
Most procedure-related factors were found to be strongly associated with BSI and the 
risk of BSI increased with the intensity of care. Babies spending any time in special care 
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had a lower risk of BSI than babies who spent no time in special care. This is because, 
by definition, babies who spent no time in special care were exclusively looked after in 
the more intensive levels. In high dependency and intensive care, BSI risk increased 
with the duration of care, and intensive care was associated with the greatest risk. 
 
These analyses enabled exploration of risk factors recorded only as the sum of days 
treated. It also provided a simple exploration of risk factors which change over time, by 
analysing associations between treatment periods of varying length, and the 
development of BSI at any time during the NICU stay. Disadvantages of these analyses 
include the fact that factors analysed in this way were correlated with each other. As 
sicker babies received more intensive care and spent longer in the NICU, their days of 
stay at each of the levels of care and days of treatment with intensive procedures were 
positively correlated. It was therefore impossible to perform multivariable analyses, and 
associations found in univariable analyses may be subject to many confounders. For 
example, the association between BSI and total parenteral nutrition may be due to the 
fact that more vulnerable babies were treated with parenteral nutrition in the first place, 
or may be due to another invasive procedure correlated with parenteral nutrition, rather 
than to any effect of parenteral nutrition itself. Babies with longer periods of treatment 
with procedure-related factors spent more time in the NICU, which would also increase 
the probability of succumbing to BSI, as shown by the Kaplan-Meier plots.  
 
Because the timing of procedure-related factors in relation to BSI episodes was not 
taken into account, associations between them may reflect either cause or consequence. 
The procedure may contribute to the infection, or the procedure may have been 
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necessary as a result of deteriorating symptoms of infection. The disadvantages I have 
described in this and the preceding paragraph illustrate the limited value of factors 
recorded as the sum of days treated. Recognising this, the BAPM revised its 
recommendations for the neonatal ‘minimum dataset’ in 2004, to include daily records 
rather than the sum of days treated with procedure-related factors. It recommended daily 
recording of invasive procedures, such as parenteral nutrition, and all other factors 
necessary for defining NHS levels of care.87 Chapters 6 and 7 provide more complex 
analyses, using daily records of procedure-related factors and a method which enabled 
the levels of care to be analysed in the same multivariable model. These analyses 
described procedure-related factors which predict infection, as they were restricted to 
risk factors that preceded BSI episodes. 
 
In contrast to the analyses in Chapter 3, blood sampling frequency was strongly 
associated with BSI rates. This is because this chapter analysed the relationship between 
blood sampling frequency and BSI in individual babies, whereas Chapter 3 analysed 
this relationship at the unit level. Within individual babies, the number of blood samples 
taken was, by definition, strongly correlated with the number of BSI episodes, as blood 
samples were used to diagnose infection and to monitor the response to treatment. 
Within units, blood sampling frequency and BSI were less strongly correlated, as the 
experiences of many babies were combined. In addition, in Chapter 3, the relationship 
between blood sampling frequency and BSI rates was adjusted for the confounding 
effects of gestational age and days spent at each level of care. As my project focused on 
differences in BSI rates at the unit level, the approach for Chapter 3 was most relevant. 
This approach found that blood sampling rate was not a risk factor for total BSI.  
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 As mentioned in Chapter 1, previous studies have used clinical symptoms to 
differentiate between ‘true’ BSI and contamination. However, Gastmeier et al. (2008) 
warn that differences between hospitals in the sensitivity and specificity of clinical 
diagnoses may lead to differences in HAI rates that are not necessarily associated with 
infection control. They chose 10 case studies from real adult patient records, including 
13 HAI defined by CDC criteria and agreed upon by an expert panel. In 169 adult 
intensive care units participating in the German Krankenhaus Infektions Surveillance 
System (KISS), the diagnosis of HAI for the case studies ranged in sensitivity from 31% 
to 100% (median 69%) and ranged in specificity from 65% to 100% (median 94%).88 
As mentioned in Chapter 3, Section 3.5, reporting BSI rates by organisms, for example 
by CONS and non-CONS, may be the only way to differentiate between infections 
more or less likely to represent contamination using routine data. Reporting rates of 
CONS may also be useful for monitoring and addressing contamination itself, as false 
positive blood cultures can lead to increased antibiotic use and longer durations of 
hospital stay. As results for CONS and non-CONS were similar, I focus on total BSI in 
the following four chapters. 
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 Key conclusions of Chapter 5 
Findings  
 Birth weight and inborn/outborn status were strong independent risk factors 
for BSI. 
 NHS levels of care and other procedure-related factors may be strongly 
associated with BSI. 
 Recording the sum of days exposed to procedure-related factors had limited 
value for risk adjusted analyses. 
 Differences in sampling frequency did not confound comparisons of BSI 
rates between NICUs.  
Conclusions 
 Birth weight and inborn/outborn status could be used to adjust BSI rates to 
give risk adjusted comparisons between NICUs. 
 More complex analyses are required to determine if BSI rates could be 
adjusted by days at each level of care, or days with other procedure-related 
factors, to give risk adjusted comparisons between NICUs. 
 A monitoring system for hospital-acquired BSI in NICUs employing routine 
data could rely on rates of CONS, non-CONS or total BSI occurring after the 
first 48 hours of life. 
 
 
 115
Figure 5.1 Deriving a threshold to differentiate between maternally-
transmitted and hospital-acquired BSI 
 
Age at first BSI episode was explored using finite mixture latent class 
regression models. These were fitted with up to five components, and models 
were compared using the BIC. 
 
Number of components in model BIC 
1 2761.40 
2 2503.80 
3 2480.70 
4 2351.63 – lowest BIC indicates the best model 
5 2351.64 
 
Cumulative probabilities of the four model components against age at first 
BSI episode 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Maximal difference in cumulative probability between component 1 and 
component 2 
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Figure 5.2 Organisms giving rise to BSI episodes by day of life. Graph 
includes babies admitted to NICUs 1 and 2 between May 2001 and 
February 2005 inclusive 
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Figure 5.3 Diagram to describe stays in the NICU for three hypothetical babies, and how these stays would be translated into a 
dataset with babies categorised according to the sum of days exposed to each procedure-related factor 
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Figure 5.3 (continued) Dataset with babies categorised according to the sum of days exposed to each procedure-related factor 
Number of days treated in/with: 
Baby Gestational age (wks) 
Birth 
weight (g) Sex 
Inborn/ 
Outborn 
Delivery 
method Special care 
High 
dependency 
care  
Intensive 
care 
Total 
parenteral 
nutrition 
Ventilation 
Total 
CONS 
episodes 
Total 
non-CONS 
episodes 
Total  
baby-
days 
Total 
blood 
samples 
taken 
1 <26 700-<1200 Male Inborn Vaginal 0 0 ≥7 ≥7 ≥7 1 1 8 0-3 
2 32-<37 ≥1200 Female Inborn Vaginal 1-3 1-3 0 0 0 1 0 5 0-3 
3 ≥37 ≥1200 Male Inborn Vaginal 1-3 1-3 1-3 0 0 1 0 5 0-3 
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Figure 5.4 Graphs showing statistical power for increasing sample sizes 
and rate ratios, for total BSI.  
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Each plot corresponds to a multiple of the sample size. The contour lines show 
the statistical power to detect hypothetical rate ratios for total BSI incidence at 
each NICU. To read each graph, find the intersection of the rate ratios of 
interest, and read the statistical power on the corresponding contour line. For 
example, if the sample size was doubled, the statistical power to detect a rate 
ratio of two at NICU 2 and one at NICU 1 would be about 45%.  
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Figure 5.5 Graphs showing correlations between potential risk factorsb, c 
 
Factors reflecting baby susceptibility at birth 
Correlation coefficient = 0.85
0
1000
2000
3000
4000
5000
6000
7000
8000
9000
10000
20 25 30 35 40 45 50
Gestational age (weeks)
B
irt
h 
w
ei
gh
t (
g)
 
 
 
 
 
 
Procedure-related factors 
Correlation coefficient = 0.67
0
20
40
60
80
100
120
140
160
0 100 200 300 400 500 600 700
Total days in intensive care
To
ta
l d
ay
s 
tr
ea
te
d 
w
ith
 T
PN
 Correlation coefficient = 0.70
0
50
100
150
200
250
300
350
0 50 100 150
Total days treated with TPN
To
ta
l d
ay
s 
ve
nt
ila
te
d 
 
 
 
 
Correlation coefficients: 
 
+1 indicates positive correlation 
-1 indicates negative correlation 
0 indicates no correlation 
 
For all correlations, p-value for the null hypothesis of no correlation was <0.001 
(H0=correlation coefficient of 0)  
 
b - Outliers were identified for some variables, for example one baby had a birth weight of 
8913g, another baby was in intensive care for 600 days. As mentioned in Chapter 4, it was 
often unclear whether extreme values represented errors in data entry, so they were left 
unchanged. Factors were analysed as categorical variables, which tempered the potential bias 
presented by outliers. 
c - TPN- total parenteral nutrition 
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Figure 5.6 Kaplan-Meier estimates showing time to infection with total BSI, 
by birth weightd 
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Figure 5.7 Kaplan-Meier estimates showing time to infection with total BSI, 
by inborn/outborn statusd 
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Figure 5.8 Kaplan-Meier estimates showing time to infection with CONS 
BSI, by birth weightd 
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Figure 5.9 Kaplan-Meier estimates showing time to infection with CONS 
BSI, by inborn/outborn statusd 
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Figure 5.10 Kaplan-Meier estimates showing time to infection with non-
CONS BSI, by birth weightd 
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d - The y-axis shows the proportion of babies in the NICU population who had never 
experienced a hospital-acquired BSI episode (total BSI, CONS or non-CONS, depending on the 
graph). The x-axis shows the number of days since NICU admission or day 3 of life, whichever 
came first. Vertical tick marks indicate when an uninfected baby was discharged from the NICU. 
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Table 5.1 Poisson regression models for the effect of birth susceptibility factors on total BSI, for NICUs 1, 2 and 3 
Potential risk factor 
BSI episodes/baby-days 
(Rate per 1000 baby-days) 
Crude rate ratios 
(95% CI) p-value 
Adjusted rate ratios 
(95% CI) p-value 
         
Gestational age (weeks)         
<26 117/10,101 (11.58) 2.57 (1.85, 3.58) <0.001    
26-<28 55/7097 (7.75) 1.71 (1.17, 2.51) 0.006    
28-<32 88/16,369 (5.38) 1.18 (0.83, 1.67) 0.347     
32-<37 37/14,331 (2.58) 0.55 (0.36, 0.84) 0.006    
≥37 50/10,090 (4.96)  1     
Missinge 0/58        
         
Birth weight (g)         
<700 104/8543 (12.17) 3.65 (2.79, 4.78) <0.001 3.43 (2.60, 4.53) <0.001 
700-<1200 135/18,792 (7.18) 2.15 (1.67, 2.77) <0.001 2.00 (1.54, 2.60) <0.001 
≥1200 108/30,658 (3.52)  1   1  
Missinge 0/53        
         
Where born         
Outborn 101/11,389 (8.87) 1.73 (1.37, 2.18) <0.001 1.28 (1.01, 1.63) 0.041 
Inborn 242/46,197 (5.24)  1   1  
Missinge 4/460        
         
Hospital         
NICU 3 76/14,499 (5.24) 0.85 (0.64, 1.13) 0.254    
NICU 2 146/23,199 (6.29) 1.02 (0.80, 1.29) 0.890    
NICU 1 125/20,348 (6.14)  1     
         
Sex         
Male 182/29,940 (6.08) 1.03 (0.83, 1.27) 0.811    
Female 165/28,030 (5.89)  1     
Missinge 0/76        
         
Delivery method         
Emergency CSf 145/22,096 (6.56) 1.11 (0.89, 1.39)  0.357    
Elective CSf 43/9251 (4.65) 0.78 (0.56, 1.10)  0.154    
Vaginal 156/26,144 (5.97)  1     
Missinge 3/555        
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Table 5.2 Poisson regression models for the effect of birth susceptibility factors on CONS BSI, for NICUs 1, 2 and 3 
Potential risk factor 
CONS BSI episodes/baby-days 
(Rate per 1000 baby-days) 
Crude rate ratios 
(95% CI) p-value 
Adjusted rate ratios 
(95% CI) p-value 
         
Gestational age (weeks)         
<26 82/10,101 (8.12) 2.50 (1.69, 3.70)  <0.001    
26-<28 43/7097 (6.06) 1.86 (1.20, 2.90)  0.006    
28-<32 70/16,369 (4.28) 1.30 (0.87, 1.95)  0.194    
32-<37 28/14,331 (1.95) 0.58 (0.35, 0.94)  0.029    
≥37 36/10,090 (3.57)  1     
Missinge 0/58        
         
Birth weight (g)         
<700 76/8543 (8.90) 3.61 (2.63, 4.93)  <0.001 3.36 (2.43, 4.65) <0.001 
700-<1200 103/18,792 (5.48) 2.21 (1.65, 2.96)  <0.001 2.04 (1.50, 2.76) <0.001 
≥1200 80/30,658 (2.61)  1   1  
Missinge 0/53        
         
Where born         
Outborn 77/11,389 (6.76) 1.79 (1.37, 2.34) <0.001 1.33 (1.01, 1.76) 0.043 
Inborn 178/46,197 (3.85)  1   1  
Missinge 4/460        
         
Hospital         
NICU 3 64/14,499 (4.41) 0.99 (0.72, 1.37) 0.954    
NICU 2 105/23,199 (4.53) 1.02 (0.77, 1.35) 0.913    
NICU 1 90/20,348 (4.42)  1     
         
Sex         
Male 135/29,940 (4.51) 1.01 (0.79, 1.29) 0.919    
Female 124/28,030 (4.42)  1     
Missinge 0/76        
         
Delivery method         
Emergency CSf 115/22,096 (5.20) 1.23 (0.95, 1.59) 0.121    
Elective CSf 30/9251 (3.24) 0.76 (0.51, 1.14) 0.182    
Vaginal 112/26,144 (4.28)  1     
Missinge 2/555        
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Table 5.3 Poisson regression models for the effect of birth susceptibility 
factors on non-CONS BSI, for NICUs 1, 2 and 3 
Potential risk factor 
Non-CONS BSI episodes/baby-days 
(Rate per 1000 baby-days) 
Crude rate ratios 
(95% CI) p-value 
      
Gestational age (weeks)      
<26 35/10,101 (3.47) 2.75  (1.48, 5.11) 0.001 
26-<28 12/7097 (1.69) 1.34  (0.62, 2.89) 0.461 
28-<32 18/16,369 (1.20) 0.86  (0.43, 1.73) 0.679 
32-<37 9/14,331 (0.63) 0.48  (0.21, 1.10) 0.083 
≥37 14/10,090 (1.39)  1  
Missinge 0/58     
      
Birth weight (g)      
<700 28/8,543 (3.28) 3.79  (2.25, 6.41) <0.001 
700-<1200 32/18,792 (1.70) 1.96  (1.18, 3.26) 0.009 
≥1200 28/30,658 (0.91)  1  
Missinge 0/53     
      
Where born      
Outborn 24/11,389 (2.11) 1.55  (0.97, 2.48) 0.066 
Inborn 64/46,197 (1.39)  1  
Missinge 0/460     
      
Hospital      
NICU 3 12/14,499 (0.83) 0.48  (0.25, 0.92) 0.027 
NICU 2 41/23,199 (1.77) 1.02  (0.65, 1.60) 0.931 
NICU 1 35/20,348 (1.72)  1  
      
Sex      
Male 47/29,940 (1.57) 1.07  (0.70, 1.62) 0.764 
Female 41/28,030 (1.46)  1  
Missinge 0/76     
      
Delivery method      
Emergency CSf 30/22,096 (1.36) 0.82  (0.51, 1.30) 0.390 
Elective CSf 13/9251 (1.41) 0.84  (0.45, 1.56) 0.577 
Vaginal 44/26,144 (1.68)  1  
Missinge 1/555     
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Table 5.4 Cox regression models for the effect of birth susceptibility factors on total BSI, for NICUs 1, 2 and 3 
Potential risk factor BSI episodes/baby-days 
Crude hazard ratios 
(95% CI) p-value 
Adjusted hazard ratios 
(95% CI) p-value 
        
Gestational age (weeks)        
<26 70/4963 4.59 (3.10, 6.80) <0.001    
26-<28 39/4418 2.68 (1.72, 4.18) <0.001    
28-<32 68/12,979 1.46 (0.98, 2.16) 0.060    
32-<37 33/13,328 0.51 (0.32, 0.80) 0.003    
≥37 44/9263  1     
Missinge 0/58       
        
Birth weight (g)        
<700 61/3314 7.33 (5.28, 10.16) <0.001 6.80 (4.84, 9.54) <0.001 
700-<1200 96/13,143 3.16 (2.35, 4.24) <0.001 2.86 (2.10, 3.90) <0.001 
≥1200 97/28,494  1   1  
Missinge 0/58       
        
Where born        
Outborn 73/7671 2.06 (1.56, 2.71) <0.001 1.29 (0.97, 1.72) 0.085 
Inborn 177/37,005  1   1  
Missinge 4/333       
        
Hospital        
NICU 3 56/10,787 0.88 (0.63, 1.23) 0.467    
NICU 2 108/18,171 1.08 (0.81, 1.42) 0.612    
NICU 1 90/16,051  1     
        
Sex        
Male 139/23,526 1.10 (0.86, 1.40) 0.462    
Female 115/21,407  1     
Missinge 0/76       
        
Delivery method        
Emergency CSf 99/16,645 1.01 (0.77, 1.32) 0.942    
Elective CSf 34/8032 0.75 (0.51, 1.09) 0.135    
Vaginal 118/19,911  1     
Missinge 3/421       
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Table 5.5 Cox regression models for the effect of birth susceptibility factors on CONS BSI, for NICUs 1, 2 and 3 
Potential risk factor CONS BSI episodes/baby-days 
Crude hazard ratios 
(95% CI) p-value 
Adjusted hazard ratios 
(95% CI) p-value 
        
Gestational age (weeks)        
<26 60/5490 4.90 (3.16, 7.60) <0.001    
26-<28 34/4749 2.90 (1.78, 4.74) <0.001    
28-<32 60/13,330 1.66 (1.08, 2.56) 0.022    
32-<37 25/13,526 0.49 (0.29, 0.83) 0.008    
≥37 34/9396  1     
Missinge 0/58       
        
Birth weight (g)        
<700 53/3803 7.53 (5.26, 10.78) <0.001 7.11 (4.89, 10.33) <0.001 
700-<1200 84/13,789 3.49 (2.53, 4.83) <0.001 3.22 (2.30, 4.53) <0.001 
≥1200 76/28,899  1   1  
Missinge 0/58       
        
Where born        
Outborn 61/8146 2.00 (1.48, 2.70) <0.001 1.21 (0.88, 1.65) 0.243 
Inborn 148/38,070  1   1  
Missinge 4/333       
        
Hospital        
NICU 3 53/10,970 1.05 (0.74, 1.50) 0.784    
NICU 2 87/18,778 1.07 (0.79, 1.47) 0.650    
NICU 1 73/16,801  1     
        
Sex        
Male 113/24,414 1.02 (0.78, 1.34) 0.884    
Female 100/22,059  1     
Missinge 0/76       
        
Delivery method        
Emergency CSf 89/17,025 1.15 (0.86, 1.53) 0.356    
Elective CSf 27/8199 0.75 (0.49, 1.15) 0.183    
Vaginal 95/20,853  1     
Missinge 2/472       
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Table 5.6 Cox regression models for the effect of birth susceptibility 
factors on non-CONS BSI, for NICUs 1, 2 and 3 
Potential risk factor Non-CONS BSI episodes/baby-days 
Crude hazard ratios 
(95% CI) p-value 
     
Gestational age (weeks)     
<26 28/8696 4.21 (2.03, 8.72) <0.001 
26-<28 11/6168 1.98 (0.84, 4.66) 0.119 
28-<32 16/15,468 1.03 (0.47, 2.25) 0.941 
32-<37 9/14,042 0.52 (0.22, 1.25) 0.143 
≥37 12/9882  1  
Missinge 0/58    
     
Birth weight (g)     
<700 24/6649 6.89 (3.80, 12.50) <0.001 
700-<1200 27/17,603 2.56 (1.44, 4.54) 0.001 
≥1200 25/30,004  1  
Missinge 0/58    
     
Where born     
Outborn 21/10,413 1.63 (0.98, 2.70) 0.060 
Inborn 55/43,441  1  
Missinge 0/460    
     
Hospital     
NICU 3 10/13,728 0.48 (0.23, 0.98) 0.044 
NICU 2 37/21,783 1.12 (0.68, 1.82) 0.657 
NICU 1 29/18,803  1  
     
Sex     
Male 41/28,518 1.08 (0.69, 1.70) 0.739 
Female 35/25,720  1  
Missinge 0/76    
     
Delivery method     
Emergency CSf 25/20,641 0.77 (0.46, 1.27)  0.305 
Elective CSf 12/8973 0.85 (0.45, 1.63)  0.629 
Vaginal 38/24,196  1  
Missinge 1/504    
     
e - Babies with missing variables were few and experienced few episodes of BSI. For this 
reason I considered it acceptable to remove them from the analyses. 
f - CS- Caesarean section 
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Table 5.7 Poisson regression models for the effect of procedure-related 
factors on total BSI, for NICUs 1, 2 and 3 
Potential risk factor 
BSI episodes/baby-days 
(Rate per 1000 baby-days) 
Crude rate ratios 
(95% CI) p-value 
      
No of blood samples taken      
≥7 170/13,907 (12.22) 5.06 (3.91, 6.55) <0.001 
4-6 89/9625 (9.25) 3.79 (2.82, 5.09) <0.001 
0-3 88/34,514 (2.55)  1  
      
Number of days spent in:      
      
Special care      
≥7 216/44,969 (4.80) 0.39 (0.31, 0.50)  <0.001 
4-6 11/2457 (4.48) 0.32 (0.17, 0.60)  <0.001 
1-3 14/2087 (6.71) 0.46 (0.26, 0.80)  <0.006 
0 106/8533 (12.42)  1  
      
High dependency care      
≥7 103/12,396 (8.31) 1.53 (1.20, 1.94)  <0.001 
4-6 19/3719 (5.11) 0.93 (0.58, 1.49)  0.756 
1-3 34/8024 (4.24) 0.76 (0.52, 1.09)  0.133 
0 191/33,907 (5.63)  1  
      
Intensive care      
≥7 259/30,368 (8.53) 3.90 (2.78, 5.45) <0.001 
4-6 18/3847 (4.68) 2.07 (1.19, 3.62)  0.011 
1-3 31/7246 (4.28) 1.88 (1.17, 3.01) 0.009 
0 39/16,585 (2.35)  1  
      
Number of days treated with:      
      
Ventilation      
≥7 214/24,110 (8.88) 2.61 (2.03, 3.37)  <0.001 
4-6 15/2716 (5.52) 1.59 (0.92, 2.75)  0.100 
1-3 36/8538 (4.22) 1.21 (0.82, 1.79)  0.348 
0 82/22,682 (3.62)  1  
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Table 5.8 Poisson regression models for the effect of procedure-related 
factors on CONS BSI, for NICUs 1, 2 and 3 
Potential risk factor 
CONS BSI episodes/baby-days 
(Rate per 1000 baby-days) 
Crude rate ratios 
(95% CI) p-value 
      
No of blood samples taken      
≥7 124/13,907 (8.92) 4.78 (3.55, 6.42) <0.001 
4-6 67/9625 (6.96) 3.69 (2.63, 5.17) <0.001 
0-3 68/34,514 (1.97)  1  
      
Number of days spent in:      
      
Special care      
≥7 167/44,969 (3.71) 0.43 (0.33, 0.56) <0.001 
4-6 7/2457 (2.85) 0.29 (0.13, 0.63) 0.002 
1-3 10/2087 (4.79) 0.46 (0.24, 0.89) 0.022 
0 75/8533 (8.79)  1  
      
High dependency care      
≥7 75/12,396 (6.05) 1.50 (1.14, 1.99) 0.004 
4-6 17/3719 (4.57) 1.12 (0.68, 1.86) 0.647 
1-3 26/8024 (3.24) 0.78 (0.52, 1.19) 0.252 
0 141/33,907 (4.16)  1  
      
Intensive care      
≥7 193/30,368 (6.36) 3.65 (2.50, 5.34) <0.001 
4-6 15/3847 (3.90) 2.17 (1.17, 4.03) 0.014 
1-3 20/7246 (2.76) 1.52 (0.87, 2.67) 0.142 
0 31/16,585 (1.87)  1  
      
Number of days treated with:      
      
Ventilation      
≥7 155/24,110 (6.43) 2.46 (1.84, 3.30) <0.001 
4-6 13/2716 (4.79) 1.79 (0.99, 3.25) 0.056 
1-3 28/8538 (3.28) 1.22 (0.78, 1.91) 0.378 
0 63/22,682 (2.78)  1  
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Table 5.9 Poisson regression models for the effect of procedure-related 
factors on non-CONS BSI, for NICUs 1, 2 and 3 
Potential risk factor 
Non-CONS BSI episodes/baby-days 
(Rate per 1000 baby-days) 
Crude rate ratios 
(95% CI) p-value 
      
No of blood samples taken      
≥7 46/13,907 (3.31) 6.03 (3.57, 1.02) <0.001 
4-6 22/9625 (2.29) 4.12 (2.25, 7.55) <0.001 
0-3 20/34,514 (0.58)  1  
      
Number of days spent in:      
      
Special care      
≥7 49/44,969 (1.09) 0.31 (0.19, 0.48) <0.001 
4-6 4/2457 (1.63) 0.40 (0.14, 1.14) 0.088 
1-3 4/2087 (1.92) 0.45 (0.16, 1.27) 0.130 
0 31/8533 (3.63)  1  
      
High dependency care      
≥7 28/12,396 (2.26) 1.58 (1.00, 2.52) 0.051 
4-6 2/3719 (0.54) 0.37 (0.09, 1.53) 0.172 
1-3 8/8024 (1.00) 0.68 (0.32, 1.43) 0.310 
0 50/33,907 (1.47)  1  
      
Intensive care      
≥7 66/30,368 (2.17) 4.84 (2.32, 0.10) <0.001 
4-6 3/3847 (0.78) 1.68 (0.45, 6.35) 0.441 
1-3 11/7246 (1.52) 3.24 (1.31, 8.07) 0.011 
0 8/16,585 (0.48)  1  
      
Number of days treated with:      
      
Ventilation      
≥7 59/24,110 (2.45) 3.11 (1.85, 5.21) <0.001 
4-6 2/2716 (0.74) 0.91 (0.21, 3.92)  0.903 
1-3 8/8538 (0.94) 1.16 (0.51, 2.64)  0.729 
0 19/22,682 (0.84)  1  
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6. Analyses of factors predicting infection: 
Poisson regression 
 
6.1 Summary 
Clinicians need to know which factors predict BSI in order to identify high risk groups 
who could benefit from preventive action or close monitoring. I determined which 
procedure-related factors predict infection, by restricting analyses to risk factors that 
preceded BSI episodes. In comparison with Chapters 3 and 5, this chapter provides 
more complex analyses to determine which potential risk factors should be adjusted for 
when comparing BSI rates between NICUs.  
 
NHS level of care, total parenteral nutrition, birth weight, inborn/outborn status and 
postnatal age were significant independent risk factors for BSI, with level of care and 
total parenteral nutrition being the strongest. The rate ratio for BSI, adjusted for birth 
weight, inborn/outborn status and postnatal age, was 3.15 (95% confidence interval 
2.01, 4.94) for intensive care and 6.58 (4.18, 10.36) for high dependency care, relative 
to special care. Total parenteral nutrition was significantly associated with BSI 
incidence but explained less of the variance among babies than level of care. 
 
Days at each level of care, birth weight, inborn/outborn status and postnatal age are risk 
factors that should be adjusted for when comparing BSI rates between NICUs. The next 
chapter will address bias associated with differences in the length of hospital stay. 
 136
 6.2 Introduction 
In this chapter I present analyses to determine which predictive risk factors should be 
adjusted for when comparing BSI rates between NICUs. In Chapter 3 and Chapter 5 I 
described simple associations between procedure-related factors and BSI. As described 
in Chapter 5, Section 5.5, because the timing of procedure-related exposures in relation 
to BSI episodes was not taken into account, some associations may have reflected 
consequences of infection. It would be useful for clinicians to know which factors 
precede or predict BSI, in order to identify high risk groups who could benefit from 
preventive action or close monitoring. In Chapter 6 and Chapter 7, I determine which 
procedure-related factors are most strongly predictive of BSI, by restricting analyses to 
factors preceding BSI episodes. As mentioned in Chapter 5, this was only possible for 
factors for which precise dates were recorded by NICU staff. This meant that data for 
NICUs 1 and 2 only could be included. 
 
6.3 Methods 
 
6.3.1 Study population 
The datasets described in Chapter 4 for NICUs 1 and 2, each of which contain a record 
for each baby-day, were used for the analysis. Data were analysed for babies admitted 
on or after the 1st May 2001 and discharged up to and including the 28th February 
2005.  
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6.3.2 Case definition 
As in Chapter 5, an episode of BSI was defined as one or more blood cultures in which 
the same bacterial organism was isolated within a seven day period, and BSI episodes 
and baby-days from the first 48 hours of life were excluded from the analyses. 
 
6.3.3 Potential risk factors 
As in Chapter 5, potential risk factors reflecting susceptibility to BSI at birth included 
gestational age at birth in weeks (<26, 26-<28, 28-<32, 32-<37, ≥37), birth weight in 
grams (<700, 700-<1200, ≥1200), inborn/outborn status, NICU, sex and delivery 
method.  
 
In Chapter 3 and Chapter 5 I suggested that procedure-related factors which change 
during the NICU stay may be associated with an increased risk of BSI. In this chapter, I 
determine which procedure-related factors predict BSI, and may therefore be amenable 
to infection control interventions. Factors which change during the NICU stay included: 
NHS level of care, total parenteral nutrition, ventilation, postnatal age in days (3-<10, 
10-<20, 20-<30, 30-<40, 40-<50, ≥50), the number of blood samples taken and surgery. 
 
Precise dates of treatment with total parenteral nutrition and ventilation were only 
available for NICU 2. To identify risk factors which may have a predictive role in BSI, I 
analysed procedure-related factors recorded in the three days preceding infection. For 
this three day period, the most intensive level of care was recorded and total parenteral 
nutrition and ventilation were labelled as either present or absent. The structure of the 
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datasets used, with each baby-day labelled according to procedure-related exposures in 
the previous three days, is shown in Figure 6.1. 
 
6.3.4 Statistical analyses   
 
Poisson regression models for rates of blood stream infection with potential risk factors 
The advantage of this approach was that it allowed comparisons with findings reported 
by Holmes et al. (2008).34 Following their methods, I calculated rates of BSI as days 
with onset of a first BSI episode divided by total days of NICU stay, for each level of 
each potential risk factor. To differentiate days of stay that may contribute to BSI from 
days of stay that may be the consequence of BSI, baby-days were counted up until the 
first BSI episode for infected babies and up until discharge from NICU for uninfected 
babies. Thus only risk factors preceding BSI episodes were included in the analyses. 
Poisson generalised linear models were fitted to estimate crude rate ratios for BSI, for 
each potential risk factor in turn. The models were fitted using generalised estimating 
equations, to account for the fact that days pertaining to the same baby were not 
independent. Poisson generalised linear models fitted using generalised estimating 
equations yield parameter estimates adjusted for within-subject correlation.89 Potential 
risk factors with significant associations with BSI (p<0.01) were examined in 
combination using Poisson generalised linear models and forward stepwise model 
selection for risk factors based on the quasi-likelihood information criterion (the QIC is 
defined in the paragraph below).90 As gestational age at birth and birth weight were 
correlated, separate adjusted models were built for each of these variables. A similar 
approach was taken for total parenteral nutrition and ventilation, which were also 
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correlated with each other and with level of care (for all correlations, the p-value for the 
null hypothesis of no correlation was <0.001) (refer to Chapter 5, Figure 5.5). The 
combination of risk factors giving the lowest QIC was included in the final adjusted 
model.90 
 
The QIC was used to assess goodness of fit as Poisson generalised linear models using 
generalised estimating equations do not satisfy the assumptions associated with the AIC 
and the BIC. The QIC is another measure of goodness of fit of an estimated statistical 
model, similar to the AIC described in Chapter 3, Section 3.3.4, and the BIC described 
in Chapter 5, section 5.3.2. However, the QIC is different in that it adjusts for over-
dispersion, or lack of fit, with a variance inflation factor c, and it is suitable for models 
fitted with generalised estimating equations. The QIC can be written as: 
 
QIC = -(1/c)2ln(L) + 2k 
k = number of parameters in the model 
c = variance inflation factor 
L = maximised value of the likelihood function90 
 
The analyses were repeated for each hospital separately. 
 
 
 
 
 140
6.3.5 Sensitivity analyses incorporating five and eight categories of birth 
weight and birth weight standardised for gestational age 
 
Analyses incorporating five and eight categories of birth weight 
It is possible that the three, broad birth weight categories used for the main analysis, and 
chosen by Holmes et al. (2008) (<700, 700-<1200, ≥1200g), may mask variations in 
BSI risk in babies with birth weights above 1200g. The ≥1200g birth weight category 
may include both babies born moderately preterm who are otherwise healthy and 
growing, and term babies undergoing surgery who may have more complex problems. 
This variation in risk was observed in Chapter 5 (Section 5.5) as babies with gestational 
ages between 28 and 36 weeks were at lower risk for BSI than term babies born at 37 
weeks or above. This variation in risk is more likely in this study than in Holmes et al. 
(2008). While both study populations were drawn from inner London, level 3 NICUs 
admitting inborn babies and referrals, this study included one NICU (NICU 1) admitting 
specialist surgical cases. In this sensitivity analysis I analysed the effect on BSI of birth 
weight split into five and eight categories, to differentiate effects in preterm and term 
babies, who I expected to differ slightly in birth weight. 
 
The following birth weight categories were used for the sensitivity analysis: 
 
1. Five categories: <700, 700<-1200, 1200-<2500, 2500-<3500, ≥3500g. These 
categories were comparable with those chosen by Holmes et al. (2008), except that 
babies with birth weights above 1200g were split into three groups rather than one. 
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2. Eight categories: <500, 500-<1000, 1000-<1500, 1500-<2000, 2000-<2500, 
2500-<3000, 3000-<3500, ≥3500g standard 500g birth weight groups. 
 
Analyses incorporating birth weight standardised for gestational age 
Chapter 5 showed that birth weight and gestational age were risk factors for BSI in 
separate analyses. This may signify that babies born smaller than expected for their 
gestational age are at increased risk for BSI. I therefore analysed the effect of birth 
weight standardised for gestational age, expressed as standard deviation scores, 
calculated using the lmsGrowth add-in to Microsoft Excel.91 Reference centile curves 
show the distribution of birth weight as it changes according to gestational age. The 
LMS method uses the British 1990 growth reference centiles,92 and it summarises this 
changing distribution using three curves representing the median (), coefficient of 
variation () and skewness () of birth weight against gestational age. The program 
standardised the birth weight (y) measurements in the dataset against this reference, 
using values appropriate for each baby’s gestational age and sex. Standard deviation 
scores (Z) were calculated thus: 
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The standard deviation score measured the number of standard deviations a baby’s birth 
weight lay, above or below the mean birth weight for his or her gestational age and sex 
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in the reference population. Babies with birth weights corresponding to the mean had a 
score of 0, those with birth weights above or below the mean had positive and negative 
scores, respectively. Because standard deviation score represents a single variable 
combining birth weight and gestational age, it enabled the two factors to be combined in 
the same Poisson regression model. However, it must be stressed that the score is a 
standardised measure and therefore cannot be used to assess the simple effects of either 
factor. 
 
6.4 Results 
A total of 236 first episodes of BSI were recorded, of which: 176 were Coagulase-
negative staphylococcus, 2 were Group B streptococcus, 27 were Gram positive 
organisms other than Group B streptococcus, 17 were Gram negative organisms, and 4 
were yeasts. Ten episodes were mixed cultures, of which six contained CONS. The 
analysis included 2269 babies (940 from NICU 1 and 1329 from NICU 2). The two 
NICUs had similar rates of BSI, of around 6 per 1000 baby-days. 
 
Level of care was the single strongest risk factor for BSI, in terms of optimising the 
QIC. Intensive care accounted for 36% of total NICU days (14,443/40,218) and 58% of 
BSI (138/236) and high dependency care accounted for 9% of NICU days 
(3603/40,218) and 20% of BSI (47/236) (Table 6.2). The optimal adjusted model 
consisted of level of care, birth weight, inborn/outborn status and postnatal age (Table 
6.3). 
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Total parenteral nutrition was the second strongest risk factor for BSI. In NICU 2, it 
accounted for 16% of NICU days (3375/21,281) and 56% of BSI (72/129). Total 
parenteral nutrition could not be adjusted for in models already including level of care, 
as these variables were correlated. The optimal adjusted model incorporating total 
parenteral nutrition also included birth weight, inborn/outborn status and postnatal age 
(Table 6.5). The effect of ventilation was attenuated by adjustment for birth weight, 
inborn/outborn status and postnatal age (adjusted rate ratio 1.30, 95% confidence 
interval 0.81, 2.11, p=0.277).  
 
As in Chapter 5, BSI risk was highest in the most premature and in term babies, with 
preterm babies born in the third trimester having the lowest risk. Babies with birth 
weights below 1200g were also at higher risk for BSI than heavier babies. The optimal 
adjusted model retained birth weight as an independent risk factor for BSI (Table 6.3). 
 
Outborn babies had a higher risk for BSI than inborn babies. The risk of BSI was 
highest between days 3 and 20 of life in crude analyses, and this effect remained after 
adjustment for level of care, birth weight and inborn/outborn status (Table 6.3). No 
significant associations were found between BSI and NICU, sex, delivery method, the 
number of blood samples taken or surgery.  
 
Similar results were found when the NICUs were analysed separately (Tables 6.3 and 
6.4). For NICU 1, birth weight was a strong risk factor for BSI in crude analyses, but it 
was not included in the multivariable model as it did not optimise the QIC (Table 6.4). 
Postnatal age was only a significant risk factor for BSI at NICU 2 (Table 6.5). 
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 6.4.1 Sensitivity analyses incorporating five and eight categories of birth 
weight and birth weight standardised for gestational age 
 
Analyses incorporating five and eight categories of birth weight 
The sensitivity analyses based on five categories of birth weight revealed a reverse J-
shaped relationship. While babies with very low birth weights (below 700g) were at 
highest risk for BSI, babies with low to moderately low birth weights (between 1200g 
and 3500g) were at lowest risk. Babies weighing between 1200g and 3500g at birth 
were at lower risk than babies weighing more than 3500g. A similar relationship was 
found when birth weight was categorised into eight 500g birth weight groups, but 
confidence intervals were wide due to the small number of babies in some strata (n=10 
in the <500g birth weight group) (Table 6.2). In the multivariable analysis, variation in 
risk in babies with birth weights above 1200g diminished after adjustment for level of 
care, inborn/outborn status and postnatal age. As a result, the best fitting model, based 
on the QIC for goodness of fit, grouped babies with birth weights above 1200g into a 
single category (Table 6.3). 
 
Analyses incorporating birth weight standardised for gestational age 
I found no significant association between standard deviation scores and BSI in crude or 
adjusted analyses. Figure 6.2 describes the standard deviation scores which standardised 
birth weight measurements for gestational age. Scores could not be calculated for seven 
babies born at 21-22 weeks’ gestation, as reference centiles were not available for 
gestational ages below 23 weeks. Birth weight standardised for gestational age had no 
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significant effect on BSI in crude analyses, so it was not included in the adjusted models 
(Table 6.2). 
 
6.5 Discussion 
High intensity care and total parenteral nutrition in the previous three days were the 
strongest single risk factors for BSI. The optimal adjusted models combined these 
factors with birth weight, inborn/outborn status and postnatal age. 
 
In this chapter I used similar statistical methods to those of the study by Holmes et al. 
(2008)34 However, Holmes et al. analysed the risk associated with various specific 
invasive procedures in one NICU, whereas I also included NHS level of care as a 
composite potential risk factor and I analysed a larger study population spanning two 
NICUs. Holmes et al. identified parenteral nutrition and gestational age at birth below 
26 weeks as the only significant independent risk factors for BSI, and recommended 
stratification by these factors for BSI monitoring. I found similar results for total 
parenteral nutrition and a similarly strong association between BSI and NHS level of 
care. The effects of total parenteral nutrition and level of care on BSI could not be 
compared together in the same model as they were correlated. Which factors should be 
used for risk adjustment depend on the clinical and health service questions being 
addressed. When comparing overall quality of care between NICUs, adjustment for 
daily level of care may be preferable because it includes all babies across the full 
spectrum of risk. In contrast, only a minority (24%)67 of NICU patients receive 
parenteral nutrition, and the remaining babies have widely differing risks of BSI. 
Comparisons between NICUs could be based on BSI rates stratified by level of care. 
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This would describe BSI rates by their location and clinical team, which is useful for 
targeting infection control measures. Additional stratification of BSI rates by parenteral 
nutrition may be useful for monitoring infection control interventions focused on 
parenteral nutrition. 
 
In addition to level of care, the optimal multivariable model included birth weight, 
inborn/outborn status and postnatal age, indicating that these factors may also need to 
be adjusted for when comparing BSI incidence between NICUs. Birth weight and 
inborn/outborn status were described as independent risk factors for BSI in Chapter 5. 
In the crude model for both NICUs combined, babies between 3 and 20 days of age 
experienced twice the risk of BSI, compared with babies above 50 days of age (Table 
6.2). This effect was only evident at NICU 2 (Tables 6.4 and 6.5). It may be due to 
chance or because, as described in Section 6.3.5, babies at NICU 2 were predominantly 
born preterm, thus those surviving above 50 days of age were likely to be mostly 
healthy, growing and more resistant to BSI than newborn babies. In contrast, NICU 1 
included babies referred for neonatal surgery whose clinical course may have been more 
complex. 
 
As mentioned in Chapter 5 (Section 5.5), associations between potential risk factors and 
infections are not necessarily causal; they can arise from chance, from confounding by 
other risk factors, or they can reflect the consequence of infection. To determine factors 
predicting BSI, procedure-related factors were analysed for the three days preceding 
BSI. It is important to note that relationships found between BSI episodes and the risk 
factors closely preceding BSI are not necessarily causal relationships. Chronology is 
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only one requirement for establishing causality, another requirement is a biological 
mechanism for infection by invasive procedures, which is beyond the scope of this 
thesis. It is also important to remember that, as explained in Chapter 1 (Section 1.8), 
level of care is a composite risk factor that reflects a number of specific procedures and 
baby susceptibility factors, that could themselves be associated with infection. 
 
Length of hospital stay is an example of a potential risk factor which could have a 
complex association with BSI. A longer length of stay may increase the risk of 
infection, but it can also be the consequence of an infection which causes a baby’s 
condition to deteriorate. To determine factors predicting BSI, follow-up time was 
truncated at infection. However, this truncation is prone to bias, as it may result in 
systematic differences in follow-up time between infected and uninfected individuals 
(Figure 6.3).93 Studies in NICUs are more prone to this type of bias than studies in adult 
intensive care, as babies tend to have longer lengths of stay in intensive care. A novel, 
alternative analytical method to overcome bias associated with length of follow-up is 
presented in Chapter 7.  
 
Results for this analysis were similar to those for Chapter 5, except that neither the 
number of blood samples taken nor surgery showed significant relationships with BSI, 
in contrast with the previous chapter. This is likely to be because neither factor had a  
predictive relationship with BSI, which the analysis in this chapter was designed to 
detect. As described in Chapter 5, a baby’s overall number of blood samples taken was, 
by definition, strongly correlated with his or her number of BSI episodes, as blood 
samples were used to diagnose infection. This chapter found that the number of blood 
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samples taken in the three-day period of relevant exposure before a first BSI episode did 
not predict that episode. This suggests that increases in the frequency of blood sampling 
do not result in a greater risk of detecting asymptomatic BSI or a contaminated sample. 
This finding was in keeping with the results for Chapter 3, which showed no significant 
association between the number of blood samples taken and total BSI at the unit level in 
adjusted analyses. Similarly, Chapter 5 showed that babies undergoing surgery at any 
time during their NICU stay were more likely to experience BSI episodes, whereas the 
analysis in this chapter showed that, during the relevant period of exposure, treatment 
with surgery did not predict the development of a first BSI episode. The association 
found in Chapter 5 was probably due to the fact that babies undergoing surgery were 
likely to be susceptible to BSI through their more serious clinical conditions and 
increased requirement for invasive procedures, rather than through any effect of the 
surgery itself. In this chapter, blood sampling frequency and surgery did not predict the 
development of BSI episodes. 
  
6.5.1. Sensitivity analyses incorporating five and eight categories of birth 
weight and birth weight standardised for gestational age 
 
Analyses incorporating five and eight categories of birth weight 
The three birth weight categories chosen by Holmes et al. (2008) (<700, 700-<1200, 
≥1200g) were suitable for risk adjusting comparisons of BSI incidence between NICUs 
in this study. Variation in risk among babies with birth weights above 1200g diminished 
with adjustment for level of care, inborn/outborn status and postnatal age. The three 
birth weight categories therefore produced a more parsimonious model, which 
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optimised the QIC. This suggests that the study populations in Holmes et al. (2008) and 
this study were fairly similar, which is supported by the similarity in findings regarding 
parenteral nutrition described above. This similarity may indicate that the findings of 
both studies could be transportable to other level 3 NICUs, including those providing 
specialist surgical care. 
 
Analyses incorporating birth weight standardised for gestational age 
Birth weight standardised for gestational age had no significant effect on BSI in this 
study. This may be the result of a selection effect, as the babies most at risk of BSI, 
those who were very preterm (23 to 28 weeks’ gestation) and small for gestational age, 
were also those least likely to survive and be represented in the unit.  
 
Bartels et al. (2007) described an increased risk of BSI among babies born at 24 to 28 
weeks’ gestation who were also small for gestational age. They evaluated babies born 
between 2000 and 2004, within 47 German NICUs participating in the NEO-KISS 
infection surveillance system. The outcome was at least one episode of hospital-
acquired BSI, defined using modified CDC criteria.15 42% (163/392) of small for 
gestational age babies, defined as below the 10th percentile, experienced BSI episodes. 
87% (787/2526) of appropriate for gestational age babies, between the 10th and the 90th 
percentile, experienced BSI episodes (odds ratio 1.41, 95% CI 1.05 to 1.89, adjusted for 
various birth susceptibility and procedure-related factors) The authors speculated that 
this increased risk was due to interactions between nutritional status and immunological 
function.94 Low counts of white blood cells involved in immune function (total 
neutrophils, immature neutrophils, lymphocytes and monocytes) have been observed in 
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preterm small for gestational age babies, in comparison with their appropriate for 
gestational age counterparts.95  
 
Babies described as being most at risk from BSI, those who were very preterm (24 to 28 
weeks’ gestation) and small for gestational age, were few in this study (Table 6.1, refer 
to the first two columns of the first two rows in the table). This was probably due to a 
selection effect, which was not so evident in Bartels et al. (2008) as their study 
population was very large, covering 47 NICUs. Larger babies and babies with greater 
gestational ages may have been more likely to survive and be represented in the unit, as 
well as being more resistant to BSI. Studies investigating the risk of BSI in babies 
above 28 weeks’ gestation and small for gestational age are scarce, and they give 
conflicting results.94,96,97 Because my focus was to determine factors which could adjust 
for BSI risk in the entire NICU population, birth weight standardised for gestational age 
was not included in the final risk adjustment model.  
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 Key conclusions of Chapter 6 
Findings  
 I identified level of care, total parenteral nutrition, birth weight, gestational 
age, inborn/outborn status and postnatal age as significant independent risk 
factors for BSI. 
 The analysis described in this chapter was able to elaborate predictive 
associations between procedure-related risk factors and BSI episodes. 
Conclusions 
 Adjustment of BSI rates by level of care, birth weight, inborn/outborn status 
and postnatal age could provide fair and meaningful comparisons between 
NICUs. 
 The analysis was prone to bias associated with differences in the length of 
follow-up between babies. This bias will be addressed in the following 
chapter. 
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Figure 6.1 Diagram to describe stays in the NICU for three hypothetical babies, and how these stays would be translated into a 
dataset with each baby-day labelled according to procedure-related exposures in the previous three days  
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Figure 6.1 (continued) Dataset with each baby-day labelled according to procedure-related exposures in the previous three 
days. For infected babies, baby-days were truncated at the first infection episode  
 
In previous three days: 
Baby Date Gestational age (wks) 
Birth 
weight (g) Sex 
Inborn/ 
Outborn 
Delivery 
method Highest level of care 
Total 
parenteral 
nutrition? 
Ventilation? 
Number of 
blood samples 
taken 
CONS 
episode 
Non-CONS 
episode 
1 5/5/2001 <26 700-<1200 Male Inborn Vaginal Other No No 0 0 0 
1 6/5/2001 <26 700-<1200 Male Inborn Vaginal Intensive care Yes Yes 0 0 0 
1 7/5/2001 <26 700-<1200 Male Inborn Vaginal Intensive care Yes Yes 0 1 0 
2 16/5/2001 32-<37 ≥1200 Female Inborn Vaginal Other No No 0 1 0 
3 3/5/2001 ≥37 ≥1200 Male Inborn Vaginal Other No No 0 1 0 
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Figure 6.2 Description of standard deviation scores standardising birth 
weight measurements for gestational age 
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Standard deviation score and birth weight were positively correlated, showing a linear 
relationship: 
 
Correlation coefficient = 0.40 
p-value for the null hypothesis of no correlation <0.001 
(H0 = correlation coefficient of 0) 
 
Linear regression coefficient = 0.0006 (95% CI 0.0005, 0,0006) 
p-value for the null hypothesis of no linear relationship <0.001  
 
The dataset contained outliers for birth weight and gestational age. As mentioned in Chapter 5, 
Figure 5.5, factors were analysed as categorical variables, which tempered the potential bias 
presented by outliers. 
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Figure 6.3 If only days preceding infection are analysed, uninfected babies 
can contribute more person-time to the analysis. Example showing a baby 
with an infection at day 7 and discharge from NICU at day 14 
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Table 6.1 Number of babies by gestational age and standard deviation 
score 
 
 Standard deviation score 
Gestational 
age (weeks) <-2 -2-<-1 -1-<0 0-<1 1-<2 ≥2 Missing 
<26 1 11 46 48 9 4 7 
26-<28 9 21 33 26 12 5 0 
28-<32 39 58 92 87 35 12 0 
32-<37 94 122 186 141 68 38 1 
≥37 132 234 309 237 98 40 2 
Missing 0 0 0 0 0 0 12 
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Table 6.2 Crude Poisson regression models for NICU 1 and NICU 2 
combined 
 
 
Potential risk factor 
Days with onset of BSI/Total baby-days 
(Rate per 1000 baby-days) 
Crude rate ratios 
(95% CI) p-value 
    
Highest level of careb      
Intensive care 138/14,443 (9.55) 5.42  (3.78, 7.77) <0.001 
High dependency care 47/3603 (13.04) 7.30  (4.76, 11.19) <0.001 
Special care 36/20,919 (1.72)  1  
Otherc 15/1253     
     
Gestational age (weeks)      
<26 72/5619 (12.81) 2.67  (1.80, 3.94) <0.001 
26-<28 35/4398 (7.96) 1.58  (1.00, 2.48) 0.050 
28-<32 53/11,319 (4.68) 0.92  (0.61, 1.37) 0.668 
32-<37 30/10,620 (2.82) 0.51  (0.32, 0.81) 0.005 
≥37 46/8233 (5.59)  1  
Missingd 0/29     
     
Birth weight (g)      
<700g 62/3634 (17.06) 4.82  (3.39, 6.85) <0.001 
700g-<1200g 78/12,400 (6.29) 1.76  (1.29, 2.40) <0.001 
≥1200g 96/24,146 (3.98)  1  
Missingd 0/38     
     
Postnatal age (days)      
3-<20 153/20,991 (7.29) 1.97  (1.24, 3.13) 0.004 
20-<56 63/13,804 (4.56) 1.24  (0.75, 2.04) 0.407 
≥56 20/5423 (3.69)  1  
     
Inborn status      
Outborn 80/7571 (10.57) 2.21  (1.68, 2.89) <0.001 
Inborn 154/32,476 (4.74)  1  
Missingd 2/171     
     
Hospital      
NICU 2 129/21,281 (6.06) 1.08  (0.84, 1.41) 0.544 
NICU 1 107/18,937 (5.65)  1  
     
Sex      
Male 130/21,015 (6.19) 1.12  (0.86, 1.45), 0.413 
Female 106/19,203 (5.52)  1  
     
Delivery method      
Emergency CSe 92/15,531 (5.92) 0.97  (0.73, 1.29) 0.824 
Elective CSe 33/6789 (4.86) 0.79  (0.53, 1.17) 0.237 
Vaginal 110/17,856 (6.16)  1  
Missingd 1/42     
     
Number of blood samples takenb      
≥2 2/388 (5.15) 0.78  (0.19, 3.24) 0.734 
1 27/6169 (4.38) 0.69  (0.46, 1.02) 0.060 
0 207/33,661 (6.15)  1  
     
Surgeryb      
Yes 5/935 (5.35) 0.89  (0.38, 2.10) 0.796 
No 231/39,283 (5.88)  1  
      
Sensitivity analyses      
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incorporating five and eight 
categories of birth weight and 
birth weight standardised for 
gestational age 
      
Birth weight (g)      
<700 62/3634 (17.06) 2.28 (1.25, 4.17) 0.007 
700-<1200 78/12,400 (6.29) 0.83 (0.47, 1.49) 0.537 
1200-<2500 58/16,404 (3.54) 0.42 (0.24, 0.77) 0.004 
2500-<3500 24/6108 (3.93) 0.46 (0.24, 0.90) 0.022 
≥3500 14/1634 (8.57)  1  
Missingd 0/38     
      
Birth weight (g)      
<500 5/272 (18.38) 2.63 (0.79, 8.72)    0.114 
500-<1000 115/11,116 (10.35) 1.41 (0.80, 2.48)    0.238 
1000-<1500 46/10,232 (4.50) 0.57 (0.31, 1.05)    0.071 
1500-<2000 20/6957 (2.87) 0.35 (0.17, 0.69)    0.002 
2000-<2500 12/3861 (3.11) 0.36 (0.17, 0.79)    0.011 
2500-<3000 8/3180 (2.52) 0.28 (0.12, 0.67)    0.004 
3000-<3500 16/2928 (5.46) 0.66 (0.32, 1.37)    0.262 
≥3500 14/1634 (8.57)  1  
Missingd 0/38     
      
Standard deviation score      
<-2 38/5660 (6.71) 1.04 (0.68, 1.59) 0.849 
-2-<-1 49/7811 (6.27) 0.97 (0.66, 1.42) 0.855 
-1-<0 62/12,529 (4.95) 0.77 (0.54, 1.10) 0.147 
0-<1 61/9446 (6.46)  1  
1-<2 18/3052 (5.90) 0.91 (0.53, 1.55) 0.714 
≥2 6/1365 (4.40) 0.66 (0.30, 1.45) 0.296 
Missingd: gest age <23 weeks 2/317     
Missingd: birth weight missing 
or birth weight and gest age 
missing 
0/38     
      
 
 
 
 
 
 
 
Table 6.3 Adjusted Poisson regression models for NICU 1 and NICU 2 combined 
Sensitivity analyses incorporating five and eight categories of 
birth weight 
 
Potential risk factor 
 
Optimal risk adjustment model 
 
Adjusted rate ratios 
(95% CI) p-value 
QIC for model: 2526 
Model including five birth 
weight categories 
 
Adjusted rate ratios 
(95% CI) p-value 
QIC for model: 2529 
Model including eight birth 
weight categories 
 
Adjusted rate ratios 
(95% CI) p-value 
QIC for model: 2537 
    
Highest level of careb          
Intensive care 3.15 (2.01, 4.94) <0.001 3.16 (2.02, 4.94)    <0.001 2.90 (1.85, 4.54) <0.001 
High dependency care 6.58 (4.18, 10.36) <0.001 6.61 (4.19, 10.43)   <0.001 6.57 (4.15, 10.38)    <0.001 
Special care  1   1   1  
Otherc        
        
Birth weight (g)          
<700g 3.69 (2.37, 5.74) <0.001       
700g-<1200g 1.60 (1.09, 2.35) 0.016       
≥1200g  1        
Missingd        
        
Postnatal age (days)        
3-<10 2.79 (1.64, 4.74) <0.001 2.79 (1.64, 4.75)    <0.001 3.01 (1.76, 5.14) <0.001 
10-<20 2.94 (1.78, 4.83) <0.001 2.94 (1.78, 4.83)    <0.001 3.08 (1.87, 5.07) <0.001 
20-<30 1.93 (1.10, 3.39) 0.023 1.93 (1.10,  3.39)   0.022 1.98 (1.13, 3.48) 0.017 
30-<40 2.15 (1.19, 3.89) 0.011 2.15 (1.19, 3.88)    0.011 2.20 (1.22, 3.97) 0.009 
40-<50 1.42 (0.68, 2.96) 0.358 1.41 (0.68, 2.96)    0.358 1.42 (0.68, 2.96)     0.349 
≥50  1  1  1  
        
Inborn status        
Outborn 1.51 (1.12, 2.04) 0.007 1.51 (1.12, 2.03)    0.007 1.45 (1.08, 1.95)     0.014 
Inborn  1  1  1  
Missingd        
          
Birth weight (g)          
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<700g    3.00 (1.32, 6.80)    0.009    
700g-<1200    1.30 (0.59, 2.87)    0.513   
1200-<2500    0.84 (0.39, 1.81)    0.653   
2500-<3500    0.70 (0.30, 1.62)    0.403    
≥3500    1     
Missingd          
          
Birth weight (g)          
<500       3.65 (1.24, 10.75)    0.019 
500-<1000       2.23 (1.00, 4.94) 0.049 
1000-<1500       1.03 (0.47, 2.27)    0.934 
1500-<2000       0.77 (0.33, 1.79)    0.537 
2000-<2500       0.59 (0.22, 1.56)    0.286 
2500-<3000       0.55 (0.21, 1.45)    0.225 
3000-<3500       0.89 (0.35,  2.26)    0.804 
≥3500        1  
Missingd          
          
Table 6.4 Poisson regression models for NICU 1 
 
Potential risk factor 
Days with onset of BSI/Total baby-days 
(Rate per 1000 baby-days) 
Crude rate ratios 
(95% CI) p-value 
Adjusted rate ratios 
(95% CI) p-value 
QIC for model: 1196 
         
Highest level of careb         
Intensive care 60/6400 (9.38) 5.68 (3.24, 9.97) <0.001 5.02 (2.65, 9.52) <0.001 
High dependency care 28/2418 (11.58) 7.02 (3.75, 13.14) <0.001 7.40 (3.84, 14.26) <0.001 
Special care 16/9540 (1.68)  1   1  
Otherc 3/579        
         
Gestational age (weeks)         
<26 33/2653 (12.44) 2.63 (1.49, 4.64) 0.001    
26-<28 17/2753 (6.18) 1.30 (0.67, 2.53) 0.442    
28-<32 28/5237 (5.35) 1.11 (0.61, 2.01) 0.730    
32-<37 10/4422 (2.26) 0.46 (0.21, 1.00) 0.048    
≥37 1/3843 (4.94)  1     
Missingd 0/29        
         
Birth weight (g)         
<700g 41/10,432 (3.93) 3.75 (2.21, 6.37) <0.001    
700g-<1200g 42/6743 (6.23) 1.65 (1.07, 2.56) 0.025    
≥1200g 24/1724 (13.92)  1     
Missingd 0/38        
         
Postnatal age (days)         
3-<10 26/4970 (5.23) 1.18 (0.62, 2.26) 0.614    
10-<20 35/4589 (7.63) 1.72 (0.93, 3.20) 0.085    
20-<30 13/3082 (4.22) 0.95 (0.45, 2.03) 0.898    
30=<40 11/2053 (5.36) 1.21 (0.55, 2.66) 0.638    
40-<50 9/1317 (6.83) 1.54 (0.67, 3.56) 0.312    
≥50 13/2926 (4.44)  1     
         
Inborn status         
Outborn 50/4696 (10.65) 2.71 (1.86, 3.95) <0.001 1.78 (1.17, 2.73) 0.008 
Inborn 55/14,070 (3.91)     1  
Missingd 2/171        
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Sex         
Male 58/9917 (5.85) 1.08 (0.74, 1.58) 0.705    
Female 49/9020 (5.43)  1     
         
Delivery method         
Emergency CSe 46/8138 (5.65) 0.95 (0.64, 1.41) 0.793    
Elective CSe 8/2069 (3.87) 0.65 (0.31, 1.35) 0.248    
Vaginal 52/8698 (5.98)  1     
Missingd 1/32        
         
Number of blood samples takenb         
≥2 1/181 (5.52) 0.93 (0.13, 6.90) 0.944    
1 13/2670 (4.87) 0.83 (0.47, 1.48) 0.533    
0 93/16,086 (5.78)  1     
         
Surgeryb         
Yes 2/291 (6.87) 1.22 (0.31, 4.84) 0.781    
No 105/18,646 (5.63)  1     
         
 
Table 6.5 Poisson regression models for NICU 2 
 
Potential risk factor 
Days with onset of BSI/Total baby-days 
(Rate per 1000 baby-days) 
Crude rate ratios 
(95% CI) p-value 
Adjusted rate ratios 
incorporating level of care 
(95% CI) p-value 
QIC for model: 1323 
Adjusted rate ratios 
incorporating total  
parenteral nutrition 
(95% CI) p-value 
QIC for model:1450 
Highest level of careb            
Intensive care 78/8043 (9.70) 5.36 (3.37, 8.52) <0.001 2.48 (1.34, 4.59) 0.004    
High dependency care 19/1185 (16.03) 8.38 (4.61, 15.23) <0.001 7.25 (3.73, 14.13) <0.001    
Special care 20/11,379 (1.76)  1   1     
Otherc 12/674           
            
Gestational age (weeks)            
<26 39/2966 (13.15) 2.90 (1.70, 4.96) <0.001       
26-<28 18/1645 (10.94) 2.15 (1.14, 4.04) 0.018       
28-<32 25/6082 (4.11) 0.80 (0.46, 1.39) 0.420       
32-<37 20/6198 (3.23) 0.54 (0.30, 0.96) 0.036       
≥37 27/4390 (6.15)  1        
Missingd 0/0           
            
Birth weight (g)            
<700g 38/1910 (19.90) 5.88 (3.69, 9.36) <0.001 5.78 (3.27, 10.22) <0.001 2.66 (1.58, 4.48)  <0.001 
700g-<1200g 36/5657 (6.36) 1.94 (1.24, 3.03) 0.004 2.22 (1.27, 3.86) 0.005 1.19 (0.71, 1.98)  0.508 
≥1200g 55/13,714 (4.01)  1   1   1  
Missingd 0/0           
            
Postnatal age (days)            
3-<10 56/6347 (8.82) 3.29 (1.66, 6.51) 0.001 5.06 (2.31, 11.09) <0.001 3.13 (1.45, 6.74) 0.004 
10-<20 36/5085 (7.08) 2.63 (1.29, 5.36) 0.008 4.09 (1.90,  8.80) <0.001 2.04 (0.90, 4.63) 0.086 
20-<30 15/3014 (4.98) 1.85 (0.82, 4.16) 0.138 2.93 (1.26, 6.81) 0.013 1.73 (0.72, 4.15) 0.218 
30-<40 11/1881 (5.85) 2.17 (0.91, 5.15) 0.079 2.98 (1.25, 7.13) 0.014 1.98 (0.78, 5.04) 0.153 
40-<50 1/1284 (0.78) 0.29 (0.04, 2.31) 0.239 0.38 (0.05, 2.93) 0.351 0.26 (0.03, 2.33) 0.229 
≥50 10/3670 (2.72)  1   1   1  
            
Inborn status            
Outborn 30/2875 (10.43) 1.95 (1.27, 3.00) 0.002 1.67 (1.12, 2.50) 0.013 1.58 (1.06, 2.35)  0.024 
Inborn 99/18,406 (5.38)  1   1   1  
  Missingd 0/0           
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Sex            
Male 72/11,098 (6.49) 1.14 (0.80, 1.64) 0.467       
Female 57/10,183 (5.60)  1        
            
Delivery method            
Emergency CSe 46/7393 (6.22) 0.99 (0.66, 1.48) 0.965       
Elective CSe 25/4720 (5.30) 0.83 (0.51, 1.33) 0.431       
Vaginal 58/9158 (6.33)  1        
Missingd 0/10           
            
Number of blood samples 
taken b 
           
≥2 1/207 (4.83) 0.68 (0.10, 4.85) 0.703       
1 14/3499 (4.00) 0.59 (0.35, 0.99) 0.047       
0 114/17,575 (6.49)  1        
            
Surgeryb            
Yes 3/644 (4.66) 0.73 (0.25, 2.16) 0.573       
No 126/20,637 (6.11)  1        
            
Total parenteral nutritionb            
Yes 72/3375 (21.33) 6.50 (4.53, 9.33) <0.001    4.30 (2.63, 7.04)  <0.001 
No 57/17,906 (3.18)  1      1  
            
Ventilationb            
Yes 75/7093 (10.57) 2.80 (1.99, 3.93) <0.001       
No 54/14,188 (3.81)  1        
b - In the previous three days 
c - ‘Other’ indicates that for the previous three days, the baby was outside the NICU. For example at another hospital or undergoing surgery. 
d - Days/babies with missing variables were few and represented few episodes of BSI. For this reason I considered it acceptable to remove them from the 
analyses. 
e - CS- Caesarean section 
7. Analyses of factors predicting infection: Case 
control study 
 
7.1 Summary 
In Chapter 6 I suggested that adjustment of BSI rates by level of care, birth weight,  
inborn/outborn status and postnatal age could provide meaningful comparisons between 
NICUs. This chapter provides an alternative analysis to that described in Chapter 6. It 
presents a novel method which can describe predictive associations between procedure-
related risk factors and BSI episodes, whilst removing bias in the length of follow-up. 
 
I used a case control study design: cases were babies experiencing at least one episode 
of BSI, and controls were babies who were present in the NICU at the same age (in 
days) as their matched case’s age at first BSI. This age was taken as the censoring day 
for both cases and controls. In conditional logistic regression models, NHS level of 
care, total parenteral nutrition, birth weight, gestational age at birth and inborn/outborn 
status were significant independent risk factors for BSI, with level of care being the 
strongest. The effect of postnatal age could not be evaluated in this analysis as this 
factor was used to match cases and controls. The odds ratio for BSI adjusted for birth 
weight and inborn/outborn status was 4.38 (95% CI 2.32, 8.27) in intensive care and 
14.63 (95% CI 6.94, 30.83) in high dependency care, relative to the baseline special 
care. The case control study gave larger risk estimates than the Poisson regression 
analyses described in Chapter 6. 
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 The true effects on BSI of the risk factors analysed were likely to be between the effects 
estimated by the analytical approaches described in Chapter 6 and this chapter. Despite 
the methodological differences between the two analyses, they yielded similar 
conclusions. 
 
7.2 Introduction 
The previous chapter identified various significant independent risk factors for BSI, and 
suggested that adjustment of BSI rates by NHS level of care, birth weight, 
inborn/outborn status and postnatal age could provide meaningful comparisons between 
NICUs.  A strength of the analysis in Chapter 6 was its comparability with a previous 
study that had used similar analytic methods,34 however it was prone to bias associated 
with differences in the length of follow-up between babies with and without BSI. 
 
This chapter provides an alternative analysis to that described in Chapter 6, using 
logistic regression models assuming a matched case control design. Cases and controls 
were chosen from the same dataset used for Chapter 6. This is a novel method which 
can describe predictive associations between procedure-related risk factors and BSI 
episodes, whilst removing bias in the length of follow-up. 
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7.3 Methods 
 
7.3.1 Study population, case definition and potential risk factors 
The study population, case definition and potential risk factors were defined as for 
Chapter 6 (refer to Sections 6.3.1, 6.3.2 and 6.3.3). Probable maternally-transmitted BSI 
episodes occurring during the first 48 hours of life were excluded.  
 
In a case control study, factors used to match cases and controls cannot be analysed in 
regression models. Age at infection was used for matching cases and controls in this 
study, which ensured consistent follow-up time for babies within each matched pair, but 
it meant that the effect of postnatal age could not be analysed. To be able to investigate 
the BSI risk associated with the other potential risk factors, only age at infection was 
used for matching. 
 
7.3.2 Selection of controls  
Babies experiencing at least one episode of BSI were defined as cases. Controls were 
babies who were present in the NICU at the same age (in days) as their matched case’s 
age at first BSI. Controls were defined using the following control selection strategies: 
 
1 - Babies who had no episodes of BSI during their NICU stay 
2 - Babies who had no episodes of BSI on or before the age used for matching 
3 - Babies who had no episodes of BSI in the eight days up to and including the age 
used for matching 
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With control selection strategy 1, controls were babies who remained completely free 
of infection. Control selection strategy 3 included the greatest number of babies with 
potential experience of infection. 
 
For each control selection strategy, each case was matched with two controls. Except 
for one to two cases described in footnotes to the results tables, controls were not 
selected twice, so the vast majority of cases did not share controls. Each control 
selection strategy was carried out for the hospitals combined and separate. When the 
hospitals were combined, matched cases and controls did not necessarily come from the 
same NICU. When the hospitals were separated, all cases and controls were taken from 
the same NICU. 
 
Each case’s age at first BSI was the age used for matching, and this was taken as the 
censoring age for both cases and controls. In contrast to the Poisson regression models 
described in Chapter 6, this removed bias due to differences in follow-up by ensuring 
that infected and uninfected babies were observed for similar lengths of time. For each 
baby, I recorded the presence of each procedure-related factor in the three days prior to 
the censoring age. The structure of the datasets used, with censoring ages labelled 
according to the procedure-related exposures in the previous three days, is shown in 
Figure 7.1. 
 
7.3.3 Statistical analyses 
Conditional logistic regression models98 were fitted to estimate the ratio of the odds of 
BSI in cases and controls, between separate strata of each potential risk factor. Potential 
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risk factors significantly associated with BSI (p<0.01) were examined in combination 
using conditional logistic regression and stepwise forward selection of risk factors based 
on the AIC. As in Chapter 6, due to correlations between covariates, separate adjusted 
models were built incorporating gestational age at birth, birth weight, total parenteral 
nutrition and ventilation. The set of risk factors corresponding to the lowest AIC was 
included in the final adjusted model. Once the optimal combination of risk factors was 
defined, the AIC was compared between models fitted with and without interactions 
between level of care, total parenteral nutrition or ventilation and gestational age, birth 
weight or inborn/outborn status. The analyses were repeated for each control selection 
strategy and for each hospital separately. 
 
7.3.4 Sensitivity analyses incorporating five and eight categories of birth 
weight and birth weight standardised for gestational age 
As in Chapter 6, Section 6.3.5, I carried out the following sensitivity analyses: 
 
Analyses incorporating five and eight categories of birth weight 
To investigate effects in babies with birth weights above 1200g, I analysed the effect on 
BSI of birth weight split into five and eight categories: 
 
1. 700, 700<-1200, 1200-<2500, 2500-<3500, ≥3500g 
2. <500, 500-<1000, 1000-<1500, 1500-<2000, 2000-<2500, 2500-<3000, 3000-
<3500, ≥3500g 
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 Analyses incorporating birth weight standardised for gestational age 
I also investigated whether babies born smaller than expected for their gestational age 
were at increased risk for BSI, by analysing the effect of birth weight standardised for 
gestational age, expressed as standard deviation scores.  
 
7.4 Results 
The 236 first episodes of BSI included in the analysis for Chapter 6 (whose constituent 
organisms are listed in Chapter 6, Section 6.4) were used to define the cases. When the 
hospitals were combined, each control selection strategy included 708 babies (236 cases 
and 472 controls), split roughly equally between both hospitals. 
 
Control selection strategy 1 
In keeping with the results from Chapter 6, level of care was the single strongest risk 
factor for BSI, in terms of optimising the AIC. The odds of infection were eleven to 
twelve times higher in babies recently cared for in high dependency or intensive care, 
rather than in special care (Table 7.1). The optimal adjusted model consisted of level of 
care, birth weight and inborn/outborn status (Table 7.2). No significant interactions 
were found between level of care and birth weight or between level of care and 
inborn/outborn status. 
 
Total parenteral nutrition was the second strongest risk factor for BSI. In NICU 2, the 
odds of infection were about ten times higher in babies recently treated with total 
parenteral nutrition, than in babies not recently treated with this procedure. The optimal 
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adjusted model incorporating total parenteral nutrition also included gestational age at 
birth and inborn/outborn status (Table 7.4). The effect of ventilation was attenuated by 
adjustment for gestational age and inborn/outborn status (adjusted odds ratio 1.74, 95% 
CI 0.84, 3.58, p=0.135). No significant interactions were found between total parenteral 
nutrition or ventilation and gestational age, or inborn/outborn status. 
 
As in Chapters 5 and 6, BSI risk was highest in the most premature and in term babies, 
in babies with birth weights below 1200g, and in outborn babies. The optimal adjusted 
model retained birth weight and inborn/outborn status as independent risk factors for 
BSI (Table 7.2). No significant associations were found between BSI and NICU, sex, 
delivery method, the number of blood samples taken or surgery (Table 7.1).  
 
Similar results were found when the NICUs were analysed separately (Tables 7.3 and 
7.4). However, for NICU 1, the optimal adjusted model included level of care, 
gestational age and inborn/outborn status, rather than level of care, birth weight and 
inborn/outborn status (Table 7.3). 
 
Control selection strategies 2 and 3 
By definition, the controls selected in strategy 1 could not include any babies with BSI 
episodes. For control selection strategies 2 and 3, babies could be counted twice in the 
analyses, as both case and control. When both hospitals were combined, 39 out of 708 
babies were counted twice in strategy 2, and 100 out of 708 babies were counted twice 
in strategy 3. 
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Analyses based on control selection strategy 2 gave similar results to those based on 
strategy 1. However, both crude and adjusted estimates of effect generally decreased 
(Tables 7.5, 7.6, 7.7, Appendix to Chapter 7). In addition, in crude analyses, gestational 
age was not significantly associated with BSI incidence at NICU 1 (Table 7.6, 
Appendix to Chapter 7) and inborn/outborn status was not significantly associated with 
BSI incidence at NICU 2 (Table 7.7, Appendix to Chapter 7). 
 
Analyses based on control selection strategy 3 also gave similar results to those based 
on strategy 1, but estimates of effect were decreased even further than those resulting 
from strategy 2 (Tables 7.8, 7.9, 7.10, Appendix to Chapter 7). In addition, when both 
hospitals were combined, the optimal adjusted model included level of care, gestational 
age and inborn/outborn status, rather than level of care, birth weight and inborn/outborn 
status (Table 7.8, Appendix to Chapter 7). At NICU 1, the optimal adjusted model 
included level of care and inborn/outborn status only (Table 7.9, Appendix to Chapter 
7). At NICU 2, inborn/outborn status was not significantly associated with BSI 
incidence in crude analyses (Table 7.10, Appendix to Chapter 7).  
 
7.4.1 Sensitivity analyses incorporating five and eight categories of birth 
weight and birth weight standardised for gestational age 
 
Analyses incorporating five and eight categories of birth weight 
The sensitivity analyses did not reveal any significant variation in BSI risk for babies 
with birth weights above 1200g (Table 7.1). In the multivariable analysis, the model 
 173
including three birth weight categories was optimal, having the smallest AIC (Table 
7.2). 
 
Analyses incorporating birth weight standardised for gestational age 
Birth weight standardised for gestational age had no significant effect on BSI in crude 
analyses, so it was not included in the multivariable models (Table 7.1). 
 
The results of these sensitivity analyses were consistent with the results of the Poisson 
regression analyses in Chapter 6, described in Section 6.4.1 and discussed in Section 
6.5.1.  
 
7.5 Discussion 
As in Chapter 6, highest NHS level of care and total parenteral nutrition in the previous 
three days were the strongest single risk factors for BSI. The optimal adjusted models 
combined these risk factors with either birth weight or gestational age at birth and 
inborn/outborn status. 
 
In this chapter I present a novel, alternative analytical method in the case control study 
design. As described in Chapter 6 (Section 6.5), previous analyses of predictive 
relationships between potential risk factors and BSI episodes have truncated follow-up 
time at infection for infected babies, and at discharge from the NICU for uninfected 
babies.34 This approach is prone to bias as follow-up time differs systematically 
between infected and uninfected individuals.93 The case control analyses avoided this 
bias, as infected and uninfected babies were followed up for similar lengths of time. By 
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simulating censoring dates for controls, I created equivalent, age-matched time points 
for cases and controls. However, as explained in Section 7.3.1, whilst ensuring 
consistent follow-up for cases and controls, this approach precluded the analysis of 
postnatal age, which was found to be a significant independent risk factor for BSI in the 
Poisson regression analyses described in Chapter 6. 
 
Whereas the Poisson regression models in Chapter 6 compared admission days with and 
without infection, the analyses based on control selection strategy 1 in this chapter 
compared babies experiencing infection with babies never having experienced infection. 
These babies may differ in susceptibility in ways that are not measured, and that may be 
correlated with potential risk factors. The associations found between potential risk 
factors and BSI may thus be partly due to these unmeasured confounders. This 
confounding may explain why the associations found in the case control study were 
stronger than those established by the Poisson regression models. Associations may also 
have been stronger for the case control study because conditional logistic regression 
models estimate odds ratios, which are larger than rate ratios for non-rare events. 
Confidence intervals were also wider for the results of the case control study in 
comparison with the results of the Poisson regression models, because of the smaller 
number of subjects analysed. On the other hand, the Poisson regression analyses 
included prolonged periods of follow up of uninfected babies, during which more 
mature babies exposed to potential risk factors would have been less susceptible to 
infection than at earlier ages. This may have attenuated associations between risk 
factors and BSI. The true effects on BSI of the risk factors analysed are therefore likely 
to be in between the effects estimated by these two analytical approaches. Despite the 
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methodological differences between the two analyses, in practice they yielded similar 
conclusions. I would recommend using both approaches when analysing risk factors for 
BSI in NICUs. 
 
The unmeasured differences in susceptibility between cases and controls described 
above may also explain why effect estimates decreased with control selection strategies 
2 and 3. From strategy 1 to strategy 3, the rule specifying that controls should not have 
had a BSI episode was progressively relaxed, and controls became closer in 
susceptibility to cases. Differences between cases and controls in unmeasured 
confounders may therefore have reduced, which may have decreased the estimates of 
effect for the risk factors I analysed. The results for control selection strategy 1 
described factors which predict whether a baby experiences any infection during the 
NICU stay. The results for control selection strategy 3 described factors which predict 
when a baby experiences infection. In this respect, control selection strategy 3 was 
closest to the Poisson regression method described in Chapter 6. In terms of infection 
monitoring, control selection strategy 3 may be the most relevant, provided the 
assumption that eight days following a BSI episode is sufficient time for a baby’s 
infection risk to return to his or her baseline. This assumption is reasonable, as 
following an infection episode, we could expect about five days of antibiotic treatment, 
followed by about three days for the development of clinical symptoms of a new 
infection, prompting a repeat blood culture. In strategies 2 and 3, some babies featured 
as both cases and controls. This may have introduced bias as cases spending longer 
periods in the NICU were more likely to also be included as controls. Babies remaining 
for longer in the NICU may have more complex conditions requiring very invasive care, 
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which would make them more susceptible to BSI and would decrease estimates of 
effect. However, babies spending longer in the NICU may also be more mature and less 
susceptible to infections, which would increase estimates of effect.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Key conclusions of Chapter 7 
Findings  
 Optimal adjusted models generally included level of care, birth weight 
and inborn/outborn status as the strongest independent predictors for 
BSI when the NICUs were combined. 
Conclusions 
 This confirmed the conclusion of Chapter 6 that adjustment of BSI 
rates by these factors could provide meaningful comparisons between 
NICUs.  
 The case control study design is a novel, alternative analytical method 
which can elaborate predictive associations between risk factors and 
BSI, whilst minimising bias associated with the length of follow-up. 
 However, this approach did preclude the evaluation of postnatal age, 
which was found to be a significant independent risk factor for BSI in 
Chapter 6. 
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Figure 7.1 Diagram to describe stays in the NICU for three hypothetical cases and their controls. NICU stays were translated 
into a dataset with censoring ages labelled according to procedure-related exposures in the previous three days  
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Controls selected according to control scheme 1 
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Figure 7.1 (continued) Dataset with censoring ages labelled according to procedure-related exposures in the previous three 
days. Baby-days were truncated at the censoring age 
 
In three days prior to censoring age: 
Baby Censoring age (days) 
Gestational 
age (wks) 
Birth 
weight (g) Sex 
Inborn/ 
Outborn 
Delivery 
method Highest level of care 
Total 
parenteral 
nutrition? 
Ventilation? 
Number 
of blood 
samples 
taken 
CONS 
episode 
Non-CONS 
episode 
Total 
baby-days in 
NICU up to 
and including 
censoring 
age 
1 4 <26 700-<1200 Male Inborn Vaginal Intensive care Yes Yes 0 1 0 3 
4 4 ≥37 ≥1200 Female Inborn Elective 
CS 
High 
dependency 
care 
No No 1 0 0 4 
2 2 32-<37 ≥1200 Female Inborn Vaginal Other No No 0 1 0 1 
5 2 <26 <700 Male Outborn Vaginal Intensive care Yes Yes 0 0 0 2 
3 1 ≥37 ≥1200 Male Inborn Vaginal Other No No 0 1 0 1 
6 1 ≥37 ≥1200 Male Inborn Vaginal Other No No 0 0 0 1 
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Table 7.1 Case control study, control selection strategy 1. Crude results 
for NICU 1 and NICU 2 combined 
 
Potential risk factor 
Number 
of cases 
Number of 
controls 
Crude odds ratios  
(95% CI) p-value 
      
Highest level of carec      
Intensive care 138 130 11.16 (6.51, 19.13) <0.001 
High dependency care 47 41 12.32 (6.32, 23.98) <0.001 
Special care 36 286  1  
Otherd 15 15    
      
Gestational age (weeks)      
<26 72 32 7.43 (3.97, 13.89) <0.001 
26-<28 35 39 3.35 (1.69, 6.64) 0.001 
28-<32 53 127 1.23 (0.71, 2.12) 0.460 
32-<37 30 159 0.48 (0.28, 0.82) 0.007 
≥37 46 114  1  
Missinge 0 1    
      
Birth weight (g)      
< 700g 62 21 18.26 (8.99, 37.09) <0.001 
700g-<1200g 78 107 3.61 (2.31, 5.61) <0.001 
≥1200g 96 342  1  
Missinge 0 2    
      
Inborn status      
Outborn 80 78 2.78 (1.88, 4.11) <0.001 
Inborn 154 389  1  
Missinge 2 5    
      
Hospital      
NICU 2 129 240 1.16 (0.85, 1.58) 0.344 
NICU 1 107 232  1  
      
Sex      
Male  130 245 1.14 (0.83, 1.55) 0.426 
Female 106 227  1  
      
Delivery method      
Emergency CSf 92 181 0.98 (0.69, 1.39) 0.895 
Elective CSf 33 79 0.79 (0.50, 1.27) 0.333 
Vaginal 110 211  1  
Missinge 1 1    
      
Number of blood samples takenc      
≥2 2 2 1.77 (0.24, 12.77) 0.572 
1 27 66 0.77 (0.46, 1.31) 0.342 
0 207 404  1  
      
Surgeryc      
Yes 5 12 0.83 (0.29, 2.37) 0.732 
No 231 460  1  
      
Sensitivity analyses 
incorporating five and eight 
categories of birth weight and 
birth weight standardised for 
gestational age 
     
      
Birth weight (g)      
<700 62 21 10.01 (3.61, 27.77) <0.001 
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700-<1200 78 107 1.96 (0.82, 4.67) 0.128 
1200-<2500 58 234 0.48 (0.21, 1.13) 0.092 
2500-<3500 24 81 0.61 (0.25, 1.50) 0.285 
≥3500 14 27  1  
Missinge 0 2    
      
Birth weight (g)      
<500 5 1 16.28 (1.50, 176.87) 0.022 
500-<1000 115 79 4.09 (1.70, 9.85) 0.002 
1000-<1500 46 117 0.92 (0.38, 2.25) 0.856 
1500-<2000 20 105 0.33 (0.13, 0.86) 0.024 
2000-<2500 12 60 0.35 (0.13, 0.97) 0.044 
2500-<3000 8 42 0.34   (0.12, 1.02) 0.054 
3000-<3500 16 39 0.83 (0.31, 2.23) 0.711    
≥3500 14 27  1  
Missinge 0 2    
      
Standard deviation score      
<-2 38 68  0.95 (0.56, 1.61) 0.843 
-2-<-1 49 85 0.93 (0.58, 1.50) 0.773 
-1-<0 62 146 0.68 (0.43, 1.05) 0.083 
0-<1 61 98   1  
1-<2 18 51 0.57 (0.31, 1.07) 0.081 
≥2 6 19 0.50 (0.19, 1.32) 0.164 
Missinge: gest age <23 weeks 2 3    
Missinge: birth weight missing 
or birth weight and gest age 
missing 
0 2    
      
 
 
 
 
 
 
 
 
 
Table 7.2 Case control study, control selection strategy 1. Adjusted results for NICU 1 and NICU 2 combined. 
Sensitivity analyses incorporating five and eight categories of birth 
weight 
Potential risk factor 
Optimal risk adjustment model 
 
Adjusted odds ratios 
(95% CI) p-value 
AIC for model: 291 
Model including five birth 
weight categories 
 
Adjusted odds ratios 
(95% CI) p-value 
AIC for model: 294 
Model including eight birth weight 
categories 
 
Adjusted odds ratios 
(95% CI) p-value 
AIC for model: 299 
          
Highest level of carec          
Intensive care 4.38 (2.32, 8.27) <0.001 4.42 (2.33, 8.38) <0.001 4.84 (2.49, 9.38) <0.001 
High dependency care 14.63 (6.94, 30.83) <0.001 14.36 (6.83, 30.19) <0.001 15.50 (7.24, 33.20) <0.001 
Special care  1   1   1  
Otherd          
          
Birth weight (g)          
< 700g 12.03 (4.76, 30.43) <0.001       
700g-<1200g 2.37 (1.35, 4.16) 0.003       
≥1200g  1        
Missinge          
          
Inborn status          
Outborn 1.97 (1.16, 3.35) 0.012 2.04 (1.19, 3.47) 0.009 1.65 (0.99, 2.75) 0.057 
Inborn  1   1   1  
Missinge          
          
Birth weight (g)          
<700g    7.77 (1.81, 33.39) 0.006    
700g-<1200    1.52 (0.43, 5.34) 0.513    
1200-<2500    0.59 (0.18, 1.97) 0.389    
2500-<3500    0.72 (0.20, 2.63) 0.623    
≥3500     1     
Missinge          
          
Birth weight (g)          
<500       17.26 (1.04, 287.64) 0.047 
500-<1000       2.91 (0.84, 10.16) 0.093 
1000-<1500       0.78 (0.23, 2.64) 0.688 
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1500-<2000       0.45 (0.12, 1.67) 0.235 
2000-<2500       0.41 (0.10, 1.74) 0.228 
2500-<3000       0.37 (0.09, 1.52) 0.168 
3000-<3500       1.32 (0.31, 5.71) 0.710 
≥3500        1  
Missinge          
          
 
 
Table 7.3 Case control study, control selection strategy 1. Results for NICU 1g 
 
Potential risk factor 
Number of 
cases 
Number of 
controls 
Crude odds ratios 
(95% CI) p-value 
Adjusted odds ratios 
(95% CI) p-value 
         
Highest level of carec         
Intensive care 60 41 12.64 (5.82, 27.49) <0.001 8.30 (2.96, 23.25) <0.001 
High dependency care 28 27 10.51 (4.23, 26.09) <0.001 15.08 (5.06, 44.97) <0.001 
Special care 16 139  1   1  
Otherd 3 7       
         
Gestational age (weeks)         
<26 33 16 11.76 (4.30, 32.15) <0.001 2.15 (0.57, 8.07) 0.256 
26-<28 17 20 3.82 (1.47, 9.95) 0.006 0.73 (0.20, 2.65) 0.637 
28-<32 28 51 2.07 (0.98, 4.40) 0.058 1.31 (0.49, 3.49) 0.593 
32-<37 10 66 0.38 (0.14, 1.01) 0.053 0.30 (0.08, 1.05) 0.060 
≥37 19 60  1   1  
Missinge 0 1       
         
Birth weight (g)         
≤ 700g 24 12 16.77 (5.62, 49.98) <0.001    
700g-<1200g 42 57 3.81 (2.02, 7.21) <0.001    
≥1200g 41 144  1     
Missinge 0 1       
         
Inborn status         
No 50 38 3.41 (2.06, 5.67) <0.001 1.72 (0.83, 3.59) 0.146 
Yes 55 172  1   1  
Missinge 2 4       
         
Sex         
Male 58 100 1.29 (0.84, 2.00) 0.242    
Female 49 114  1     
         
Delivery method         
Emergency CSf 46 83 1.16 (0.71, 1.91) 0.546    
Elective CSf 8 22 0.77 (0.33, 1.82) 0.555    
Vaginal 52 108  1     
Missinge 1 1       
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Number of blood samples takenc         
≥2 1 1 2.18 (0.13, 35.21) 0.583    
1 13 20 1.37 (0.65, 2.91) 0.411    
0 93 193  1     
         
Surgeryc         
Yes 2 3 1.33 (0.22, 7.98) 0.753    
No 105 211  1     
         
 
 
 
 
 
 
Table 7.4 Case control study, control selection strategy 1. Results for NICU 2 
 
 
 
Potential risk factor 
Number of 
cases 
Number of 
controls 
Crude odds ratios 
(95% CI) p-value 
Adjusted odds ratios 
incorporating level of care 
(95% CI) p-value 
AIC= 171.45 
Adjusted odds ratios 
incorporating total 
parenteral nutrition 
(95% CI) p-value 
AIC= 192.39 
            
Highest level of carec            
Intensive care 78 76 9.32 (4.64, 18.70) <0.001 3.60 (1.54, 8.39) 0.003    
High dependency care 19 15 10.40 (4.13, 26.19) <0.001 10.61 (4.02, 28.01) <0.001    
Special care 20 156  1   1     
Otherd 12 11          
            
Gestational age (weeks)            
<26 39 14 10.66 (4.18, 27.22) <0.001    3.07 (1.01, 9.34) 0.048 
26-<28 18 14 4.72 (1.81, 12.34) 0.002    1.72 (0.58, 5.12) 0.333 
28-<32 25 64 1.09 (0.50, 2.36) 0.827    0.62 (0.25, 1.52) 0.296 
32-<37 20 99 0.50 (0.25, 1.00) 0.051    0.48 (0.22, 1.04) 0.062 
≥37 27 67  1      1  
Missinge 0   0          
            
Birth weight  (g)            
≤ 700g 38 14 11.12 (5.17, 23.94) <0.001 6.16 (2.29, 16.57) <0.001    
700g-<1200g 36 44 3.56 (1.96, 6.47) <0.001 2.21 (1.01, 4.82) 0.046    
≥1200g 55 200  1   1     
Missinge 0   0          
            
Inborn status            
No 30 23 3.18 (1.72, 5.90) <0.001 1.83 (0.83, 4.04) 0.133 2.21 (0.96, 5.07) 0.062 
Yes 99 235  1   1   1  
Missinge 0 0          
            
Sex            
Male 72 139 1.09 (0.70, 1.70) 0.706       
Female 57 119  1        
            
Delivery method            
Emergency CSf 46 92 0.98 (0.61, 1.57) 0.943       
Elective CSf 25 51 0.97 (0.55, 1.70) 0.914       
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Vaginal 58 114  1        
Missinge 0 1          
            
Number of blood samples takenc            
≥2 1 2 0.94 (0.08, 10.36) 0.956       
1 14 39 0.64 (0.32, 1.29) 0.215       
0 114 217  1        
            
Surgeryc            
Yes 3 6 1 (0.25, 4.00) 1.00       
No 126 252  1        
            
Total parenteral nutritionc            
Yes 72 29 9.98 (5.38, 18.49) <0.001    6.32 (3.14, 12.70) <0.001 
No 57 229  1      1  
            
Ventilationc            
Yes 75 63 4.86 (2.92, 8.11) <0.001       
No 54 195  1        
            
   c - In the three days prior to the censoring age 
   d - ‘Other’ indicates that for the three days prior to the censoring age, the baby was outside the NICU. For example at another hospital or undergoing surgery. 
e - Babies with missing variables were few and represented few episodes of BSI. For this reason I considered it acceptable to remove them from the analyses. 
f - CS- Caesarean section 
g - For cases with higher ages (in days) at BSI, the number of controls available for selection became scarce. For control selection strategy 1 at NICU 1, two cases 
with ages at BSI of 111 and 132 days had to share controls with other cases.  
 
 
 
 
8. A method for monitoring blood stream 
infection in neonatal intensive care units  
 
8.1 Summary 
Findings from previous chapters are collated to propose a method for prospective 
monitoring of NICU-acquired BSI. The method is demonstrated for NICUs 1 and 2, to 
illustrate how it could be applied to a larger group of units. Two monitoring techniques 
are demonstrated which could be used in tandem. Both relied on comparisons of 
observed numbers of BSI episodes at each NICU with expected numbers derived from 
both units. Comparisons were adjusted for differences between hospitals and over time 
in the distributions of: baby-days spent at each NHS level of care, birth weight, 
inborn/outborn status and postnatal age. 
 
Firstly, to give standardised infection ratios, observed numbers of BSI episodes were 
divided by expected numbers for each NICU and year. These showed no significant 
differences between hospitals, except for a slightly increased incidence for NICU 1 in 
2002 (standardised infection ratio 1.43, 95% CI  1.08, 1.85). Secondly, a sequential 
probability ratio test (SPRT) can trigger alarms if BSI incidence increases significantly 
over time. No significant increases or decreases were observed for either NICU over the 
time period. 
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Both monitoring techniques are easy to implement with software available to NICUs. 
They can monitor changes in infection incidence over time and could encourage sharing 
of improved infection control practices between NICUs.  
 
8.2 Introduction: synthesis of thesis findings into a method 
for prospective monitoring 
This chapter brings together findings from the previous chapters to propose a method 
for prospective monitoring of BSI in NICUs that could be used in practice. 
 
Findings from the various analytic approaches used in Chapters 3, 5, 6 and 7 
consistently showed that there was no significant difference in the incidence of BSI 
between the NICUs analysed. In this chapter I demonstrate a method for comparative 
monitoring in NICUs 1 and 2, which could be applied to a wider group of NICUs which 
may display significant differences.  
 
The analytic approaches used in previous chapters showed that the strongest predictors 
for BSI incidence recorded in routine data were: NHS level of care, total parenteral 
nutrition, birth weight, gestational age, and inborn/outborn status. The risk adjustment 
model which most consistently provided a good fit to the data, whilst describing risk for 
all babies throughout their NICU stay, included level of care, birth weight and 
inborn/outborn status. The analytic approach described in Chapter 6 enabled the 
evaluation of postnatal age, and its results indicated that this factor should also be 
included in the risk adjustment model. I will demonstrate a method for monitoring BSI 
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incidence, adjusted for differences between hospitals and over time in the distributions 
of: baby-days spent at each NHS level of care, baby-days grouped according to 
postnatal age, and babies cared for with various birth weights and inborn/outborn status. 
 
As described in Chapter 5, if a monitoring system is to rely on current routine data 
systems, positive blood cultures provide the only information on which to base a case 
definition for BSI. If NICUs wish to differentiate between infections more or less likely 
to represent blood sample contamination, rates can be reported separately for CONS and 
non-CONS BSI. As I found patterns in CONS and non-CONS BSI incidence to be 
broadly similar, I will demonstrate a method for monitoring total BSI incidence. In 
Chapter 5 I also described a shift in the aetiology of BSI from maternally-transmitted to 
hospital-acquired at around day two of life. In this chapter I used data from day three of 
life to demonstrate monitoring for hospital-acquired BSI. 
 
I will describe a monitoring method encompassing two approaches: yearly standardised 
infection ratios and a quarterly sequential probability ratio test (SPRT).  
 
8.3 Methods 
 
8.3.1 Study population and case definition 
As mentioned in Chapter 5, adjustment of BSI incidence by procedure-related factors 
was only possible if precise dates were recorded for these variables, so the risk adjusted 
monitoring method could only be demonstrated for NICUs 1 and 2, and not for NICU 3. 
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The study population and case definition were defined as in Chapters 6 and 7 (refer to 
Sections 6.3.1 and 6.3.2). I excluded probable maternally-transmitted BSI episodes 
occurring during the first 48 hours of life. Chapters 6 and 7 included only the first 
episode of BSI per baby, in order to concentrate on predictive risk factors for infection. 
In this chapter I aimed to monitor the burden of infection in NICUs, so all BSI episodes 
were included.  
 
8.3.2 Creating an aggregated dataset 
In Chapter 3, I demonstrated an aggregated dataset relying on routine data, which would 
permit the monitoring of BSI incidence with minimal data manipulation (refer to Figure 
3.2). Instead of re-using this dataset, I aggregated the datasets created in Chapter 4 
(Figure 4.4), which contain a record for each baby-day, because they were created using 
the more thorough strategies to match blood cultures with administrative data. I 
generated a dataset with a structure resembling that described in Chapter 3 (Figure 3.2), 
consisting of aggregated quarterly totals of BSI episodes and baby-days, stratified by 
NHS level of care, birth weight, inborn/outborn status and postnatal age. The following 
birth weight strata were chosen: <700g, 700-<1200g, ≥1200g, as these categories best 
described variation in BSI risk in Chapters 6 and 7 (Section 6.4.1 and Section 7.4.1). 
Strata of 3-<20 days and ≥20 days of postnatal age were chosen, as the risk of BSI was 
significantly greater in babies below 20 days of age than in older babies (Chapter 6, 
Section 6.5). BSI episodes and baby-days from the first two days of life were removed, 
as early-onset BSI is likely to reflect maternally-transmitted infection. Baby-days 
pertaining to babies with missing birth weights and/or missing inborn/outborn status 
were also removed, as these could not be stratified. Rates were aggregated by quarter 
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rather than by month, as I judged that quarterly monitoring would maintain continuity 
of surveillance whilst minimising workload for NICUs. 
 
8.3.3 Estimating expected numbers of BSI episodes 
Both the yearly standardised infection ratios and the quarterly SPRT were based on a 
comparison of the observed number of BSI episodes against the number expected 
according to a risk adjustment procedure. Expected numbers were estimated using a 
Poisson generalised linear model. The model included data for both hospitals over the 
whole time period. The outcome was episodes of BSI, the offset or denominator was 
baby-days, and level of care, birth weight category, inborn/outborn status and postnatal 
age category were included as covariates. The model’s coefficients referred to the 
expected rate of BSI for each risk stratum (refer to the worked example in Figure 8.1). 
These rates were multiplied by the numbers of stratified baby-days for each hospital and 
year (for standardised infection ratios) and for each hospital and quarter (for the SPRT). 
This gave the number of BSI episodes expected, given variations between hospitals and 
over time in the number of baby-days at each risk stratum.   
 
8.3.4 Yearly standardised infection ratios 
Standardised infection ratios were calculated by dividing the observed by the expected 
number of BSI episodes, for each hospital and year.99 Confidence limits assuming 
Poisson counts were defined for each ratio. 
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8.3.5 Quarterly sequential probability ratio test 
The SPRT is a method for continuous monitoring first developed by Wald.100 It defines 
thresholds to determine when the observed outcome diverges unacceptably from the 
expected. These thresholds could be set for a single time point using confidence 
intervals. However, this does not allow for the fact that, with many time points, the true 
null hypothesis is likely to be eventually rejected, which could result in unfair 
accusations of poor performance. The SPRT allows for multiple time points and is 
described below. 
 
The test statistic100,101 
The SPRT was designed to carry out a test of a null hypothesis H0, versus an alternative 
H1 defined as: 
 
H0 : no increase in observed numbers of BSI episodes over expected 
H1 : a level of performance considered importantly divergent.  
 
I considered H1 as a 30% increase over the expected number of BSI episodes. An 
‘important’ change in BSI incidence has not been defined for the NICU context, so this 
was an arbitrary figure, chosen as Kilbride et al. (2003) considered a 30% change in 
BSI incidence to be an important indicator of infection control practices within the 
Vermont Oxford Network of NICUs.52 The choice of H1 is discussed further in Chapter 
9. 
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The SPRT involves plotting, for each yearly quarter, t: 
Xt = Xt-1 + Wt 
X = 0 0 
Where t = 1,2,3… is the yearly quarters numbered sequentially for the whole time 
period  
 
For each value of t, the probability of witnessing the observed number of BSI episodes, 
Yt, is proportional to: L0t under H0, and L1t under H1 
 
 
 
 
Wt = log(L1t/L0t) 
  
The observed numbers of BSI episodes follow a Poisson distribution, so Wt can be 
calculated thus: 
 
Wt = Ytlog(R1) - λ0(R1-1)
where 
Yt = observed number of BSI episodes 
λ0 = expected number of BSI episodes 
R1 = λ1/ λ0 = change to be measured
 
I assumed λ1/ λ0 = 1.3, corresponding to a 30% increase as previously defined.
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Thresholds100,101 
Values of the test statistic lie between lower and upper thresholds denoted a and b. 
When the test statistic exceeds b, H1 is accepted over H0, and when it is less than a, H0 
is accepted over H1. The thresholds form horizontal lines, and are defined as: 
 
a = log[β/(1- α)] 
b = log[(1- β)/α)] 
 
where 
α - probability of eventually rejecting H0 when it is true (Type I error) 
β - probability of eventually rejecting H1 when it is true (Type II error) 
 
The values of α and β can be chosen to reflect the relative costs of making the two types 
of error. Because they are defined for the whole SPRT process, rather than for each 
quarter, they account for multiple testing. Several values can be chosen for α and β 
respectively, to denote different degrees of urgency, for example ‘alert’ and ‘alarm’. I 
chose equal values for α and β, which gave the following values for a and b:  
 
α = β = 0.01 for ‘alert’, corresponding to:  
a = - 4.6 
b = 4.6 
 
α = β = 0.001 for ‘alarm’, corresponding to: 
a = - 6.91 
b = 6.91 
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The calculation of the test statistic was restarted (by bringing the cumulative calculation 
back to 0) when the ‘accept H0’ boundary a was crossed. This avoided the build-up of 
credit, where unacceptable increases in infection rates are masked by previous 
decreases.  
 
I also constructed an SPRT for which H1 was defined as a 30% decrease below the 
expected number of BSI episodes. The test statistic was calculated the same way, except 
that R1 was defined as 0.7 (λ1/ λ0 = 0.7).  
 
Finally, I constructed an SPRT to detect increases in infection incidence without risk 
adjustment. Expected numbers of BSI episodes were estimated by multiplying the 
single, non-stratified rate of BSI for both hospitals over the whole time period, by the 
numbers of baby-days in each quarter, for each hospital.  
 
8.4 Results 
A total of 322 episodes of BSI were included in the monitoring method, of which: 232 
were CONS, 4 were Group B streptococcus, 46 were Gram positive organisms other 
than Group B streptococcus, 35 were Gram negative organisms and 5 were yeasts. 2230 
babies were included (901 from NICU 1 and 1329 from NICU 2). The slight 
discrepancy compared with the number of babies analysed in Chapter 6 (2269) is 
because baby-days that could not be stratified were excluded. 24 babies not cared for in 
either special care, high dependency or intensive care after day two of life (for example 
because they were treated in surgery) were excluded, as were 15 babies with missing 
birth weights and/or missing inborn/outborn status.  
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 Tables 8.2 to 8.6 (Appendix to Chapter 8) show the stratified observed numbers of BSI 
episodes and baby-days for each hospital and year. Figure 8.2 shows quarterly rates of 
BSI, for both hospitals. As the study period ran from May 2001 to February 2005 
inclusive, the first and last years and quarters did not contain data for the full time 
interval. This did not affect the analysis, as expected numbers of BSI episodes were 
calculated for the truncated numbers of baby-days observed. 
 
8.4.1 Yearly standardised infection ratios 
Table 8.1 shows standardised infection ratios for each hospital and year. The ratios were 
mostly close to 1, indicating no statistically significant difference between observed and 
expected numbers of BSI episodes. However in 2002, NICU 1 had more BSI episodes 
than expected, and this difference was significant (56 observed/39.26 expected, ratio 
1.43, 95% CI (1.08, 1.85), observed BSI rate 9.18 per 1000 baby-days). 
 
8.4.2 Quarterly sequential probability ratio test 
Figure 8.3 shows the risk adjusted SPRTs to detect increases in BSI incidence. Far from 
indicating any problems with infection control, the test statistic crossed the lower 
threshold, a, during April to June 2004 for NICU 1, and during January to February 
2005 for NICU 2. This indicated an acceptance of H0 over H1, and the assurance that a 
30% increase in observed numbers of BSI episodes over expected numbers had not 
occurred. Calculation of the test statistic was restarted at this point. 
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Figure 8.4 shows the SPRTs to detect decreases in BSI incidence. The test statistic 
crossed the lower threshold, a, during April to June 2002 for both hospitals. This 
indicated an acceptance of H0 over H1, signifying that a 30% decrease in observed 
numbers of BSI episodes over expected numbers had not occurred. The relatively early 
acceptance of H0 corresponded with a small, but non-significant, rise in BSI incidence 
during April to June 2002 for both NICUs, visible in Figure 8.2. Calculation of the test 
statistic was restarted at this point, and remained between the two thresholds for the rest 
of the study period. 
 
Figure 8.5 shows the SPRTs to detect increases in BSI incidence, constructed without 
risk adjustment. It is similar to the corresponding risk adjusted chart, except that the test 
statistic crossed the lower ‘accept H0’ threshold, a, two yearly quarters earlier for NICU 
2 (July to September 2004). 
 
8.5 Discussion 
In keeping with the findings in previous chapters, there was no significant difference in 
BSI incidence between NICUs or over time. This chapter demonstrates what could be 
carried out in larger groups of NICUs, which may display significant differences.  
 
Standardised infection ratios provide a straightforward method for comparing hospitals 
and can be included in annual reports. Infection control investigations could be targeted 
at units with BSI incidence significantly above expected (with a standardised infection 
ratio significantly above one). However, this measure does not take account of the fact 
that, with increasing hospitals and time points, it becomes more likely that a ratio will 
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exceed one significantly, simply by chance. This multiple testing problem may have 
given rise to the slightly increased ratio for NICU 1 in 2002. Monitoring systems should 
be aware of this problem, to avoid unfairly penalising units with single high ratios. 
Standardised infection ratios should be used in conjunction with the SPRT, which is 
better suited to continuous monitoring over shorter intervals because it takes multiple 
time points into account. It can also include an adjustment for multiple hospitals, like 
the one described below. 
 
The SPRT can trigger alarms if BSI incidence increases significantly over time. As the 
priority of a monitoring system is to detect unacceptable increases in incidence, the 
SPRT to detect decreases is not useful for long-term surveillance. However, it could be 
used to detect target decreases in incidence following infection control interventions. 
The SPRT is a novel approach to infection monitoring in NICUs. It is a robust method 
for comparisons over time, but it provides less information concerning differences 
between hospitals than the standardised infection ratios. Spiegelhalter et al. (2003)102 
recommend the following modifications to the SPRT, depending on a system’s 
priorities. H1 should be defined so that the chart detects the lowest range in incidence 
deemed acceptable. Different values for α and β can be chosen to reflect the relative 
costs of making Type I and Type II error. If a monitoring system wishes to avoid falsely 
identifying a satisfactory NICU as ‘higher risk’, then α should be very small. If it is 
keen not to miss a ‘higher risk’ NICU, then β should be very small. When comparing a 
large number of NICUs, more stringent thresholds are appropriate. For example, if α = β 
= 0.1 is chosen, of 10 units performing normally, we would expect one to cross the 
threshold just by chance. When monitoring n units, α = β could be adjusted to 0.1/n for 
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‘alert’ or 0.01/n for ‘alarm’. Resetting of the test statistic when it crosses the ‘accept H0’ 
boundary can retain sensitivity to changes in performance. However, NICUs should be 
aware that a series of these restarts avoids acceptance of the hypothesis that there is no 
increase in observed numbers of BSI episodes over expected (or avoids the acceptance 
of H0). This would, overall, increase the probability of falsely concluding that there is a 
significant increase (or increase the chance of a Type I error to 1) and decrease the 
probability of falsely concluding that there is no significant increase (or decrease the 
chance of a Type II error to 0).102 
 
Tables 8.2 to 8.6 (Appendix to Chapter 8) show that both monitoring techniques relied 
on small numbers of baby-days for some strata. This should not matter in practice, but 
for simplicity NICUs may prefer to group high dependency care, which includes the 
fewest babies, with intensive care, which shares a similar risk of BSI. As an alternative 
to using the Poisson regression model, expected rates can be calculated by dividing BSI 
episodes by baby-days in each risk stratum, for both hospitals over the whole time 
period, which gives almost identical results. Neither monitoring technique takes account 
of the fact that hospitals may have varying numbers of BSI episodes which are recurrent 
within babies. The risk adjustment model described would not be strictly accurate in 
this case, as babies experiencing one infection may be more or less likely to experience 
another, over and above the risk factors already adjusted for. This is difficult to correct 
for with aggregated datasets, as recurrent infections are no longer linked with babies and 
cannot be identified. However, the development of datasets with daily records for each 
baby could allow regression models which estimate expected rates adjusted for 
recurrencies. In the NICUs I analysed, the proportions of recurrencies within hospital-
 201
acquired BSI episodes were similar: 30% were recurrent at NICU 1 and 25% were 
recurrent at NICU 2 (95% CI for difference - 0.04, 0.15, p = 0.315). These percentages 
differ from the proportions of recurrent infections given in Chapter 3, Section 3.5, 
because they exclude probable maternally-transmitted BSI episodes from the first 48 
hours of life. 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Both monitoring techniques were adjusted for differences between 
hospitals and over time in the distributions of: baby-days spent at each 
NHS level of care, baby-days grouped according to postnatal age and 
babies cared for with various birth weights and inborn/outborn status. 
 Standardised infection ratios are most informative concerning 
differences between hospitals, whereas SPRTs are more robust for 
monitoring changes over time. 
Conclusions 
 Used together, standardised infection ratios and SPRTs could provide a 
powerful tool for evaluating risk-adjusted changes in BSI incidence 
between NICUs. 
Key conclusions of Chapter 8 
Findings  
 Standardised infection ratios showed that BSI incidence, analysed on a 
yearly basis, was similar for NICUs 1 and 2. 
 The SPRTs showed no substantial changes in BSI incidence over time. 
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Figure 8.1 Expected BSI rates 
 
Exponentiated coefficients of the Poisson generalised linear model 
 
Intercept (baseline rate of BSI)  
Corresponding to special care, birth weight ≥1200g, inborn and 
postnatal age ≥20 days 0.001 
Rate ratios corresponding to changes in the baseline to:  
High dependency care 5.73 
Intensive care 4.36 
Birth weight 700g-<1200g 1.08 
Birth weight <700g 1.76 
Outborn status 1.23 
Postnatal age 3-<20 days 1.76 
 
 
Worked example: calculating an expected rate 
 
For the stratum defined by intensive care, birth weight 700g-<1200g, outborn status and postnatal age 3-<20 days 
BSI rate estimated by the model  0.001 x 4.36 x 1.08 x 1.23 x 1.76 = 0.01 or ~10 per 1000 baby-days 
 
 
Expected rates (per 1000 baby-days) for each risk stratum (calculated using exact coefficients, rather than the rounded coefficients shown above) 
 
Birth weight (g) <700 700g-<1200 ≥1200 
Inborn/outborn status Inborn Outborn Inborn Outborn Inborn Outborn 
Postnatal age (days) 3-<20 ≥20 3-<20 ≥20 3-<20 ≥20 3-<20 ≥20 3-<20 ≥20 3-<20 ≥20 
Level of care             
Special care 4.44 2.53 5.48 3.12 2.72 1.55 3.36 1.91 2.52 1.43 3.11 1.77 
High dependency care 25.43 14.46 31.37 17.84 15.58 8.86 19.22 10.93 14.41 8.20 17.78 10.11 
Intensive care 19.37 11.02 23.89 13.59 11.87 6.75 14.64 8.33 10.98 6.24 13.54 7.70 
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Figure 8.2 Quarterly rates of BSI episodes, per 1000 baby-daysa 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NICU 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NICU 2 
a - As the study period ran from May 2001 to February 2005 inclusive, the first and last quarters 
did not contain the full three months of data. The vertical lines are 95% CIs.
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Figure 8.3 Risk adjusted SPRTs to detect a 30% increase in BSI episodes 
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Figure 8.4 Risk adjusted SPRTs to detect a 30% decrease in BSI episodes 
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Figure 8.5 Crude SPRTs to detect a 30% increase in BSI episodes 
 
 
 
 
 
 207
Table 8.1 Standardised infection ratios (95% CI) by NICU and year 
 
Year NICU 1 NICU 2 
2001 0.79 (0.48, 1.22) 0.96 (0.63, 1.41) 
2002 1.43 (1.08, 1.85) 1.22 (0.92, 1.59) 
2003 0.91 (0.65, 1.24) 0.98 (0.71, 1.32) 
2004 0.77 (0.54, 1.08) 0.96 (0.70, 1.28) 
2005 0.41 (0.01, 2.31) 0.28 (0.01, 1.56) 
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9. Discussion and future directions for research 
 
9.1 Summary of thesis findings 
The premise of this thesis was that comparisons between NICUs can reveal important 
differences in BSI incidence, which may result from variations in infection control 
practices. Examination of these differences can reveal NICUs with potentially better 
practices, which can be shared with other units. The systematic literature review in 
Chapter 1 showed that adjustment for case mix and the use of invasive procedures is 
commonly regarded as necessary for fair and meaningful comparisons of BSI incidence 
between NICUs. However, there is no consensus on how risk adjustment should be 
carried out. The review also indicated that the use of electronic routine hospital data 
would accelerate data collection and minimise staff workload in monitoring. 
 
The main aim of the thesis was to establish risk factors for BSI incidence recorded in 
routine data at three London NICUs. These risk factors could be adjusted for to give 
meaningful comparisons between NICUs. I presented a range of analytic approaches to 
determine risk factors (summarised in Chapter 2, Table 2.1) for two reasons. Firstly, the 
way in which procedure-related factors were recorded varied between NICUs, which 
required a variety of analytic methods. Secondly, I explored various methods for 
establishing risk factors to determine a robust approach. These methods included 
analyses of aggregate data (Chapter 3), analyses of procedure-related factors recorded as 
the sum of days treated (Chapter 5), investigation of time to the development of BSI 
(Chapter 5), and analyses of risk factors predicting BSI (Chapter 6 and Chapter 7). I 
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assessed consistency in the results, and the advantages and disadvantages of each 
method.  
 
Chapter 6 and Chapter 7 provided the two most robust methods for determining risk 
factors for BSI, these methods involved Poisson regression and a case control study. 
The two methods had different strengths, so I recommended using both approaches 
when analysing risk factors for BSI incidence in NICUs. They focused on risk factors 
preceding BSI, which can therefore be regarded as predictors, rather than potential 
consequences of BSI. Predictive risk factors can identify high risk groups who could 
benefit from preventive action or close monitoring. The Poisson regression method 
described in Chapter 6 permitted the investigation of postnatal age, which was found to 
be a significant independent risk factor for BSI, but it was prone to bias associated with 
the length of follow-up. The case control study method in Chapter 7 removed this bias, 
but it led to larger estimates of effect. The true effects of the risk factors analysed were 
likely to be in between the effects estimated by the two analytical approaches. Despite 
the differences between the two analyses, in practice they yielded similar conclusions. 
These conclusions were consistent with the interpretation of the results in previous 
chapters. In the dataset used for this thesis, daily level of care, birth weight, 
inborn/outborn status and postnatal age were significant independent risk factors for 
BSI.  
 
In Chapter 8 I demonstrated a method for prospective, comparative monitoring of BSI 
incidence, adjusted for the risk factors I had established, using a pragmatic aggregated 
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dataset. The prospective monitoring method demonstrated what could be carried out in 
larger groups of NICUs to achieve the objectives of monitoring described in Chapter 1: 
 
 Assess the burden of infection 
 Monitor changes in infection incidence over time and to trigger alarms if 
incidence increases significantly 
 Encourage sharing of improved infection control practices between NICUs 
 Monitor the outcome of interventions to improve infection control 
 
To inform NICUs concerning infection burden, feedback to NICUs could include yearly 
or quarterly observed and expected rates of BSI episodes. Rates could be stratified by 
predictive risk factors to display groups at higher risk who may benefit from close 
monitoring or preventive action. The standardised infection ratio method could 
encourage sharing of improved practices between NICUs. In any units with BSI 
incidence significantly below expected (with a standardised infection ratio significantly 
below one), infection control practices could be investigated as potentially better 
practices. These could be shared with any units with BSI incidence significantly above 
the expected. Risk adjusted standardised ratios are increasingly being used to 
investigate differences in outcomes between hospitals with a view to improving the 
overall quality of care. They are used to measure variations in adult surgical site 
infections within the German Krankenhaus Infektions Surveillance System (KISS),99 as 
well as variations in hospital mortality within several countries.103,104 
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The risk adjusted SPRT is a novel approach to infection monitoring in NICUs. It can 
trigger alarms if BSI incidence increases significantly over time, which could prompt 
investigation into the cause of the increase and the instigation of measures to control 
infection. As the priority of a monitoring system is to detect unacceptable increases in 
incidence, the SPRT to detect decreases is not useful for long-term surveillance. 
However it could be used to detect target decreases in incidence following infection 
control interventions.  
 
Used together, standardised infection ratios and the SPRT could provide risk adjusted 
monitoring using minimal time, effort and expense. Standardised infection ratios 
provide a straightforward method for comparing hospitals and can be included in annual 
reports, whereas the SPRT is better suited to continuous monitoring over time. Both rely 
on existing data collection systems, and can be calculated using software easily 
available to NICUs, such as Microsoft Excel. A data manager could arrange procedures 
for the extraction of the necessary information in to pre-prepared spreadsheets on a 
quaterly basis. Ward clerks or NICU staff would then require only minimal training to 
understand the necessary concepts and to produce the statistics in tables and graphs such 
as those shown in Chapter 8, which could be included in regular reports and audits.  
 
9.2 Thesis findings in the current UK context 
These findings are timely as they comply with recent recommendations made to the UK 
Department of Health. The second National Audit Office report on HAI recommended 
the development of infection surveillance initiatives in high risk areas such as adult, 
paediatric and neonatal intensive care.105 In response to this, the Steering Group on 
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Healthcare Associated Infection convened the ‘Surveillance in adult, paediatric and 
neonatal intensive care and high dependency units’ subgroup in April 2006, to provide 
advice to the Health Protection Agency and the Department of Health. In 2007, the 
work of the Steering Group was passed to the Advisory Committee on Antimicrobial 
Resistance and Healthcare Associated Infection (ARHAI), which published 
recommendations for HAI surveillance in February 2010. A key recommendation was 
that surveillance should use routine patient management systems to minimise costs and 
staff workload, thus ensuring long-term buy-in from hospital management and staff. It 
noted that the reporting of childhood infections by paediatricians was low in several 
studies conducted through the British Paediatric Surveillance Unit, underlining the need 
to ‘become more innovative and use routinely available data sources rather than 
conducting a series of individual and more expensive projects.’ The Appendix to 
Chapter 9 gives the full criteria for HAI surveillance established in the report.106 
 
The recommendation to exploit routine data is possible due to recent developments in 
the collection and storage of neonatal records, described in Chapter 4 (Section 4.8). 
Firstly, NICUs are increasingly using the same definitions and common systems for 
data capture and storage, which will facilitate risk adjusted comparisons between them. 
This began with the recording of ‘minimum datasets’ using standard definitions, such as 
the Neonatal Critical Care Minimum Dataset and the BAPM dataset.78 Common 
neonatal data systems, the most widespread of which is SEND, now incorporate these 
minimum datasets. Secondly, information collected by systems such as SEND is likely 
to be fairly complete and accurate. SEND is used for the day-to-day running of the 
NICU, as well as for collecting data for audits and health service commissioning. There 
is therefore considerable incentive to keep its content complete, accurate and current. 
 213
This is enhanced by the inclusion of automatic quality checks and mandatory fields in 
the data entry process.75 The exciting potential of SEND as a resource for monitoring 
and research has been recognised by the Neonatal Data Analysis Unit, which exploits it 
for the National Neonatal Audit Programme and the Newborn Patient Safety 
Programme among other projects.106 
 
As described in Chapter 4 (Section 4.8), further aspects of SEND are relevant to the 
monitoring method devised in this thesis. Firstly, SEND currently records all the factors 
used to adjust for differences in risk between NICUs, as levels of care, birth weight, 
inborn/outborn status and date of birth (used to calculate postnatal age) are required for 
each baby by the BAPM minimum dataset.78 Secondly, SEND records data items used 
to calculate levels of care on a daily basis, as this is also a BAPM requirement.87 Daily 
patient records provide the best format for infection monitoring, as BSI episodes and 
baby-days can be reported by days with potential risk factors.  
 
If a routine neonatal data system is to be used for infection monitoring, it must be linked 
with information concerning infection episodes. The case definition used for monitoring 
BSI represents an important trade-off. On the one hand, case definitions including 
clinical symptoms help to differentiate between clinically-relevant BSI and subclinical 
infection or contaminated blood cultures, but they require skilled data collection by 
clinicians. On the other hand, case definitions based on blood cultures alone may be 
more ambiguous, but they could rely on routine data from hospital microbiology 
laboratories. This would reduce the burden of data collection and may therefore provide 
a monitoring system that is more practical and sustainable than one relying on clinician 
 214
reporting. In Chapter 4 (Section 4.8) I argued that microbiology laboratory data should 
be automatically linked with neonatal data systems.  
 
An advantage of using routine microbiology laboratory data in BSI monitoring is that 
blood sampling frequency can be measured and taken into account. As explained in 
Chapter 3, Section 3.3.2, variations in blood sampling frequency could confound 
comparisons of BSI incidence, although confounding by blood sampling frequency was 
not detected in the population studied for this thesis. As explained in Chapter 5 (Section 
5.5), if NICUs wish to differentiate between infections more or less likely to represent 
blood sample contamination using routine data, rates can be reported separately for 
CONS and non-CONS BSI. I found patterns in CONS and non-CONS BSI incidence to 
be broadly similar.  
 
The NeonIN surveillance system described in Chapter 1 is similar to the monitoring 
system proposed in this thesis because it relies on positive blood cultures (excluding 
cultures for CONS) and it plans to link with neonatal data systems such as SEND 
(personal communication, Dr. Paul Heath, St George’s Healthcare NHS Trust). It differs 
from the system proposed here because it relies on reporting of infection episodes by 
clinicians. In addition, it is not risk-adjusted, its aim being to determine patterns of 
bacterial organisms in NICUs, not to provide multicentre comparisons to improve the 
overall quality of care.17 
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9.3 Future directions for research 
The approach for monitoring described in Chapter 8 should be validated using a larger 
number of NICUs. As I analysed only two NICUs from the same city, the scope for 
detecting variation was small. Even before risk adjustment, they had similar incidences 
of infection which changed little over time, as shown by the similar curves for the crude 
and risk adjusted SPRTs. This was compounded by the fact that expected rates were 
based on data for both the hospitals combined. The consistency found may partly be the 
result of comparing ‘like with like’. A greater number of NICUs would increase the 
potential to detect variation, and would provide more generalisable expected rates based 
on the overall average. The time period used to calculate expected rates should also be 
considered carefully. For example, following an infection control intervention leading 
to an overall, sustained decrease in infection incidence, expected rates should be  
recalculated to maintain sensitivity to increases in incidence. 
 
Ideally, performance of the monitoring system should be tested in about five or six 
NICUs, which equates to a neonatal network. This is convenient as neonatal networks 
are more likely to share common data systems, which would facilitate monitoring. A 
BSI monitoring system based on routine data must be constantly reevaluated as neonatal 
data systems evolve. The case definition for BSI could include some clinical symptoms, 
where these are captured by data systems. Similarly, the appropriate method of risk 
adjustment may evolve with neonatal data systems, as risk adjustment factors were 
chosen for their existence and reliability in routine data as well as for their association 
with BSI. As any statistical monitoring technique may include unforeseen bias and 
inaccuracies, the comparison of multiple techniques is most informative. I have 
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demonstrated two techniques in Chapter 8 which could be used in conjunction with each 
other, but NICUs may wish to develop more depending on the time and resources 
available to them. 
 
I found no evidence that differences in sampling frequency affected comparisons of BSI 
incidence between the NICUs analysed. However, differences in sampling frequency 
should always be investigated before NICUs are included in a monitoring system. If 
these differences are shown to confound comparisons of BSI incidence in multivariable 
analyses, measures can be taken to standardise blood sampling protocols between 
NICUs. Standardisation of blood sampling protocols is always desirable. This could 
involve the definition of clinical signs required before a blood sample is taken, as well 
as criteria for the method of sampling itself. Between 1997 and 2000, six NICUs in the 
Vermont Oxford Network implemented standardisation guidelines relating to the 
sampling method. These guidelines included: a requirement for two blood cultures on 
suspicion of BSI, protocols to prepare the skin for phlebotomy, and a recommended 
blood sample volume of 1ml.52 
 
In addition to the further research described above, a successful monitoring system will 
require thorough consultation with the stakeholders. Firstly, neonatologists and 
infection control specialists should define the threshold used to determine an 
‘unacceptable’ increase in infection over time. For the SPRT described in Chapter 8, I 
defined this threshold (H1) as a 30% increase over the expected number of BSI 
episodes. NICUs participating in a monitoring system should decide on their own 
threshold, based on their priorities, resources and current infection rates. Secondly, 
 217
 218
NICU staff must decide on the actions they will take in the event of significant variation 
in infection incidence between units or over time. As described in Chapter 1 (Section 
1.3 and Section 1.4), interventions could include the introduction of aseptic techniques 
for invasive procedures, hygiene promotion programmes and changes to NICU 
environments and staffing.16,44,45 Collaborative quality improvement initiatives could be 
introduced at the group level.51-53 ARHAI recommended that the economic effects of 
surveillance and infection control interventions must be assessed during the planning 
phase. Although investment could be more than offset by decreases in BSI and its 
associated effects such as hospital stays, treatment, readmissions, re-operations and 
social support, this economic benefit should not be taken for granted.106  
 
Thirdly, consultation among stakeholders should determine who will have access to the 
results of surveillance. The purpose of this thesis was to provide an approach for 
improving the care of babies in NICU, by alerting staff to clinically important increases 
in BSI incidence and by triggering the sharing of improved practices between units. As 
a minimum, feedback to NICUs should include their own performance in relation to the 
overall group. Issues such as whether NICUs should have access to the BSI rates of 
other participating units, or whether the results of monitoring should be made available 
to other stakeholders or the general public are beyond the scope of this thesis. Research 
and consultation will be necessary to determine best practice in these areas, to avoid the 
negative connotations associated with ranking or penalising units, which may have 
adverse effects on the morale of staff. Experience from other infection surveillance 
systems stresses that engagement with staff is fundamental to the success of any 
monitoring system.52,99,107,108 
 Key conclusions of Chapter 9 
 I achieved the main aim of this PhD project, which was to establish risk 
factors for BSI incidence in NICUs, which could be adjusted for to give 
meaningful comparisons of BSI incidence between hospitals. 
 The Poisson regression method described in Chapter 6 and the case 
control study method described in Chapter 7 have different strengths, and 
should be used together for determining risk factors for BSI incidence in 
NICUs. 
 The thesis demonstrated a method for risk adjusted, comparative 
monitoring of BSI incidence, relying exclusively on routine data. 
 Standardised infection ratios, used in conjunction with SPRTs can fulfill 
the objectives of monitoring BSI incidence in NICUs. 
 The findings of this thesis are timely. Recent recommendations made to 
the UK Department of Health call for infection surveillance in intensive 
care units and the exploitation of recent developments in routine 
electronic data systems. 
 The approach to monitoring must be validated in a wider group of 
NICUs. Research and consultation must determine ways to optimise the 
potential benefits of monitoring, whilst engaging NICU staff in the 
process. 
 219
References 
 1.  National Audit Office (2007) Caring for Vulnerable Babies: The reorganisation 
of neonatal services in England. National Audit Office, London, UK 
 2.  Draper ES, Manktelow B, Field DJ, James D (1999) Prediction of survival for 
preterm births by weight and gestational age: retrospective population based 
study. BMJ 319:1093-1097 
 3.  Moser K, Macfarlane A, Chow YH, Hilder L, Dattani N (2007) Introducing new 
data on gestation-specific infant mortality among babies born in 2005 in 
England and Wales. Health Stat Q 35;13-27 
 4.  EXPRESS Group, Fellman V, Hellström-Westas L, Norman M, Westgren M, 
Källén K, Lagercrantz H, et al (2009) One-year survival of extremely preterm 
infants after active perinatal care in Sweden. JAMA 301(21):2225-2233 
 5.  EPICure Study Group, Marlow N, Wolke D, Bracewell MA, Samara M (2005) 
Neurologic and developmental disability at six years of age after extremely 
preterm birth. N Engl J Med 352(1):9-19 
 6.  EPICure Study Group, Marlow N, Hennessy EM, Bracewell MA, Wolke D 
(2007) Motor and executive function at 6 years of age after extremely preterm 
birth. Pediatrics 120(4):793-804 
 7.  EPICure Study Group, Wolke D, Samara M, Bracewell M, Marlow N (2008) 
Specific language difficulties and school achievement in children born at 25 
weeks of gestation or less. J Pediatr 152(2):256-262 
 8.  ASDI Study Group, Metnitz B, Schaden E, Moreno R, Le Gall JR, Bauer P, 
Metnitz PG (2009) Austrian validation and customization of the SAPS 3 
Admission Score. Intensive Care Med 35(4):616-622 
 9.  Paediatric Intensive Care Audit Network (PICANet) (2009) South West Audit of 
Critically Ill Children. Annual Report April 2007-March 2008. Paediatric 
Intensive Care Audit Network, Leeds, UK 
 10.  Nagata E, Brito AS, Matsuo T (2002) Nosocomial infections in a neonatal 
intensive care unit: incidence and risk factors. Am J Infect Control 30(1):26-31 
 11.  Zafar N, Wallace CM, Kieffer P, Schroeder P, Schootman M, Hamvas A (2001) 
Improving survival of vulnerable infants increases neonatal intensive care unit 
nosocomial infection rate. Arch Pediatr Adolesc Med 155(10):1098-1104 
 12.  Horan TC, Andrus M, Dudeck MA (2008) CDC/NHSN surveillance definition 
of health care-associated infection and criteria for specific types of infections in 
the acute care setting. Am J Infect Control 36(5):309-332 
 220
 13.  Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM (1988) CDC 
definitions for nosocomial infections. Am J Infect Control 16(3):128-140 
 14.  Pediatric Prevention Network, Sohn AH, Garrett DO, Sinkowitz-Cochran RL, 
Grohskopf LA, Levine GL, Stover BH, et al. (2001) Prevalence of nosocomial 
infections in neonatal intensive care unit patients: Results from the first national 
point-prevalence survey. J Pediatr 139(6):821-827 
 15.  Gastmeier P, Hentschel J, de Veer I, Obladen M, Rüden H (1998) Device-
associated nosocomial infection surveillance in neonatal intensive care using 
specified criteria for neonates. J Hosp Infect 38(1):51-60 
 16.  UK Neonatal Staffing Study Group, Parry GJ, Tucker JS, Tarnow-Mordi WO 
(2005) Relationship between probable nosocomial bacteraemia and 
organisational and structural factors in UK neonatal intensive care units. Qual 
Saf Health Care 14(4):264-269 
 17.  Pattnayak S, Samanta S, Watts T, Menson E, Heath P (2007) Use of the neonatal 
infection network (neonin) surveillance database for analysis of infections in 
two neonatal units in London. Conference proceedings, 25th Annual Meeting of 
the European Society for Paediatric Infectious Diseases, Porto, Portugal 
 18.  UK Neonatal Staffing Study Group, Tucker J (2002) Patient volume, staffing, 
and workload in relation to risk-adjusted outcomes in a random stratified sample 
of UK neonatal intensive care units: a prospective evaluation. Lancet 
359(9301):99-107 
 19.  Gaynes RP, Edwards JR, Jarvis WR, Culver DH, Tolson JS, Martone WJ (1996) 
Nosocomial infections among neonates in high-risk nurseries in the United 
States. National Nosocomial Infections Surveillance System. Pediatrics 98(3 Pt. 
1):357-361 
 20.  Bizzarro MJ, Raskind C, Baltimore RS, Gallagher PG (2005) Seventy-five years 
of neonatal sepsis at Yale: 1928-2003. Pediatrics 116(3):595-602 
 21.  Johnson AP, Pearson A, Duckworth G (2005) Surveillance and epidemiology of 
MRSA bacteraemia in the UK. J Antimicrob Chemother 56(3):455-462 
 22.  Lessa FC, Edwards JR, Fridkin SK, Tenover FC, Horan TC, Gorwitz RJ (2009) 
Trends in Incidence of Late-Onset Methicillin-Resistant Staphylococcus aureus 
Infection in Neonatal Intensive Care Units: Data From the National Nosocomial 
Infections Surveillance System, 1995-2004. Pediatr Infect Dis J 28(7):577-581 
 23.  McNeeley DF, Saint-Louis F, Noel GJ (1996) Neonatal enterococcal 
bacteremia: an increasingly frequent event with potentially untreatable 
pathogens. Pediatr Infect Dis J 15:800-805 
 24.  Nosocomial Infection National Surveillance Service (2002) Surveillance of 
Hospital-Acquired Bacteraemia in English Hospitals 1997-2002. Public Health 
Laboratory Service, London, UK  
 221
 25.  Stiehm ER (1986) The physiologic immunodeficiency of immaturity. In: 
Immunologic Disorders in Infants and Children, 4th edition. WB Saunders, 
Philadelphia, USA 
 26.  Malek A, Sager R, Schneider H (1994) Maternal-fetal transport of 
immunoglobulin G and its subclasses during the third trimester of human 
pregnancy. Am J Reprod Immunol 32(1):8-14 
 27.  Goldmann DA, Leclair J, Macone A (1978) Bacterial colonization of neonates 
admitted to an intensive care environment. J Pediatr 93(2):288-293 
 28.  Sirota L, Straussberg R, Notti I, Bessler H (1997) Effect of lipid emulsion on IL-
2 production by mononuclear cells of newborn infants and adults. Acta Paediatr 
86(4):410-413 
 29.  Beck-Sague CM, Azimi P, Fonseca SN, Baltimore RS, Powell DA, Bland LA, et 
al. (1994) Bloodstream infections in neonatal intensive care unit patients: results 
of a multicenter study. Pediatr Infect Dis J 13(12):1110-1116 
 30.  NICHD Neonatal Research Network, Stoll BJ, Hansen N, Fanaroff AA, Wright 
LL, Carlo WA, Ehrenkranz RA, et al. (2002) Late-onset sepsis in very low birth 
weight neonates: the experience of the NICHD Neonatal Research Network. 
Pediatrics 110:285-291 
 31.  Remington JS, Klein JO, Baker C, Wilson C (2006) Obstetric Factors 
Associated with Infections in the Fetus and Newborn Infant. In: Infectious 
Diseases of the Fetus and Newborn Infant, 6th edition. Elsevier Saunders, 
Philadelphia, USA 
 32.  NICHD Neonatal Research Network, Stoll BJ, Gordon T, Korones SB, 
Shankaran S, Tyson JE, Bauer CR, et al. (1996) Early-onset sepsis in very low 
birth weight neonates: a report from the National Institute of Child Health and 
Human Development Neonatal Research Network. J Pediatr 129:72-80 
 33.  Remington JS, Klein JO, Baker C, Wilson C (2006) Infections Acquired in the 
Nursery: Epidemiology and Control. In: Infectious Diseases of the Fetus and 
Newborn Infant, 6th edition. Elsevier Saunders, Philadelphia, USA 
 34.  Holmes A, Dore CJ, Saraswatula A, Bamford KB, Richards MS, Coello R, et al. 
(2008) Risk factors and recommendations for rate stratification for surveillance 
of neonatal healthcare-associated bloodstream infection. J Hosp Infect 68:66-72 
 35.  Canadian Neonatal Network, Chien LY, Macnab Y, Aziz K, Andrews W, 
McMillan DD, Lee SK, et al. (2002) Variations in central venous catheter-
related infection risks among Canadian neonatal intensive care units. Pediatr 
Infect Dis J 21:505-511 
 36.  Canadian Neonatal Network, Aziz K, McMillan DD, Andrews W, Pendray M, 
Qiu Z, Karuri S, et al. (2005) Variations in rates of nosocomial infection among 
 222
Canadian neonatal intensive care units may be practice-related. BMC Pediatr 
8(5):22 
 37.  NICHD Neonatal Research Network, Stoll BJ, Hansen NI, Adams-Chapman I, 
Fanaroff AA, Hintz SR, Vohr B, et al. (2004) Neurodevelopmental and growth 
impairment among extremely low-birth-weight infants with neonatal infection. 
JAMA 292(19):2357-2365 
 38.  Adams-Chapman I, Stoll BJ (2006) Neonatal infection and long-term 
neurodevelopmental outcome in the preterm infant. Curr Opin Infect Dis 
19:290-297 
 39.  Sinha SK, D'Souza SW, Rivlin E, Chiswick ML (1990) Ischaemic brain lesions 
diagnosed at birth in preterm infants: clinical events and developmental 
outcome. Arch Dis Child 65:1017-1020 
 40.  Graham EM, Holcroft CJ, Rai KK, Donohue PK, Allen MC (2004) Neonatal 
cerebral white matter injury in preterm infants is associated with culture positive 
infections and only rarely with metabolic acidosis. Am J Obstet Gynecol 
191:1305-1310 
 41.  Orsi GB, d'Ettorre G, Panero A, Chiarini F, Vullo V, Venditti M (2009) 
Hospital-acquired infection surveillance in a neonatal intensive care unit. Am J 
Infect Control 37(3):201-203 
 42.  Isaacs D (2003) A ten year, multicentre study of coagulase negative 
staphylococcal infections in Australasian neonatal units. Arch Dis Child Fetal 
Neonatal Ed 88(2):F89-F93 
 43.  Payne NR, Carpenter JH, Badger GJ, Horbar JD, Rogowski J (2004) Marginal 
increase in cost and excess length of stay associated with nosocomial 
bloodstream infections in surviving very low birth weight infants. Pediatrics 
114(2):348-355 
 44.  Maas A, Flament P, Pardou A, Deplano A, Dramaix M, Struelens MJ (1998) 
Central venous catheter-related bacteraemia in critically ill neonates: risk factors 
and impact of a prevention programme. J Hosp Infect 40(3):211-224 
 45.  Pessoa-Silva CL, Hugonnet S, Pfister R, Touveneau S, Dharan S, Posfay-Barbe 
K, et al (2007) Reduction of health care associated infection risk in neonates by 
successful hand hygiene promotion. Pediatrics 120(2):e382-e390 
 46.  Gerber SI, Jones RC, Scott MV, Price JS, Dworkin MS, Filippell MB, et al. 
(2006) Management of outbreaks of methicillin-resistant Staphylococcus aureus 
infection in the neonatal intensive care unit: a consensus statement. Infect 
Control Hosp Epidemiol 27(2):139-145 
 47.  Lee TB, Montgomery OG, Marx J, Olmsted RN, Scheckler WE (2007) 
Recommended practices for surveillance: Association for Professionals in 
 223
Infection Control and Epidemiology (APIC), Inc. Am J Infect Control 
35(7):427-440 
 48.  Schwab F, Geffers C, Bärwolff S, Rüden H, Gastmeier P (2007) Reducing 
neonatal nosocomial bloodstream infections through participation in a national 
surveillance system. J Hosp Infect 65(4):319-325 
 49.  Jamtvedt G, Young JM, Kristoffersen DT, O'Brien MA, Oxman AD (2006) 
Audit and feedback: effects on professional practice and health care outcomes. 
Cochrane Database Syst Rev 19(2);CD000259 
 50.  Oxman AD, Thomson MA, Davis DA, Haynes RB (1995) No magic bullets: a 
systematic review of 102 trials of interventions to improve professional practice 
CMAJ 153(10):1423-1431 
 51.  Vermont Oxford Network, Kilbride HW, Powers R, Wirtschafter DD, Sheehan 
MB, Charsha DS, LaCorte M, et al. (2003) Evaluation and development of 
potentially better practices to prevent neonatal nosocomial bacteremia. 
Pediatrics 111(4 Pt. 2):e504-e518 
 52.  Vermont Oxford Network, Kilbride HW, Wirtschafter DD, Powers RJ, Sheehan 
MB (2003) Implementation of evidence-based potentially better practices to 
decrease nosocomial infections. Pediatrics 111(4 Pt. 2):e519-e533 
 53.  Bloom BT, Craddock A, Delmore PM, Kurlinski JP, Voelker M, Landfish N, et 
al. (2003) Reducing acquired infections in the NICU: observing and 
implementing meaningful differences in process between high and low acquired 
infection rate centers. J Perinatol 23(6):489-492 
 54.  Couto RC, Pedrosa TM, Tofani CP, Pedroso ER (2006) Risk factors for 
nosocomial infection in a neonatal intensive care unit. Infect Control Hosp 
Epidemiol 27(6):571-575 
 55.  Brodie SB, Sands KE, Gray JE, Parker RA, Goldmann DA, Davis RB, et al. 
(2000) Occurrence of nosocomial bloodstream infections in six neonatal 
intensive care units. Pediatr Infect Dis J 19(1):56-65 
 56.  Carrieri MP, Stolfi I, Moro ML (2003) Intercenter variability and time of onset: 
two crucial issues in the analysis of risk factors for nosocomial sepsis. Pediatr 
Infect Dis J 22(7):599-609 
 57.  Gaynes RP, Martone WJ, Culver DH, Emori TG, Horan TC, Banerjee SN, et al. 
(1991) Comparison of rates of nosocomial infections in neonatal intensive care 
units in the United States. National Nosocomial Infections Surveillance System. 
Am J Med 91(3B):192S-196S 
 58.  Perlman SE, Saiman L, Larson EL (2007) Risk factors for late-onset health care-
associated bloodstream infections in patients in neonatal intensive care units. 
Am J Infect Control 35(3):177-182 
 224
 59.  Pediatric Prevention Network, Stover BH, Shulman ST, Bratcher DF, Brady 
MT, Levine GL, Jarvis WR (2001) Nosocomial infection rates in US children's 
hospitals' neonatal and pediatric intensive care units. Am J Infect Control 
29(3):152-157 
 60.  Nationales Referenzzentrum für Surveillance von nosokomialen Infektionen 
(2005) Modul NEO-KISS (Surveillance System nosokomialer Infektionen für 
Frühgeborene auf Intensivstationen). Berlin, Freiburg, Hannover, Germany. 
http://www nrz-hygiene de/surveillance/neo.htm. Accessed September 2009 
 61.  Centre de Coordination de la Lutte contre les Infections Nosocomiales de 
l’interrégion Nord (2009) Réseau NEOCAT. Paris, France. 
http://www.cclinparisnord.org/NEOCAT/neocat.html. Accessed September 
2009 
 62.  Public Health Agency of Canada (2007) The Canadian Nosocomial Infection 
Surveillance Program. Ottawa, Canada. http://www.phac-aspc.gc.ca/nois-
sinp/survprog-eng.php#co. Accessed September 2009 
 63.  VICNISS Hospital Acquired Infection Surveillance Coordinating Centre (2009) 
VICNISS Hospital Acquired Infection Surveillance. Victoria, Australia. 
http://www.vicniss.org.au/. Accessed September 2009 
 64.  National Healthcare Safety Network, Edwards JR, Peterson KD, Andrus ML, 
Tolson JS, Goulding JS, Dudeck MA, et al. (2007) National Healthcare Safety 
Network (NHSN) Report, data summary for 2006, issued June 2007. Am J 
Infect Control 35(5):290-301 
 65.  Vermont Oxford Network, Horbar JD, Rogowski J, Plsek PE, Delmore P, 
Edwards WH, Hocker J, et al. (2001) Collaborative quality improvement for 
neonatal intensive care. NIC/Q Project Investigators of the Vermont Oxford 
Network. Pediatrics 107(1):14-22 
 66.  Daschner FD, Cauda R, Grundmann H, Voss A, Widmer A (2004) Hospital 
infection control in Europe: evaluation of present practice and future goals. Clin 
Microbiol Infect 10(3):263-266 
 67.  Canadian Neonatal Network, Lee SK, McMillan DD, Ohlsson A, Pendray M, 
Synnes A, Whyte R, et al. (2000) Variations in practice and outcomes in the 
Canadian NICU network: 1996-1997. Pediatrics 106(5):1070-1079 
 68.  British Association of Perinatal Medicine (2001) Standards for Hospitals 
providing Neonatal Intensive and High Dependency Care (Second Edition) and 
Categories of Babies requiring Neonatal Care. British Association of Perinatal 
Medicine, London, UK  
 69.  Phillips P, Cortina-Borja M, Millar M, Gilbert R (2008) Risk-adjusted 
surveillance of hospital-acquired infections in neonatal intensive care units: a 
systematic review. J Hosp Infect 70(3):203-211 
 225
 70.  Huang SY, Tang RB, Chen SJ, Chung RL (2003) Coagulase-negative 
staphylococcal bacteremia in critically ill children: risk factors and antimicrobial 
susceptibility. J Microbiol Immunol Infect 36(1):51-55 
 71.  Akaike H (1974) A new look at the statistical model identification. IEEE 
Transactions on Automatic Control 19:716-723 
 72.  R Development Core Team (2008) R: A language and environment for statistical 
computing. R Foundation for Statistical Computing. Vienna, Austria. 
http://www.R-project.org. Accessed September 2009 
 73.  StataCorp LP (2007) Stata Statistical Software: Release 10. College Station, 
Texas, USA. http://www.stata.com. Accessed September 2009 
 74.  Microsoft Corporation (2003) Microsoft Office Excel 2003. USA. 
http://office.microsoft.com/en-gb/excel/default.aspx. Accessed September 2009 
 75.  NHS Neonatal Networks (2010) Standardised Electronic Neonatal Database 
(SEND), UK. http://www.neonatal.org.uk/send. Accessed September 2010 
 76.  Phillips P, Cortina-Borja M, Millar M, Kempley S, Gilbert R (2009) Variation in 
infection incidence between neonatal intensive care units can depend on the 
measures used. J Hosp Infect 72:363-365 
 77.  Phillips P, Cortina-Borja M, Gilbert R, Millar M, Kempley S (2009) Risk 
stratification by level of care for comparing bloodstream infection rates in 
neonatal intensive care units. J Hosp Infect 72:181-183 
 78.  Working Party of the British Association of Perinatal Medicine (1997) The 
BAPM Neonatal Dataset - for the annual reporting of data by neonatal intensive 
care units. British Association of Perinatal Medicine, London, UK  
 79.  Imperial College London (2010) Neonatal Data Analysis Unit, UK 
http://www1.ic.ac.uk/medicine/about/divisions/departmentofmedicine/infectious
diseases/paediatrics//neonatalmedicine/ndau/. Accessed September 2010 
 80.  Perinatal Institute (2007) Maternal and Neonatal Electronic Recording System 
(MANNERS) http://www.pi.nhs.uk/manners/neonataldata.htm. Accessed 
September 2010 
 81.  Royal College of Paediatrics and Child Health (2009) National Neonatal Audit 
Programme http://www.rcpch.ac.uk/Research/ce/Clinical-Audit/NNAP. 
Accessed September 2010 
 82.  Department of Health (2009) Payment by Results 
http://www.dh.gov.uk/en/Managingyourorganisation/Financeandplanning/NHSF
inancialReforms/DH_900. Accessed September 2010 
 83.  McLachlan G, Peel D (2000) Finite Mixture Models. WileyBlackwell, New 
York, USA 
 226
 84.  Grun B, Leisch F (2007) Fitting finite mixtures of generalized linear regressions 
in R. Computational Statistics and Data Analysis 51:5247-5252 
 85.  Schwarz G (1978) Estimating the dimension of a model. Annals of Statistics 
6:461-464 
 86.  van den Hoogen A, Gerards LJ, Verboon-Maciolek MA, Fleer A, Krediet TG 
(2010) Long-term trends in the epidemiology of neonatal sepsis and antibiotic 
susceptibility of causative agents. Neonatology 97:22-28 
 87.  Working Party of the British Association of Perinatal Medicine (2004) Review 
of the BAPM dataset. British Association of Perinatal Medicine, London, UK 
 88.  Gastmeier P, Sohr D, Schwab F, Behnke M, Zuschneid I, Brandt C, et al. (2008) 
Ten years of KISS: the most important requirements for success. J Hosp Infect 
70 Suppl 1:11-16 
 89.  Marcoulides GA, Hershberger SL (1997) Multivariate Statistical Methods: a 
First Course. Lawrence Erlbaum Associates, Inc. Publishers, Mahwah New 
Jersey, USA 
 90.  Pan W (2001) Akaike's information criterion in generalized estimating 
equations. Biometrics 57:120-125 
 91.  Medical Research Council (2008) lmsGrowth program version 2.6. London, UK. 
http://homepage.mac.com/tjcole/FileSharing1.html. Accessed September 2010  
 92.  Cole TJ, Freeman JV, Preece MA (1998) British 1990 growth reference centiles 
for weight, height, body mass index and head circumference fitted by maximum 
penalized likelihood. Stat Med 17:407-429 
 93.  de Irala-Estévez J, Martínez-Concha D, Díaz-Molina C, Masa-Calles J, Serrano 
del Castillo A, Fernández-Crehuet Navajas R (2001) Comparison of different 
methodological approaches to identify risk factors of nosocomial infection in 
intensive care units. Intensive Care Med 27(8):1254-1262 
 94.  Bartels DB, Schwab F, Geffers C, Poets CF, Gastmeier P (2007) Nosocomial 
infection in small for gestational age newborns with birth weight <1500g: a 
multicentre analysis. Arch Dis Child Fetal Neonatal Ed 92:F449-F453 
 95.  Wirbelauer J, Thomas W, Rieger L, Speer CP (2010) Intrauterine Growth 
Retardation in Preterm Infants ≤32 Weeks of Gestation is Associated with Low 
White Blood Cell Counts. Am J Perinatol May 17, epub ahead of print 
 96.  Simchen MJ, Beiner ME, Strauss-Liviathan N, Dulitzky M, Kuint J, Mashiach 
S, et al. (2000) Neonatal outcome in growth-restricted versus appropriately 
grown preterm infants. Am J Perinatol 17:187-192. 
 227
 228
 97.  Spinillo A, Capuzzo E, Piazzi G, Baltaro F, Stronati M, Ometto A et al. (1997) 
Significance of low birthweight for gestational age among very preterm infants. 
Br J Obstet Gynaecol 104:668-673 
 98.  Cox DR, Hinkley DV (1974) Theoretical statistics. Chapman and Hall, London, 
UK 
 99.  Gastmeier P, Sohr D, Just HM, Nassauer A, Daschner F, Rüden H (2000) How 
to survey nosocomial infections. Infect Control Hosp Epidemiol 21(6):366-370 
 100.  Wald A (1945) Sequential tests of statistical hypotheses. The Annals of 
Mathematical Statistics 6:117-186 
 101.  Grigg OA, Farewell VT, Spiegelhalter DJ (2003) Use of risk-adjusted CUSUM 
and RSPRT charts for monitoring in medical contexts. Stat Methods Med Res 
12(2):147-170 
 102.  Spiegelhalter D, Grigg O, Kinsman R, Treasure T (2003) Risk-adjusted 
sequential probability ratio tests: applications to Bristol, Shipman and adult 
cardiac surgery. Int J Qual Health Care 15(1):7-13 
 103.  Jarman B, Gault S, Alves B, Hider A, Dolan S, Cook A, et al. (1999) Explaining 
differences in English hospital death rates using routinely collected data. BMJ 
318:1515-1520 
 104.  Jarman B, Pieter D, van der Veen AA, Kool RB, Aylin P, Bottle A, et al. (2010) 
The hospital standardised mortality ratio: a powerful tool for Dutch hospitals to 
assess their quality of care? Qual Saf Health Care 19:9-13 
 105.  National Audit Office (2004) Improving patient care by reducing the risk of 
hospital acquired infection: A progress report. National Audit Office, London, 
UK 
 106.  Advisory Committee on Antimicrobial Resistance and Healthcare Associated 
Infection (ARHAI) Surveillance Subgroup (2010) Report on HCAI Surveillance 
Priorities – Recommendations for HCAI surveillance in England. UK  
 107.  Davies H, Powell A, Rushmer R (2007) Healthcare professionals' views on 
clinician engagement in quality improvement. A literature review. The Health 
Foundation, London, UK 
 108.  Lilford R, Mohammed MA, Spiegelhalter D, Thomson R (2004) Use and misuse 
of process and outcome data in managing performance of acute medical care: 
avoiding institutional stigma. Lancet 363:1147-1154 
 
Appendix to Chapter 1 
Pubmed literature search terms 
 
Search 1 - premature OR low birth weight OR very low birth weight OR neonatal 
intensive care OR neonatal intensive care unit OR neonatal intensive care units OR 
neonatal ICU OR neonatal ICUs OR NICU OR NICUs OR newborn intensive care OR 
newborn intensive care unit OR newborn intensive care units OR newborn ICU OR 
newborn ICUs OR neonatal critical care OR neonatal critical care unit OR neonatal 
critical care units OR neonatal high dependency OR neonatal high dependency care OR 
neonatal high dependency care unit OR neonatal high dependency care units OR 
neonatal high dependency unit OR neonatal high dependency units OR special care OR 
special care unit OR special care units OR special care baby unit OR special care baby 
units OR SCBU OR SCBUs 
Results: 145,776 studies 
 
Search 2 - bacteraemia OR bacteremia OR bloodstream infection OR bloodstream 
infections OR blood stream infection OR blood stream infections OR sepsis OR septic 
OR septicaemia OR septicaemic OR septicemia OR septicemic 
Results: 115,480 studies 
 
Search 3 – monitoring OR surveillance OR incidence OR risk-adjusted OR risk 
adjusted OR adjusted OR stratified OR time trends OR longterm OR long term OR 
long-term 
Results: 1,778,491 studies 
 
Search #1 AND #2 AND #3 
Results: 2372 studies 
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Embase free text literature search terms 
 
Search 1 - premature OR low birth weight OR very low birth weight  
Results: 76,845 studies 
 
Search 2 - neonatal intensive care OR neonatal intensive care unit OR neonatal 
intensive care units OR neonatal ICU OR neonatal ICUs OR NICU OR NICUs OR 
newborn intensive care OR newborn intensive care unit OR newborn intensive care 
units OR newborn ICU OR newborn ICUs OR neonatal critical care OR neonatal 
critical care unit OR neonatal critical care units 
Results: 10,434 studies 
 
Search 3 - neonatal high dependency OR neonatal high dependency care OR neonatal 
high dependency care unit OR neonatal high dependency care units OR neonatal high 
dependency unit OR neonatal high dependency units  
Results: 1 study 
 
Search 4 - special care OR special care unit OR special care units OR special care baby 
unit OR special care baby units OR SCBU OR SCBUs 
Results: 2325 studies 
 
Search 5 - bacteraemia OR bacteremia OR bloodstream infection OR bloodstream 
infections OR blood stream infection OR blood stream infections OR sepsis OR septic 
OR  septicaemia OR septicaemic OR septicemia OR septicemic 
Results: 101,335 studies 
 
Search 6 - monitoring OR surveillance OR incidence OR risk-adjusted OR risk 
adjusted OR adjusted OR stratified OR time trends OR longterm OR long term OR 
long-term 
Results: 1,037,069 studies 
 
Search (#1 OR #2 OR #3 OR #4) AND #5 AND #6 
Results: 1105 studies 
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Embase thesaurus mapping literature search terms 
 
Search 1 - LOW-BIRTH-WEIGHT.DE. OR PREMATURE-LABOR.DE. OR 
PREMATURITY.W..DE. OR VERY-LOW-BIRTH-WEIGHT.DE. OR NEWBORN-
SEPSIS.DE. OR NEWBORN-MORTALITY.DE. OR SEPSIS.W..DE. OR 
INFECTION.W..DE. 
Results: 155,485 studies 
 
Search 2 - PREMATURITY.W..DE. OR NEWBORN-INTENSIVE-CARE.DE. OR 
PREMATURE-LABOR.DE. OR HOSPITAL-INFECTION.DE. OR VERY-LOW-
BIRTH-WEIGHT.DE. OR CENTRAL-VENOUS-CATHETERIZATION.DE. OR 
SEPSIS.W..DE. OR EXTUBATION.W..DE. OR NEWBORN-CARE.DE. OR 
NEWBORN-SEPSIS.DE. OR NEWBORN-DISEASE.DE. OR LOW-BIRTH-
WEIGHT.DE. OR NEWBORN-INFECTION.DE. 
Results: 129,754 studies 
 
Search 3 - PREGNANCY.W..DE. OR DELIVERY.W..DE. OR INTENSIVE-
CARE.DE 
Results: 219,324 studies 
 
Search 4 - NEWBORN-CARE.DE. OR INTENSIVE-CARE.DE. OR PREMATURE-
LABOR.DE. OR HOSPITALIZATION.W..DE. OR SEPSIS.W..DE. 
Results:  139,565 studies 
 
Search 5 - SEPSIS.W..DE. OR BACTEREMIA.W..DE. OR SEPTIC-SHOCK.DE. OR 
INTENSIVE-CARE.DE. OR NEWBORN-SEPSIS.DE. OR BACTERIAL-
INFECTION.DE. OR HOSPITAL-INFECTION.DE. OR GRAM-NEGATIVE-
INFECTION.DE. OR MYCOSIS.W..DE. OR HYGIENE.W..DE. OR 
INFECTION.W..DE. OR SEPTICEMIA.W..DE. OR MENINGOCOCCOSIS.W..DE. 
OR LOW-BIRTH-WEIGHT.DE. OR NEWBORN-MORTALITY.DE. OR 
ENTEROBACTER-INFECTION.DE. OR MORBIDITY.W..DE. 
Results: 342,313 studies 
 
Search 6 - HOSPITAL-INFECTION.DE. OR HEALTH-CARE-PLANNING.DE. OR 
BACTEREMIA.W..DE. OR MICROBIOLOGY.W..DE. OR INFECTION-
CONTROL.DE. OR MYCOSIS.W..DE  
Results: 97,534 studies 
 
Search (#1 or #2 or #3 or #4) and #5 and #6 
Results: 28,622 studies 
 
Limits imposed: only studies in humans and children 
Results: 2570 studies (overlap with Embase free text search: 27 studies) 
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Searching bibliographies of shortlisted papers  
 
Bibliographies of the ten final shortlisted studies were reviewed for relevance. 
 
Searching related articles  
 
For each of the ten shortlisted studies, the first 20 studies in the ‘related articles’ 
function within PubMed were reviewed for relevance. 
 
Searching conference proceedings 
 
Reviewed from January 2005 to October 2009: 
 
 Annual Meeting for the European Society for Paediatric Infectious Diseases 
(ESPID) 
 European Congress of Clinical Microbiology and Infectious Diseases 
(ECCMID) 
 Neonatal Updates 
 UK Paediatric Research Society 
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Searching regional surveillance systems 
 
Google search 
 
Search 1- Country/region hospital infection monitoring 
Search 2- Country/region hospital infection surveillance 
 
Search 3- Country/region hospital infection neonatal intensive care monitoring  
Search 4- Country/region hospital infection neonatal intensive care surveillance 
 
Substitute country/region for: 
 
UK 
Netherlands 
Germany 
Belgium  
France 
Europe 
USA 
Canada 
Australia 
International 
 
 
This resulted in 40 Google searches (4 searches  10 countries).  
The first 30 search results for each were scanned for relevance. 
 
Appendix to Chapter 2 
British Association of Perinatal Medicine (2001) ‘Standards for Hospitals providing 
Neonatal Intensive and High Dependency Care (Second Edition) and Categories of 
Babies requiring Neonatal Care’, British Association of Perinatal Medicine, London, 
UK. Permission to reproduce this information was confirmed by the BAPM in January 
2011. 
 
Designation of Neonatal Units 
 
Level 1 
Units provide Special Care but do not aim to provide any continuing High Dependency 
or Intensive Care. This term includes units with or without resident medical staff. 
 
Level 2 
Units provide High Dependency Care and some short-term Intensive Care as agreed 
within the network. 
 
Level 3 
Units provide the whole range of medical neonatal care but not necessarily all specialist 
services such as neonatal surgery. 
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Appendix to Chapter 3 
British Association of Perinatal Medicine (2001) ‘Standards for Hospitals providing 
Neonatal Intensive and High Dependency Care (Second Edition) and Categories of 
Babies requiring Neonatal Care’, British Association of Perinatal Medicine, London, 
UK. Permission to reproduce this information was confirmed by the BAPM in January 
2011. 
 
Designation of levels of care 
 
Intensive Care 
These babies have the most complex problems. They need 1:1 care by a nurse with a 
neonatal qualification. The possibility of acute deterioration is such that there should be 
the constant availability of a competent doctor. 
 
1. receiving any respiratory support via a tracheal tube and in the first 24 hours after its 
withdrawal 
2. receiving NCPAP for any part of the day and less than five days old 
3. below 1000g current weight and receiving NCPAP for any part of the day and for 24 
hours after withdrawal 
4. less than 29 weeks gestational age and less than 48 hours old 
5. requiring major emergency surgery, for the pre-operative period and post-operatively 
for 24 hours 
6. requiring complex clinical procedures: 
• Full exchange transfusion 
• Peritoneal dialysis 
• Infusion of an inotrope, pulmonary vasodilator or prostaglandin and for 24   
hours afterwards 
7. any other very unstable baby considered by the nurse-in-charge to need 1:1 nursing 
8. a baby on the day of death. 
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High Dependency Care 
A nurse should not be responsible for the care of more than two babies in this category 
 
1. receiving NCPAP for any part of the day and not fulfilling any of the criteria for 
intensive care 
2. below 1000g current weight and not fulfilling any of the criteria for intensive care 
3. receiving parenteral nutrition 
4. having convulsions 
5. receiving oxygen therapy and below 1500g current weight 
6. requiring treatment for neonatal abstinence syndrome 
7. requiring specified procedures that do not fulfil any criteria for intensive care: 
• Care of an intra-arterial catheter or chest drain 
• Partial exchange transfusion 
• Tracheostomy care until supervised by a parent 
8. requiring frequent stimulation for severe apnoea. 
 
Special Care 
A nurse should not be responsible for the care of more than four babies receiving 
Special or Normal Care. 
 
Special care is provided for all other babies who could not reasonably be expected to be 
looked after at home by their mother. 
 
Normal Care 
Is provided for babies who themselves have no medical indication to be in hospital. 
 
 
Table 3.6 NICU 1: crude and adjusted rate ratios for total BSI 
Potential risk factor 
BSI episodes/baby-days 
(Rate per 1000 baby days) 
Crude rate ratios 
(95% CI) p-value 
Adjusted rate ratios 
(95% CI) p-value 
         
NHS level of care         
Intensive care 122/9809 (12.44) 4.68 (3.24, 6.75) <0.001 1.89 (1.05, 3.41) 0.035 
High dependency care 49/3846 (12.74) 4.59 (3.00, 7.04) <0.001 4.74 (3.09, 7.28) <0.001 
Special care 37/14,025 (2.64)  1   1  
Total 208/27,680 (7.51)       
         
Gestational age (weeks)         
<26 62/5078 (12.21) 1.60 (1.07, 2.38) 0.022 1.03 (0.67, 1.60)  0.891 
26-<28 42/4628 (9.08) 1.18 (0.77, 1.83) 0.448 0.84 (0.53, 1.33)  0.455 
28-<32 50/7352 (6.80) 0.90 (0.59, 1.36) 0.610 0.82 (0.54, 1.25)  0.360 
32-<37 15/5513 (2.72) 0.36 (0.20, 0.65) 0.001 0.41 (0.22, 0.74)  0.003 
≥37 39/5101 (7.65)  1   1  
Missingc 0/8        
         
Number of blood samples taken         
Linear increase   1.06 (1.04, 1.07) <0.001 1.05 (1.02,1.08) <0.001 
         
Month         
Linear increase   1.00 (0.99, 1.01) 0.389    
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Table 3.7 NICU 1: crude and adjusted rate ratios for CONS BSI 
Potential risk factor 
CONS episodes/baby-days 
(Rate per 1000 baby days) 
Crude rate ratios 
(95% CI) p-value 
Adjusted rate ratios 
(95% CI) p-value 
         
NHS level of care         
Intensive care 89/9809 (9.07) 4.67  (3.04, 7.19) <0.001 1.83  (0.91, 3.68) 0.088 
High dependency care 32/3846 (8.32) 4.11  (2.46, 6.86) <0.001 4.25  (2.54, 7.12) <0.001 
Special care 27/14,025 (1.93)  1   1  
Total 148/27,680 (5.34)       
         
Gestational age (weeks)         
<26 42/5078 (8.27) 1.76  (1.06, 2.90) 0.028 1.12  (0.65, 1.92) 0.683 
26-<28 34/4628 (7.35) 1.56  (0.92, 2.63) 0.097 1.09  (0.62, 1.89) 0.771 
28-<32 39/7352 (5.30) 1.14  (0.68, 1.89) 0.622 1.03  (0.62, 1.73) 0.906 
32-<37 9/5513 (1.63) 0.35  (0.16, 0.75) 0.007 0.39  (0.18, 0.85) 0.017 
≥37 24/5101 (4.70)  1   1  
Missingc 0/8        
         
Number of blood samples taken         
Linear increase   1.06  (1.04, 1.08) <0.001 1.05 (1.02, 1.09) 0.003 
         
Month         
Linear increase   1.00  (0.99, 1.01) 0.754    
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Table 3.8 NICU 1: crude and adjusted rate ratios for non-CONS BSI 
Potential risk factor 
Non-CONS episodes/baby-days 
(Rate per 1000 baby days) 
Crude rate ratios 
(95% CI) p-value 
Adjusted rate ratios 
(95% CI) p-value 
         
NHS level of care         
Intensive care 33/9809 (3.36) 4.68  (2.31, 9.49) <0.001 2.04  (0.67, 6.27)  0.212 
High dependency care 17/3846 (4.42) 5.90  (2.70, 12.88) <0.001 6.05  (2.76, 13.28) <0.001 
Special care 10/14,025 (0.71)  1   1  
Total 60/27,680 (2.17)       
         
Gestational age (weeks)         
<26 20/5078 (3.94) 1.34  (0.69, 2.62) 0.392 0.89  (0.42, 1.88) 0.778 
26-<28 8/4628 (1.73) 0.59  (0.25, 1.38) 0.223 0.43  (0.17, 1.07) 0.069 
28-<32 11/7352 (1.50) 0.51  (0.24, 1.12) 0.093 0.48  (0.22, 1.05) 0.066 
32-<37 6/5513 (1.09) 0.37  (0.14, 0.96) 0.040 0.43  (0.17, 1.12)  0.086 
≥37 15/5101 (2.94)  1   1  
Missingc 0/8        
         
Number of blood samples taken         
Linear increase   1.05  (1.02, 1.08)  <0.001 1.05  (1.00, 1.11) 0.054 
         
Month         
Linear increase   1.01  (0.99, 1.03) 0.266    
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Table 3.9 NICU 2: crude and adjusted rate ratios for total BSI 
Potential risk factor 
BSI episodes/baby-days 
(Rate per 1000 baby days) 
Crude rate ratios 
(95% CI) p-value 
Adjusted rate ratios 
(95% CI) p-value 
         
NHS level of care         
Intensive care 157/13,209 (11.89) 3.78  (2.75, 5.20) <0.001 4.29  (2.55, 7.20) <0.001 
High dependency care 18/1331 (13.52) 3.64  (2.12, 6.24) <0.001 3.90  (2.10, 7.25) <0.001 
Special care 50/15,976 (3.13)  1   1  
Total 225/30,516 (7.37)       
         
Gestational age (weeks)         
<26 74/6899 (10.73) 1.09  (0.77, 1.54) 0.625 0.47  (0.32, 0.70) <0.001 
26-<28 30/3070 (9.77) 0.97  (0.62, 1.51) 0.890 0.44  (0.28, 0.71) 0.001 
28-<32 34/7252 (4.69) 0.48  (0.31, 0.73) 0.001 0.31  (0.20, 0.49) <0.001 
32-<37 30/7525 (3.99) 0.41  (0.26, 0.63) <0.001 0.42  (0.27, 0.66) <0.001 
≥37 57/5770 (9.88)  1   1  
Missingc 0        
         
Number of blood samples taken         
Linear increase   1.04  (1.02, 1.05) <0.001 1.00  (0.98, 1.03) 0.695 
         
Month         
Linear increase   0.99  (0.98, 1.00) 0.293    
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Table 3.10 NICU 2: crude and adjusted rate ratios for CONS BSI 
Potential risk factor 
CONS episodes/baby-days 
(Rate per 1000 baby days) 
Crude rate ratios 
(95% CI) p-value 
Adjusted rate ratios 
(95% CI) p-value 
         
NHS level of care         
Intensive care 113/13,209 (8.55) 4.13  (2.80, 6.08) <0.001 3.47  (1.86, 6.50) <0.001 
High dependency care 13/1331 (9.77)  3.98  (2.10, 7.57) <0.001 5.14  (2.45, 10.78) <0.001 
Special care 33/15,976 (2.07)   1   1  
Total 159/30,516 (5.21)        
         
Gestational age (weeks)         
<26 54/6899 (7.83)  1.33  (0.87, 2.05) 0.189 0.58  (0.36, 0.95) 0.029 
26-<28 23/3070 (7.49)  1.25  (0.73, 2.11) 0.416 0.57  (0.32, 1.01)  0.054 
28-<32 26/7252 (3.59)  0.61  (0.37, 1.02) 0.059 0.41  (0.24, 0.69) 0.001 
32-<37 22/7525 (2.92)  0.50  (0.29, 0.85) 0.011 0.52  (0.30, 0.89)  0.017 
≥37 34/5770 (5.89)   1   1  
Missingc 0        
         
Number of blood samples taken         
Linear increase   1.04  (1.03, 1.06) <0.001 1.02  (1.00, 1.05)  0.189 
         
Month         
Linear increase   1.00  (0.99, 1.01) 0.929    
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Table 3.11 NICU 2: crude and adjusted rate ratios for non-CONS BSI 
Potential risk factor 
Non-CONS episodes/baby-days 
(Rate per 1000 baby days) 
Crude rate ratios 
(95% CI) p-value 
Adjusted rate ratios 
(95% CI) p-value 
         
NHS level of care         
Intensive care 44/13,209 (3.33) 3.12  (1.78, 5.46) <0.001 7.21  (2.86, 18.14)  <0.001 
High dependency care 5/1331 (3.76) 2.97  (1.10, 8.06) 0.032 2.03  (0.65, 6.36) 0.224 
Special care 17/15,976 (1.06)  1   1  
Total 66/30,516 (2.16)       
         
Gestational age (weeks)         
<26 20/6899 (2.90) 0.73  (0.40, 1.33) 0.303 0.31  (0.16, 0.62) 0.001 
26-<28 7/3070 (2.28) 0.56  (0.24, 1.31) 0.180 0.26  (0.10, 0.63) 0.003 
28-<32 8/7252 (1.10) 0.28  (0.12, 0.62) 0.002 0.18  (0.08, 0.42) <0.001 
32-<37 8/7525 (1.06) 0.27  (0.12, 0.60) 0.001 0.28  (0.13, 0.63)  0.002 
≥37 23/5770 (3.99)  1   1  
Missingc 0        
         
Number of blood samples taken         
Linear increase   1.02  (1.00, 1.05) 0.055 0.97  (0.93, 1.01)  0.184 
         
Month         
Linear increase   0.98  (0.97, 1.00)  0.073    
         
c - Babies with missing variables were few and experienced few episodes of BSI. For this reason I considered it acceptable to remove them from the analyses. 
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Table 5.10 Poisson regression models for the effect of birth susceptibility factors on total BSI, for NICU 1 
Potential risk factor 
BSI episodes/baby-days 
(Rate per 1000 baby-days) 
Crude rate ratios 
(95% CI) p-value 
Adjusted rate ratios 
(95% CI) p-value 
       
Gestational age (weeks)       
<26 43/3937  (10.92) 2.32 (1.35, 3.98) 0.002  
26-<28 18/3218  (5.59) 1.19 (0.62, 2.26) 0.605  
28-<32 34/5573  (6.10) 1.28 (0.73, 2.24) 0.388  
32-<37 11/3836  (2.87) 0.59 (0.28, 1.23) 0.157  
≥37 19/3760  (5.05)  1   
Missinge 0/24      
       
Birth weight (g)       
<700 31/2623  (11.82) 2.86 (1.80, 4.55) <0.001 2.27  (1.39, 3.70) 0.001 
700-<1200 51/7759  (6.57) 1.59 (1.06, 2.38) 0.025 1.28  (0.83, 1.98) 0.258 
≥1200 43/9933  (4.33)  1   1  
Missinge 0/33      
       
Where born       
Outborn 59/5895  (10.01) 2.26 (1.59, 3.22) <0.001 1.91  (1.30, 2.79) <0.001 
Inborn 64/14,227  (4.50)  1   1  
Missinge 2/226      
       
Sex       
Male 64/10,530  (6.08) 0.97 (0.69, 1.38) 0.880  
Female 61/9818  (6.21)  1   
Missinge 0/0      
       
Delivery method       
Emergency CSf 51/8814  (5.79) 0.88 (0.61, 1.27) 0.496  
Elective CSf 11/2135  (5.15) 0.78 (0.41, 1.49) 0.454  
Vaginal 62/9321  (6.65)  1   
Missinge 1/78      
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Table 5.11 Poisson regression models for the effect of birth susceptibility factors on CONS BSI, for NICU 1 
Potential risk factor 
CONS BSI episodes/baby-days 
(Rate per 1000 baby-days) 
Crude rate ratios 
(95% CI) p-value 
Adjusted rate ratios 
(95% CI) p-value 
       
Gestational age (weeks)       
<26 27/3937  (6.86) 1.85 (0.98, 3.47) 0.057  
26-<28 14/3218  (4.35) 1.17 (0.56, 2.42) 0.676  
28-<32 27/5573  (4.84) 1.29 (0.69, 2.42) 0.432  
32-<37 7/3836  (1.82) 0.47 (0.19, 1.16) 0.101  
≥37 15/3760  (3.99)  1   
Missinge 0/24      
       
Birth weight (g)       
<700 21/2623  (8.01) 2.53 (1.46, 4.37) <0.001 1.91  (1.06, 3.41) 0.030 
700-<1200 36/7759  (4.64) 1.46 (0.91, 2.34)  0.115 1.12  (0.67, 1.87) 0.659 
≥1200 33/9933  (3.32)  1   1  
Missinge 0/33      
       
Where born       
Outborn 44/5895  (7.46) 2.46 (1.62, 3.73)  <0.001 2.18  (1.39, 3.43) <0.001 
Inborn 44/14,227 (3.09)  1   1  
Missinge 2/226      
       
Sex       
Male 45/10,530  (4.27) 0.93 (0.61, 1.40) 0.722  
Female 45/9818  (4.58)  1   
Missinge 0/0      
       
Delivery method       
Emergency CSf 39/8814  (4.42) 0.95 (0.62, 1.46)  0.806  
Elective CSf 7/2135  (3.28) 0.70 (0.32, 1.56)  0.385  
Vaginal 44/9321  (4.72)  1   
Missinge 0/78      
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Table 5.12 Poisson regression models for the effect of birth susceptibility 
factors on non-CONS BSI, for NICU 1 
Potential risk factor 
Non-CONS BSI episodes/baby-days 
(Rate per 1000 baby-days) 
Crude rate ratios 
(95% CI) p-value 
      
Gestational age (weeks)      
<26 16/3937 (4.06) 4.10  (1.37, 12.27) 0.012 
26-<28 4/3218 (1.24) 1.25  (0.31, 5.00) 0.751 
28-<32 7/5573 (1.26) 1.25  (0.37, 4.28) 0.720 
32-<37 4/3836 (1.04) 1.01  (0.25, 4.04) 0.988 
≥37 4/3760 (1.06)  1  
Missinge 0/24     
      
Birth weight (g)      
<700 10/2623 (3.81) 3.97  (1.65, 9.55) 0.002 
700-≤1200 15/7759 (1.93) 2.01  (0.90, 4.47) 0.087 
≥1200 10/9933 (1.01)  1  
Missinge 0/33     
      
Where born      
Outborn 15/5895 (2.54) 1.84  (0.94, 3.60) 0.074 
Inborn 20/14,227 (1.41)  1  
Missinge 0/226     
      
Sex      
Male 19/10,530 (1.80) 1.10  (0.57, 2.14) 0.775 
Female 16/9818 (1.63)  1  
Missinge 0/0     
      
Delivery method      
Emergency CSf 12/8814 (1.36) 0.71  (0.34, 1.48) 0.363 
Elective CSf 4/2135 (1.87) 0.98  (0.33, 2.90) 0.972 
Vaginal 18/9321 (1.93)  1  
Missinge 1/78     
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Table 5.13 Poisson regression models for the effect of birth susceptibility factors on total BSI, for NICU 2 
Potential risk factor 
BSI episodes/baby-days 
(Rate per 1000 baby-days) 
Crude rate ratios 
(95% CI) p-value 
Adjusted rate ratios 
(95% CI) p-value 
         
Gestational age (weeks)         
<26 52/4960  (10.48) 1.77 (1.10, 2.86) 0.019    
26-<28 25/2447  (10.22) 1.72 (0.99, 3.00) 0.054    
28-<32 25/6297  (3.97) 0.66 (0.38, 1.16) 0.149    
32-<37 19/5747  (3.31) 0.53 (0.29, 0.97) 0.040    
≥37 25/3748  (6.67)  1     
Missinge 0/0        
         
Birth weight (g)         
<700 52/4278  (12.16) 3.22 (2.18, 4.76) <0.001 3.04  (2.02, 4.58) <0.001 
700-<1200 45/6706  (6.71) 1.77 (1.18, 2.66) 0.006 1.72  (1.14, 2.59) 0.010 
≥1200 49/12,215  (4.01)  1   1  
Missinge 0/0        
         
Where born         
Outborn 38/4081  (9.31) 1.69 (1.17, 2.45) 0.005 1.21  (0.82, 1.78) 0.346 
Inborn 108/19,118  (5.65)  1   1  
Missinge 0/0        
         
Sex         
Male 80/12,574  (6.36) 1.02 (0.74, 1.41) 0.912    
Female 66/10,625  (6.21)  1     
Missinge 0/0        
         
Delivery method         
Emergency CSf 52/7505  (6.93) 1.12 (0.78, 1.60) 0.551    
Elective CSf 26/4840  (5.37) 0.86 (0.55, 1.35) 0.513    
Vaginal 68/10,844  (6.28)  1     
Missinge 0/10        
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Table 5.14 Poisson regression models for the effect of birth susceptibility factors on CONS BSI, for NICU 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Potential risk factor 
CONS BSI episodes/baby-days 
(Rate per 1000 baby-days) 
Crude rate ratios 
(95% CI) p-value 
Adjusted rate ratios 
(95% CI) p-value 
         
Gestational age (weeks)         
<26 38/4960  (7.66) 2.16 (1.19, 3.93) 0.012    
26-<28 18/2447  (7.36) 2.07 (1.04, 4.10) 0.038    
28-<32 19/6297  (3.02) 0.84 (0.43, 1.66) 0.618    
32-<37 15/5747  (2.61) 0.70 (0.34, 1.44) 0.335    
≥37 15/3748  (4.00)  1     
Missinge 0/0        
         
Birth weight (g)         
<700 38/4278  (8.88) 3.61 (2.25, 5.77) <0.001 3.35 (2.04, 5.48) <0.001 
700-<1200 35/6706  (5.22) 2.11 (1.31, 3.41) 0.002 2.02 (1.24, 3.29) 0.005 
≥1200 32/12,215  (2.62)  1   1  
Missinge 0/0        
         
Where born         
Outborn 29/4081  (7.11) 1.83 (1.20, 2.81) 0.005 1.27 (0.81, 1.99) 0.296 
Inborn 76/19,118  (3.98)  1   1  
Missinge 0/0        
         
Sex         
Male 58/12,574  (4.61) 1.04 (0.71, 1.52) 0.853    
Female 47/10,625  (4.42)  1     
Missinge 0/0        
         
Delivery method         
Emergency CSf 41/7505  (5.46) 1.33 (0.87, 2.03) 0.187    
Elective CSf 19/4840  (3.93) 0.95 (0.56, 1.62) 0.850    
Vaginal 45/10,844  (4.15)  1     
Missinge 0/10        
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Table 5.15 Poisson regression models for the effect of birth susceptibility 
factors on non-CONS BSI, for NICU 2 
Potential risk factor 
Non-CONS BSI episodes/baby-days 
(Rate per 1000 baby-days) 
Crude rate ratios 
(95% CI) p-value 
      
Gestational age (weeks)      
<26 14/4960 (2.82) 1.19 (0.53, 2.69)  0.669 
26-<28 7/2447 (2.86) 1.21 (0.46, 3.17)  0.704 
28-<32 6/6297 (0.95) 0.40 (0.14, 1.10)  0.075 
32-<37 4/5747 (0.70) 0.28 (0.09, 0.90)  0.032 
≥37 10/3748 (2.67)  1  
Missinge 0/0     
      
Birth weight (g)      
<700 14/4278 (3.27) 2.50 (1.23, 5.07) 0.011 
700-<1200 10/6706 (1.49) 1.14 (0.52, 2.48) 0.750 
≥1200 17/12,215 (1.39)  1  
Missinge 0/0     
      
Where born      
Outborn 9/4081 (2.21) 1.35 (0.65, 2.83) 0.424 
Inborn 32/19,118 (1.67)  1  
Missinge 0/0     
      
Sex      
Male 22/12,574 (1.75) 0.97 (0.53, 1.80) 0.930 
Female 19/10,625 (1.79)  1  
Missinge 0/0     
      
Delivery method      
Emergency CSf 11/7505 (1.47) 0.70 (0.34, 1.43) 0.327 
Elective CSf 7/4840 (1.45) 0.68 (0.29, 1.60) 0.380 
Vaginal 23/10,844 (2.12)  1  
Missinge 0/10     
      
 
 
 
 
 
 
 
 248
Table 5.16 Poisson regression models for the effect of birth susceptibility 
factors on total BSI, for NICU 3 
Potential risk factors 
BSI episodes/baby-days 
(Rate per 1000 baby-days) 
Crude rate ratios 
(95% CI) p-value 
      
Gestational age (weeks)      
<26 22/1204 (18.27) 8.61 (3.49, 21.24) <0.001 
26-<28 12/1432 (8.38) 3.94 (1.48, 10.50) 0.006 
28-<32 29/4499 (6.45) 3.02 (1.25, 7.27) 0.014 
32-<37 7/4748 (1.47) 0.67 (0.22, 1.98) 0.464 
≥37 6/2582 (2.32)  1  
Missinge 0/34     
      
Birth weight (g)      
<700 21/1642 (12.79) 7.20 (3.76, 13.80) <0.001 
700-<1200 39/4327 (9.01) 5.05 (2.82, 9.04) <0.001 
≥1200 16/8510 (1.88)  1  
Missinge 0/20     
      
Where born      
Outborn 4/1413 (2.83) 0.52 (0.19, 1.43)  0.208 
Inborn 70/12,852 (5.45)  1  
Missinge 2/234     
      
Sex      
Male 38/6836 (5.56) 1.10 (0.70, 1.72)  0.681 
Female 38/7587 (5.01)  1  
Missinge 0/76     
      
Delivery method      
Emergency CSf 42/5777 (7.27) 1.69 (1.04, 2.76) 0.035 
Elective CSf 6/2276 (2.64) 0.61 (0.25, 1.48) 0.271 
Vaginal 26/5979 (4.35)  1  
Missinge 2/467     
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Table 5.17 Poisson regression models for the effect of birth susceptibility 
factors on CONS BSI, for NICU 3 
Potential risk factors 
CONS BSI episodes/baby-days 
(Rate per 1000 baby-days) 
Crude rate ratios 
(95% CI) p-value 
      
Gestational age (weeks)      
<26 17/1204 (14.12) 6.65 (2.62, 16.88) <0.001 
26-<28 11/1432 (7.68) 3.61 (1.34, 9.77) 0.011 
28-<32 24/4499 (5.33) 2.50 (1.02, 6.11) 0.045 
32-<37 6/4748 (1.26) 0.57 (0.18, 1.77) 0.331 
≥37 6/2582 (2.32)  1  
Missinge 0/34     
      
Birth weight (g)      
<700 17/1642 (10.35) 6.22 (3.11, 12.45) <0.001 
700-<1200 32/4327 (7.40) 4.42 (2.39, 8.17) <0.001 
≥1200 15/8510 (1.76)  1  
Missinge 0/20     
      
Where born      
Outborn 4/1413 (2.83) 0.63 (0.23, 1.74) 0.632 
Inborn 58/12,852 (4.51)  1  
Missinge 2/234     
      
Sex      
Male 32/6836 (4.68) 1.10 (0.67, 1.79) 0.706 
Female 32/7587 (4.22)  1  
Missinge 0/76     
      
Delivery method      
Emergency CSf 35/5777 (6.06) 1.59 (0.94, 2.70) 0.082 
Elective CSf 4/2276 (1.76) 0.46 (0.16, 1.32) 0.149 
Vaginal 23/5979 (3.85)  1  
Missinge 2/467     
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Table 5.18 Poisson regression models for the effect of birth susceptibility 
factors on non-CONS BSI, for NICU 3 
Potential risk factors 
Non-CONS BSI episodes/baby-days 
(Rate per 1000 baby-days) 
Crude rate ratios 
(95% CI) p-value 
      
Gestational age 
(weeks) 
     
<26 5/1204 (4.15)  -  
26-<28 1/1432 (0.70)  -  
28-<32 5/4499 (1.11)  -  
32-<37 1/4748 (0.21)  -  
≥37 0/2582   -  
Missinge 0/34     
      
Birth weight (g)      
<700 4/1642 (2.44) 21.95 (2.45, 19.62)  0.006 
700 - <1200 7/4327 (1.62) 14.51 (1.79, 117.87)  0.012 
≥1200 1/8510 (0.12)  1  
Missinge 0/20     
      
Where born      
Outborn 0/1413 (0.0)  -  
Inborn 12/12,852 (0.93)  -  
Missinge 0/234     
      
Sex      
Male 6/6836 (0.88) 1.10 (0.35, 3.41)  0.870 
Female 6/7587 (0.79)  1  
Missinge 0/76     
      
Delivery method      
Emergency CSf 7/5777 (1.21) 2.44 (0.63, 9.45) 0.195 
Elective CSf 2/2276 (0.88) 1.75 (0.29, 10.50) 0.538 
Vaginal 3/5979 (0.50)  1  
Missinge 0/467     
      
e - Babies with missing variables were few and experienced few episodes of BSI. For this 
reason I considered it acceptable to remove them from the analyses. 
f - CS- Caesarean section 
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Table 5.19 Poisson regression models for the effect of procedure-related 
factors on total BSI, for NICU 1 
Potential risk factors 
BSI episodes/baby-days 
(Rate per 1000 baby-days) 
Crude rate ratios 
(95% CI) p-value 
      
No of blood samples taken      
≥7 68/5277 (12.89) 5.33 (3.48, 8.15) <0.001 
4-6 26/2847 (9.13) 3.75 (2.23, 6.32) <0.001 
0-3 31/12,224 (2.54)  1  
      
Number of days spent in:      
      
Special care      
≥7 92/16,015 (5.74) 0.78 (0.49, 1.24) 0.296 
4-6 4/786 (5.09) 0.62 (0.21, 1.80) 0.382 
1-3 7/658 (10.64) 1.28 (0.55, 3.00) 0.566 
0 22/2889 (7.62)  1  
      
High dependency care      
≥7 63/7287 (8.65) 1.86 (1.26, 2.76)  0.002 
4-6 4/1321 (3.03) 0.64 (0.23, 1.79)  0.399 
1-3 17/3216 (5.29) 1.12 (0.64, 1.97)  0.692 
0 41/8524 (4.81)  1  
      
Intensive care      
≥7 92/11,110 (8.28) 3.40 (1.94, 5.96)  <0.001 
4-6 8/1532 (5.22) 2.09 (0.88, 4.99)  0.096 
1-3 11/2311 (4.76) 1.90 (0.86, 4.19)  0.110 
0 14/5395 (2.59)  1  
      
Number of days treated with:      
      
Ventilation      
≥7 66/7779 (8.48) 1.96 (1.32, 2.92) <0.001 
4-6 4/735 (5.44) 1.23 (0.44, 3.45) 0.691 
1-3 16/3248 (4.93) 1.12 (0.63, 2.01) 0.701 
0 39/8586 (4.54)  1  
      
Nasal continuous positive 
airway pressure 
     
≥7 63/8630 (7.30) 1.38 (0.95, 2.00) 0.094  
4-6 2/754 (2.65) 0.49 (0.12, 2.03) 0.329 
1-3 11/2172 (5.06) 0.93 (0.49, 1.80) 0.839 
0 49/8792 (5.57)  1  
      
Surgery      
Yes 34/3562 (9.55) 1.81 (1.22, 2.68) 0.003 
No 91/16,786 (5.42)  1  
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Table 5.20 Poisson regression models for the effect of procedure-related 
factors on CONS BSI, for NICU 1 
Potential risk factors 
CONS BSI episodes/baby-days 
(Rate per 1000 baby-days) 
Crude rate ratios  
(95% CI) p-value 
      
No of blood samples taken      
≥7 46/5277 (8.72) 4.14  (2.57, 6.65) <0.001 
4-6 17/2847 (5.97) 2.82  (1.53, 5.17) <0.001 
0-3 27/12,224 (2.21)  1  
      
Number of days spent in:      
      
Special care      
≥7 68/16,015 (4.25) 0.91  (0.51, 1.61) 0.738 
4-6 3/786 (3.82) 0.73  (0.21, 2.55) 0.625 
1-3 5/658 (7.60) 1.44  (0.52, 4.00) 0.484 
0 14/2889 (4.85)  1  
      
High dependency care      
≥7 45/7287 (6.18) 1.95  (1.22, 3.12) 0.006 
4-6 3/1321 (2.27) 0.71  (0.21, 2.32) 0.566 
1-3 14/3216 (4.35) 1.35  (0.71, 2.57) 0.357 
0 28/8524 (3.28)  1  
      
Intensive care      
≥7 64/11,110 (5.76) 2.76  (1.49, 5.11) 0.001 
4-6 7/1532 (4.57) 2.14  (0.84, 5.42) 0.111 
1-3 7/2311 (3.03) 1.41  (0.56, 3.59) 0.467 
0 12/5395 (2.22)  1  
      
Number of days treated with:      
      
Ventilation      
≥7 44/7779 (5.66) 1.65  (1.04, 2.61) 0.033 
4-6 3/735 (4.08) 1.16  (0.36, 3.80) 0.804 
1-3 12/3248 (3.69) 1.06  (0.54, 2.06) 0.870 
0 31/8586 (3.61)  1  
      
Nasal continuous positive 
airway pressure 
     
≥7 46/8630 (5.33) 1.49  (0.95, 2.33) 0.080 
4-6 2/754 (2.65) 0.73  (0.18, 3.06) 0.672 
1-3 9/2172 (4.14) 1.14  (0.54, 2.37) 0.736 
0 33/8792 (3.75)  1  
      
Surgery      
Yes 23/3562 (6.46) 1.66  (1.03, 2.67) 0.036 
No 67/16,786 (3.99)  1  
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Table 5.21 Poisson regression models for the effect of procedure-related 
factors on non-CONS BSI, for NICU 1 
Potential risk factors 
Non-CONS BSI episodes/baby-days 
(Rate per 1000 baby-days) 
Crude rate ratios 
(95% CI) p-value 
      
No of blood samples taken      
≥7 22/5277 (4.17) 13.35  (4.60, 38.75) <0.001 
4-6 9/2847 (3.16) 10.06  (3.10, 32.67) <0.001 
0-3 4/12,224 (0.33)  1  
      
Number of days spent in:      
      
Special care      
≥7 24/16,015 (1.50) 0.56  (0.25, 1.25) 0.155 
4-6 1/786 (1.27) 0.43  (0.05, 3.42) 0.423 
1-3 2/658 (3.04) 1.01  (0.21, 4.75) 0.992 
0 8/2889 (2.77)  1  
      
High dependency care      
≥7 18/7287 (2.47) 1.68  (0.82, 3.43) 0.154 
4-6 1/1321 (0.76) 0.51  (0.07, 3.87) 0.513 
1-3 3/3216 (0.93) 0.62  (0.18, 2.19) 0.461 
0 13/8524 (1.53)  1  
      
Intensive care      
≥7 28/11,110 (2.52) 7.24  (1.73, 30.40) 0.007 
4-6 1/1532 (0.65) 1.83  (0.17, 20.19) 0.622 
1-3 4/2311 (1.73) 4.85  (0.89, 26.46) 0.068 
0 2/5395 (0.37)  1  
      
Number of days treated with:      
      
Ventilation      
≥7 22/7779 (2.83) 3.19  (1.42, 7.17) 0.005 
4-6 1/735 (1.36) 1.50  (0.19, 12.00) 0.702 
1-3 4/3248 (1.23) 1.37  (0.41, 4.54) 0.611 
0 8/8586 (0.93)  1  
      
Nasal continuous positive 
airway pressure 
     
≥7 17/8630 (1.97) 1.14  (0.57, 2.25) 0.712 
4-6 0/754 (0.00) - - - 
1-3 2/2172 (0.92) 0.520  (0.12, 2.26) 0.384 
0 16/8792 (1.82)  1  
      
Surgery      
Yes 11/3562 (3.09) 2.22  (1.09, 4.53) 0.029 
No 24/16,786 (1.43)  1  
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Table 5.22 Poisson regression models for the effect of procedure-related 
factors on total BSI, for NICU 2 
Potential risk factors 
BSI episodes/baby-days 
(Rate per 1000 baby-days) 
Crude rate ratios 
(95% CI) p-value 
      
No of blood samples taken      
≥7 61/5683 (10.73) 3.42 (2.33, 5.03) <0.001 
4-6 40/4028 (9.93) 3.14 (2.05, 4.81) <0.001 
0-3 45/13,488 (3.34)  1  
      
Number of days spent in:      
      
Special care      
≥7 74/17,088 (4.33) 0.29 (0.20, 0.40) <0.001 
4-6 7/1220 (5.74) 0.33 (0.15, 0.73) 0.006 
1-3 6/992 (6.05) 0.32 (0.14, 0.75) 0.009 
0 59/3899 (15.13)  1  
      
High dependency care      
≥7 19/2382 (7.98) 1.32 (0.81, 2.16) 0.261 
4-6 5/865 (5.78) 0.95 (0.39, 2.33) 0.910 
1-3 16/2894 (5.53) 0.89 (0.53, 1.51) 0.674 
0 106/17,058 (6.21)  1  
      
Intensive care      
≥7 106/13,085 (8.10) 2.55 (1.58, 4.11) <0.001 
4-6 6/1362 (4.41) 1.33 (0.54, 3.32) 0.535 
1-3 14/2980 (4.70) 1.41 (0.71, 2.79) 0.326 
0 20/5772 (3.47)  1  
      
Number of days treated with:      
      
Ventilation      
≥7 106/12,737 (8.32) 2.00 (1.32, 3.01) <0.001 
4-6 6/1276 (4.70) 1.09 (0.45, 2.64) 0.840 
1-3 5/2781 (1.80) 0.41 (0.16, 1.06) 0.066 
0 29/6405 (4.53)  1  
      
Total parenteral nutrition      
≥7 106/10,965 (9.67) 3.92 (2.57, 5.98) <0.001 
4-6 9/1331 (6.76) 2.71 (1.27, 5.75) 0.010 
1-3 4/686 (5.83) 2.33 (0.82, 6.66) 0.114 
0 27/10,217 (2.64)  1  
      
Surgery      
Yes 53/5507 (9.62) 1.91 (1.36, 2.68) <0.001 
No 93/17,692 (5.26)  1  
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Table 5.23 Poisson regression models for the effect of procedure-related 
factors on CONS BSI, for NICU 2 
Potential risk factors 
CONS BSI episodes/baby-days 
(Rate per 1000 baby-days) 
Crude rate ratios 
(95% CI) p-value 
      
No of blood samples 
taken 
     
≥7 45/5683 (7.92) 3.55 (2.26, 5.58) <0.001 
4-6 28/4028 (6.95) 3.09 (1.86, 5.13) <0.001 
0-3 32/13,488 (2.37)  1  
      
Number of days spent in:      
      
Special care      
≥7 55/17,088 (3.22) 0.30 (0.20, 0.45) <0.001 
4-6 4/1220 (3.28) 0.27 (0.10, 0.75) 0.012 
1-3 4/992 (4.03) 0.30 (0.11, 0.85) 0.023 
0 42/3899 (10.77)  1  
      
High dependency care      
≥7 13/2382 (5.46) 1.26 (0.70, 2.27) 0.437 
4-6 5/865 (5.78) 1.32 (0.54, 3.27) 0.543 
1-3 11/2894 (3.80) 0.86 (0.46, 1.61) 0.632 
0 76/17,058 (4.46)  1  
      
Intensive care      
≥7 78/13,085 (5.96) 2.68 (1.52, 4.73) <0.001 
4-6 5/1362 (3.67) 1.59 (0.57, 4.41) 0.374 
1-3 8/2980 (2.68) 1.15 (0.48, 2.74) 0.753 
0 14/5772 (2.43)  1  
      
Number of days treated 
with: 
     
      
Ventilation      
≥7 78/12,737 (6.12) 2.24 (1.36, 3.70) 0.002 
4-6 5/1276 (3.92) 1.39 (0.52, 3.73) 0.510 
1-3 3/2781 (1.08) 0.38 (0.11, 1.27) 0.116 
0 19/6405 (2.97)  1  
      
Total parenteral nutrition      
≥7 79/10,965 (7.20) 4.64 (2.75, 7.83) <0.001 
4-6 7/1331 (5.26) 3.34 (1.39, 8.06) 0.007 
1-3 2/686 (2.92) 1.85 (0.43, 8.01) 0.410 
0 17/10,217 (1.66)  1  
      
Surgery      
Yes 37/5507 (6.72) 1.82 (1.22, 2.72) 0.003 
No 68/17,692 (3.84)  1  
      
 
 
 256
Table 5.24 Poisson regression models for the effect of procedure-related 
factors on non-CONS BSI, for NICU 2 
Potential risk factors 
Non-CONS BSI episodes/baby-days 
(Rate per 1000 baby-days) 
Crude rate ratios 
(95% CI) p-value 
      
No of blood samples 
taken 
     
≥7 16/5683 (2.82) 3.11 (1.49, 6.46) 0.002 
4-6 12/4028 (2.98) 3.26 (1.49, 7.14) 0.003 
0-3 13/13,488 (0.96)  1  
      
Number of days spent 
in: 
     
      
Special care      
≥7 19/17,088 (1.11) 0.25 (0.13, 0.49) <0.001 
4-6 3/1220 (2.46) 0.50 (0.15, 1.70) 0.265 
1-3 2/992 (2.02) 0.38 (0.09, 1.63) 0.190 
0 17/3899 (4.36)  1  
      
High dependency care      
≥7 6/2382 (2.52) 1.48 (0.61, 3.55) 0.383 
4-6 0/865 (0.00)  -  
1-3 5/2894 (1.73) 0.99 (0.38, 2.54) 0.977 
0 30/17,058 (1.76)  1  
      
Intensive care      
≥7 28/13,085 (2.14) 2.24 (0.93, 5.42) 0.072 
4-6 1/1362 (0.73) 0.74 (0.09, 6.16) 0.782 
1-3 6/2980 (2.01) 2.01 (0.65, 6.24) 0.226 
0 6/5772 (1.04)  1  
      
Number of days treated 
with: 
     
      
Ventilation      
≥7 28/12,737 (2.20) 1.53 (0.74, 3.15) 0.248 
4-6 1/1276 (0.78) 0.53 (0.07, 4.13) 0.544 
1-3 2/2781 (0.72) 0.48 (0.10, 2.18) 0.339 
0 10/6405 (1.56)  1  
      
Total parenteral 
nutrition 
     
≥7 27/10,965 (2.46) 2.69 (1.30, 5.57) 0.007 
4-6 2/1331 (1.50) 1.62 (0.36, 7.41) 0.532 
1-3 2/686 (2.92) 3.15 (0.69, 14.36) 0.139 
0 10/10,217 (0.98)  1  
      
Surgery      
Yes 16/5507 (2.91) 2.15 (1.15, 4.02) 0.017 
No 25/17,692 (1.41)  1  
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Table 5.25 Poisson regression models for the effect of procedure-related 
factors on total BSI, for NICU 3 
Potential risk factors 
BSI episodes/baby-days 
(Rate per 1000 baby-days) 
Crude rate ratios 
(95% CI) p-value 
      
No of blood samples taken      
≥7 41/2947 (13.91) 10.76 (5.66, 20.48) <0.001 
4-6 23/2750 (8.36) 6.35 (3.16, 12.76) <0.001 
0-3 12/8802 (1.36)  1  
      
Number of days spent in:      
      
Special care      
≥7 50/11,866 (4.21) 0.30 (0.19, 0.49) <0.001 
4-6 0/451 (0.00)  -  
1-3 1/437 (2.29) 0.13 (0.02, 0.98) 0.047 
0 25/1745 (14.33)  1  
      
High dependency care      
≥7 21/2727 (7.70) 1.51 (0.90, 2.54) 0.119 
4-6 10/1533 (6.52) 1.27 (0.64, 2.52) 0.494 
1-3 1/1914 (0.52) 0.10 (0.01, 0.71) 0.021 
0 44/8325 (5.29)  1  
      
Intensive care      
≥7 61/6173 (9.88) 11.42 (4.59, 28.42) <0.001 
4-6 4/953 (4.20) 4.71 (1.26, 17.53) 0.021 
1-3 6/1955 (3.07) 3.39 (1.03, 11.11) 0.044 
0 5/5418 (0.92)  1  
      
Number of days treated with:      
      
Ventilation      
≥7 42/3594 (11.69) 6.82 (3.72, 12.48) <0.001 
4-6 5/705 (7.09) 4.08 (1.47, 11.32) 0.007 
1-3 15/2509 (5.98) 3.42 (1.65, 7.08) <0.001 
0 14/7691 (1.82)  1  
      
Total parenteral nutrition      
≥7 62/5512 (11.25) 8.32 (4.49, 15.44) <0.001 
4-6 0/441 (0.00)  -  
1-3 2/130 (15.38) 10.79 (2.41, 48.21) 0.002 
0 12/8416 (1.43)  1  
      
Nasal continuous positive 
airway pressure 
     
≥7 45/5126 (8.78) 2.90 (1.73, 4.87) <0.001 
4-6 3/743 (4.04) 1.31 (0.39, 4.40) 0.660 
1-3 7/2089 (3.35) 1.06 (0.45, 2.50) 0.890 
0 21/6541 (3.21)  1  
      
Long line      
≥7 56/5230 (10.71) 7.43 (4.07, 13.59) <0.001 
4-6 3/445 (6.74) 4.58 (1.30, 16.06) 0.018 
1-3 4/271 (14.76) 10.12 (3.30, 31.03) <0.001 
0 13/8553 (1.52)  1  
      
Umbilical arterial catheter      
≥7 22/1555 (14.15) 4.26 (2.51, 7.21) <0.001 
4-6 10/1243 (8.05) 2.42 (1.21, 4.87) 0.013 
1-3 7/1060 (6.60) 1.97 (0.88, 4.41) 0.101 
0 37/10,641 (3.48)  1  
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Umbilical venous catheter      
≥7 19/1828 (10.39) 3.55 (2.01, 6.26) <0.001 
4-6 13/708 (18.36) 6.22 (3.26, 11.85) <0.001 
1-3 12/1554 (7.72) 2.60 (1.34, 5.05) 0.005 
0 32/10,409 (3.07)  1  
Table 5.26 Poisson regression models for the effect of procedure-related 
factors on CONS BSI, for NICU 3 
Potential risk factors 
CONS BSI episodes/baby-days 
(Rate per 1000 baby-days) 
Crude rate ratios 
(95% CI) p-value 
      
No of blood samples taken      
≥7 33/2947 (11.20) 11.55 (5.53, 24.15) <0.001 
4-6 22/2750 (8.00) 8.10 (3.73, 17.58) <0.001 
0-3 9/8802 (1.02)  1  
      
Number of days spent in:      
      
Special care      
≥7 44/11,866 (3.71) 0.35 (0.21, 0.60) <0.001 
4-6 0/451 (0.00)  -  
1-3 1/437 (2.29) 0.17 (0.02, 1.30) 0.089 
0 19/1745 (10.89)  1  
      
High dependency care      
≥7 17/2727 (6.23) 1.46 (0.82, 2.58) 0.200 
4-6 9/1533 (5.87) 1.36 (0.66, 2.82) 0.408 
1-3 1/1914 (0.52) 0.12 (0.02, 0.84) 0.033 
0 37/8325 (4.44)  1  
      
Intensive care      
≥7 51/6173 (8.26) 9.55 (3.81, 23.92) <0.001 
4-6 3/953 (3.15) 3.53 (0.84, 14.77) 0.084 
1-3 5/1955 (2.56) 2.83 (0.82, 9.76)  0.100 
0 5/5418 (0.92)  1  
      
Number of days treated with:      
      
Ventilation      
≥7 33/3594 (9.18) 5.77 (3.04, 10.96) <0.001 
4-6 5/705 (7.09) 4.39 (1.57, 12.32) 0.005 
1-3 13/2509 (5.18) 3.19 (1.48, 6.88) 0.003 
0 13/7691 (1.69)  1  
      
Total parenteral nutrition      
≥7 50/5512 (9.07) 6.71 (3.58, 12.60) <0.001 
4-6 0/441 (0.00)  -  
1-3 2/130 (15.38) 10.79 (2.41, 48.21) <0.001 
0 12/8416 (1.43)  1  
      
Nasal continuous positive 
airway pressure 
     
≥7 37/5126 (7.22) 2.79 (1.59, 4.89) <0.001 
4-6 3/743 (4.04) 1.53 (0.45, 5.20) 0.495 
1-3 6/2089 (2.87) 1.06 (0.42, 2.68) 0.898 
0 18/6541 (2.75)  1  
      
Long line      
≥7 44/5230 (8.41) 5.84 (3.15, 10.84) <0.001 
4-6 3/445 (6.74) 4.58 (1.30, 16.06) 0.018 
1-3 4/271 (14.76) 10.12 (3.30, 31.03) <0.001 
0 13/8553 (1.52)  1  
      
Umbilical arterial catheter      
≥7 16/1555 (10.29) 3.58 (1.96, 6.52) <0.001 
4-6 9/1243 (7.24) 2.52 (1.20, 5.28) 0.014 
1-3 7/1060 (6.60) 2.28 (1.00, 5.16) 0.049 
0 32/10,641 (3.01)  1  
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Umbilical venous catheter      
≥7 15/1828 (8.21) 3.32 (1.77, 6.24) <0.001 
4-6 11/708 (15.54) 6.24 (3.09, 12.57) <0.001 
1-3 11/1554 (7.08) 2.82 (1.40, 5.69) 0.004 
0 27/10,409 (2.59)  1  
 
Table 5.27 Poisson regression models for the effect of procedure-related 
factors on non-CONS BSI, for NICU 3 
Potential risk factors 
Non-CONS BSI episodes/baby-days 
(Rate per 1000 baby-days) 
Crude rate ratios 
(95% CI) p-value 
      
No of blood samples 
taken 
     
≥7 8/2947 (2.71) 8.40 (2.23, 31.67) 0.002 
4-6 1/2750 (0.36) 1.10 (0.11, 10.61) 0.932 
0-3 3/8802 (0.34)  1  
      
Number of days spent 
in: 
     
      
Special care      
≥7 6/11,866 (0.51) 0.15 (0.05, 0.47) 0.001  
4-6 0/451 (0.00)  -  
1-3 0/437 (0.00)  -  
0 6/1745 (3.44)  1  
      
High dependency care      
≥7 4/2727 (1.47) 1.81 (0.53, 6.18) 0.344 
4-6 1/1533 (0.65) 0.80 (0.10, 6.49) 0.833 
1-3 0/1914 (0.00)  -  
0 7/8325 (0.84)  1  
      
Intensive care      
≥7 10/6173 (1.62)  -  
4-6 1/953 (1.05)  -  
1-3 1/1955 (0.51)  -  
0 0/5418 (0.00)  -  
      
Number of days treated 
with: 
     
      
Ventilation      
≥7 9/3594 (2.50) 20.45 (2.59, 161.41) 0.004 
4-6 0/705 (0.00)  -  
1-3 2/2509 (0.80) 6.38 (5.78, 70.34) 0.130 
0 1/7691 (0.13)  1  
      
Total parenteral 
nutrition 
     
≥7 12/5512 (2.18)  -  
4-6 0/441 (0.00)  -  
1-3 0/130 (0.00)  -  
0 0/8416 (0.00)  -  
      
Nasal continuous 
positive airway pressure 
     
≥7 8/5126 (1.56) 3.61 (0.96, 13.62) 0.058 
4-6 0/743 (0.00)  -  
1-3 1/2089 (0.48) 1.06 (0.11, 10.21) 0.958 
0 3/6541 (0.46)  1  
      
Long line      
≥7 12/5230 (2.29)  -  
4-6 0/445 (0.00)  -  
1-3 0/271 (0.00)  -  
0 0/8553 (0.00)  -  
      
Umbilical arterial      
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catheter 
≥7 6/1555 (3.86) 8.59 (2.62, 28.14) <0.001 
4-6 1/1243 (0.80) 1.79 (0.21, 15.35) 0.594 
1-3 0/1060 (0.00)  -  
0 5/10,641 (0.47)  1  
      
Umbilical venous 
catheter 
     
≥7 4/1828 (2.19) 4.78 (1.28, 17.80) 0.020 
4-6 2/708 (2.82) 6.12 (1.19, 31.56) 0.030 
1-3 1/1554 (0.64) 1.39 (0.16, 11.87) 0.765 
0 5/10,409 (0.48)  1  
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Table 7.5 Case control study, control selection strategy 2. Results for NICU 1 and NICU 2 combined 
Potential risk factor 
Number of 
cases 
Number of 
controls 
Crude odds ratios 
(95% CI) p-value 
Adjusted odds ratios 
(95% CI) p-value 
         
Highest level of carec         
Intensive care 138 155 5.63 (3.71, 8.54) <0.001 3.15 (1.88, 5.30) <0.001 
High dependency care 47 41 7.59 (4.26, 13.49) <0.001 7.84 (4.23, 14.52) <0.001 
Special care 36 266  1   1  
Otherd 15 10       
         
Gestational age (weeks)         
<26 72 54 3.53 (2.05, 6.07) <0.001    
26-<28 35 43 2.00 (1.09, 3.69) 0.026    
28-<32 53 127 1.01 (0.61, 1.68) 0.957    
32-<37 30 144 0.46 (0.27, 0.79) 0.005    
≥37 46 104  1     
Missinge 0 0       
         
Birth weight (g)         
<700g 62 33 6.68 (3.98, 11.23) <0.001 4.42 (2.25, 8.66) <0.001 
700g-<1200g 78 121 2.41 (1.61, 3.60) <0.001 1.61 (0.96, 2.70) 0.071 
≥1200g 96 318  1   1  
Missinge 0 0       
         
Inborn status         
No 80 86 2.43 (1.67, 3.52) <0.001 1.67 (1.04, 2.68) 0.033 
Yes 154 384  1   1  
Missinge 2 2       
         
Hospital         
NICU 2 129 263 0.96 (0.70, 1.31) 0.791    
NICU 1 107 209  1     
         
Sex         
Male 130 239 1.20 (0.87, 1.64) 0.262    
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Female 106 233  1     
         
Delivery method         
Emergency CSf 92 184 0.94 (0.67, 1.33) 0.736    
Elective CSf 33 76 0.82 (0.52, 1.31) 0.410    
Vaginal 110 210  1     
Missinge 1 2       
         
Number of blood samples takenc         
≥2 2 3 1.24 (0.20, 7.50) 0.816    
1 27 63 0.83 (0.50, 1.38) 0.468    
0 207 406  1     
         
Surgeryc         
Yes 5 7 1.43 (0.45, 4.50) 0.542    
No 231 465  1     
         
Table 7.6 Case control study, control selection strategy 2. Results for NICU 1h 
 
Potential risk factor 
Number of 
cases 
Number of 
controls 
Crude odds ratios 
(95% CI) p-value 
Adjusted odds ratios 
(95% CI) p-value 
         
Highest level of carec         
Intensive care 60 75 4.84 (2.54, 9.23) <0.001 4.69 (2.26, 9.72) <0.001 
High dependency care 28 27 5.99 (2.81, 12.75) <0.001 6.80 (2.99, 15.48) <0.001 
Special care 16 108 1    1  
Otherd 3 4       
         
Gestational age (weeks)         
<26 33 33 2.24 (0.95, 5.26) 0.064    
26-<28 17 28 1.44 (0.58, 3.56) 0.434    
28-<32 28 59 0.96 (0.42, 2.20) 0.926    
32-<37 10 57 0.33 (0.13, 0.82) 0.018    
≥37 19 37  1     
Missinge 0 0       
         
Birth weight (g)         
≤ 700g 24 20 4.28 (1.99, 9.23) <0.001    
700g-<1200g 42 75 1.93 (1.07, 3.48) 0.028    
≥1200g 41 119  1     
Missinge 0 0       
         
Inborn status         
No 50 56 2.69 (1.58, 4.56) <0.001 1.56 (0.83, 2.93) 0.167 
Yes 55 157  1   1  
Missinge 2 1       
         
Sex         
Male 58 114 1.04 (0.66, 1.63) 0.877    
Female 49 100  1     
         
Delivery method         
Emergency CSf 46 92 0.99 (0.61, 1.62) 0.970    
Elective CSf 8 19 0.84 (0.35, 1.98) 0.688    
Vaginal 52 103  1     
Missinge 1 0       
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 267 
Number of blood samples takenc         
≥2 1 1 1.83 (0.11, 31.04) 0.677    
1 13 29 0.88 (0.40, 1.97) 0.763    
0 93 184  1     
         
Surgeryc         
Yes 2 4 1 (0.18, 5.46) 1.00    
No 105 210  1     
         
 
 
 
 
 
 
 
 
 
 
 
Table 7.7 Case control study, control selection strategy 2. Results for NICU 2 
 
Potential risk factor 
Number of 
cases 
Number of 
controls 
Crude odds ratios 
(95% CI) p-value 
Adjusted odds ratios 
incorporating level of care 
(95% CI) p-value 
AIC= 172.12 
Adjusted odds ratios 
incorporating total 
parenteral nutrition 
(95% CI) p-value 
AIC= 201.57 
            
Highest level of carec            
Intensive care 78 79 7.08 (3.84, 13.06) <0.001 2.67 (1.28, 5.59) 0.009    
High dependency care 19 18 9.24 (3.73, 22.91) <0.001 9.30 (3.54, 24.46) <0.001    
Special care 20 152  1   1     
Otherd 12 9          
            
Gestational age (weeks)            
<26 39 20 7.77 (3.36, 18.00) <0.001    1.86 (0.69, 5.05) 0.221 
26-<28 18 11 7.09 (2.56, 19.64) <0.001    2.39 (0.78, 7.30) 0.128 
28-<32 25 54 1.74 (0.83, 3.64) 0.141    0.66 (0.27, 1.60) 0.363 
32-<37 20 100 0.58 (0.29, 1.17) 0.130    0.42 (0.20, 0.91) 0.028 
≥37 27 73  1      1  
Missinge 0 0          
            
Birth weight (g)            
≤ 700g 38 15 10.79 (4.96, 23.51) <0.001 8.26 (3.13, 21.82) <0.001    
700g-<1200g 36 36 4.31 (2.26, 8.20) <0.001 3.99 (1.77, 9.00) 0.001    
≥1200g 55 207  1   1     
Missinge 0 0          
            
Inborn status            
No 30 37 1.92 (1.09, 3.39) 0.025       
Yes 99 221  1        
Missinge 0 0          
            
Sex            
Male 72 140 1.06 (0.70, 1.60) 0.779       
Female 57 118  1        
            
Delivery method            
Emergency CSf 46 89 0.98 (0.60, 1.58) 0.919       
Elective CSf 25 60 0.79 (0.45, 1.36) 0.387       
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Vaginal 58 108  1        
Missinge 0 1          
            
Number of blood samples takenc            
≥2 1 2 0.62 (0.05, 7.45) 0.708       
1 14 45 0.50 (0.24, 1.05) 0.067       
0 114 211  1        
            
Surgeryc            
Yes 3 7 0.86 (0.22, 3.31) 0.823       
No 126 251  1        
            
Total parenteral nutritionc            
Yes 72 35 10.05 (5.29, 19.11) <0.001    7.42 (3.45, 15.97) <0.001 
No 57 223  1      1  
            
Ventilationc            
Yes 75 68 3.59 (2.29, 5.64) <0.001       
No 54 190  1        
            
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 7.8 Case control study, control selection strategy 3. Results for NICU 1 and NICU 2 combined 
Potential risk factor 
Number of 
cases 
Number of 
controls 
Crude odds ratios 
(95% CI) p-value 
Adjusted odds ratios 
(95% CI) p-value 
         
Highest level of carec         
Intensive care 138 168 5.73 (3.60, 9.13) <0.001 3.29 (1.87, 5.78) <0.001 
High dependency care 47 58 5.10 (2.96, 8.78) <0.001 4.89 (2.81, 8.49) <0.001 
Special care 36 225  1   1  
Otherd 15 21       
         
Gestational age (weeks)         
<26 72 56 3.32 (1.95, 5.65) <0.001 2.26 (1.07, 4.78) 0.032 
26-<28 35 56 1.63 (0.90, 2.94) 0.106 1.39 (0.65, 2.99) 0.397 
28-<32 53 126 0.99 (0.61, 1.63) 0.981 0.98 (0.54, 1.80) 0.958 
32-<37 30 130 0.52 (0.30, 0.88) 0.016 0.75 (0.41, 1.39) 0.363 
≥37 46 103  1   1  
Missinge 0 1       
         
Birth weight (g)         
≤ 700g 62 52 3.95 (2.50, 6.25) <0.001    
700g-<1200g 78 129 2.17 (1.45, 3.25) <0.001    
≥1200g 96 290  1     
Missinge 0 1       
         
Inborn status         
No 80 95 2.04 (1.43, 2.92) <0.001 1.36 (0.87, 2.10) 0.173 
Yes 154 374  1   1  
Missinge 2 3       
         
Hospital         
NICU 2 129 243 1.16 (0.83, 1.62) 0.393    
NICU 1 107 229  1     
         
Sex         
Male 130 256 1.03 (0.76, 1.41) 0.832    
Female 106 216  1     
         
Delivery method         
Emergency CSf 92 185 0.97 (0.69, 1.37) 0.860    
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Elective CSf 33 74 0.87 (0.55, 1.37) 0.542    
Vaginal 110 212  1     
Missinge 1 1       
         
Number of blood samples takenc         
≥2 2 5 0.63 (0.11, 3.67) 0.610    
1 27 75 0.62 (0.36, 1.05) 0.074    
0 207 392  1     
         
Surgeryc         
Yes 5 12 0.82 (0.28, 2.41) 0.724    
No 231 460  1     
         
Table 7.9 Case control study, control selection strategy 3. Results for NICU 1 
Potential risk factor 
Number of 
cases 
Number of 
controls 
Crude odds ratios 
(95% CI) p-value 
Adjusted odds ratios 
(95% CI) p-value 
         
Highest level of carec         
Intensive care 60 65 5.34 (2.88, 9.91) <0.001 4.83 (2.45, 9.54) <0.001 
High dependency care 28 36 5.10 (2.42, 10.73) <0.001 5.37 (2.40, 11.97) <0.001 
Special care 16 109  1   1  
Otherd 3 4       
         
Gestational age (weeks)         
<26 33 28 4.11 (0.84, 9.22) 0.001    
26-<28 17 28 2.02 (0.85, 4.82) 0.112    
28-<32 28 57 1.57 (0.74, 3.33) 0.235    
32-<37 10 47 0.57 (0.23, 1.42) 0.227    
≥37 19 54  1     
Missinge 0 0       
         
Birth weight (g)         
≤700g 24 19 4.88 (2.22, 10.70) <0.001    
700g-<1200g 42 66 2.19 (1.25, 3.85) 0.006    
≥1200g 41 129  1     
Missinge 0 0       
         
Inborn status         
No 50 50 2.93 (1.75, 4.92) <0.001 1.94 (1.08, 3.49) 0.026 
Yes 55 161  1   1  
Missinge 2 3       
         
Sex         
Male 58 117 0.98 (0.62, 1.56) 0.937    
Female 49 97  1     
         
Delivery method         
Emergency CSf 46 79 1.23 (0.75, 2.00) 0.409    
Elective CSf 8 24 0.69 (0.28, 1.68) 0.414    
Vaginal 52 110  1     
Missinge 1 1       
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Number of blood samples takenc         
≥2 1 2 1.04 (0.09, 11.49) 0.976    
1 13 22 1.23 (0.57, 2.67) 0.593    
0 93 190  1     
         
Surgeryc         
Yes 2 3 1.33 (0.22, 7.98) 0.753    
No 105 211  1     
         
 
 
 
 
 
 
 
 
 
 
Table 7.10 Case control study, control selection strategy 3. Results for NICU 2 
Potential risk factor 
Number of 
cases 
Number of 
controls 
Crude odds ratios 
(95% CI) p-value 
Adjusted odds ratios 
incorporating level of care 
(95% CI) p-value 
AIC= 192.13 
Adjusted odds ratios 
incorporating total 
parenteral nutrition 
(95% CI) p-value 
AIC= 226.57 
            
Highest level of carec            
Intensive care 78 92 4.63 (2.70, 17.94) <0.001 1.81  (0.90, 3.64) 0.095    
High dependency care 19 16 6.83 (2.92, 15.96) <0.001 8.81  (3.56, 21.81) <0.001    
Special care 20 134  1   1     
Otherd 12 16          
            
Gestational age (weeks)            
<26 39 25 4.68 (2.17, 10.10) <0.001    1.99 (0.84, 4.71) 0.116 
26-<28 18 17 2.63 (1.12, 6.20) 0.027    1.08 (0.41, 2.86) 0.873 
28-<32 25 57 1.16 (0.57, 2.34) 0.679    0.69 (0.32, 1.52) 0.361 
32-<37 20 93 0.49 (0.24, 1.00) 0.052    0.39 (0.18, 0.83) 0.015 
≥37 27 66  1      1  
Missinge 0 0          
            
Birth weight (g)            
≤ 700g 38 25 5.31 (2.86, 9.86) <0.001 5.71  (2.30, 14.16) <0.001    
700g-<1200g 36 45 2.85 (1.64, 4.97) <0.001 3.37  (1.61, 7.06) 0.001    
≥1200g 55 188  1   1     
Missinge 0 0          
            
Inborn status            
No 30 36 1.89 (1.09, 3.28) 0.023       
Yes 99 222  1        
Missinge 0 0          
            
Sex            
Male 72 150 0.91 (0.60, 1.39) 0.667       
Female 57 108  1        
            
Delivery method            
Emergency CSf 46 91 0.95 (0.58, 1.54) 0.823       
Elective CSf 25 56 0.85 (0.48, 1.49) 0.570       
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Vaginal 58 110  1        
Missinge 0 1          
            
Number of blood samples takenc            
≥2 1 5 0.31 (0.03, 2.69) 0.286       
1 14 48 0.45 (0.22, 0.91) 0.027       
0 114 205  1        
            
Surgeryc            
Yes 3 9 0.64 (0.17, 2.50) 0.525       
No 126 249  1        
            
Total parenteral nutritionc            
Yes 72 51 5.19 (3.12, 8.63) <0.001    4.08 (2.26, 7.36) <0.00
1 
No 57 207  1      1  
            
Ventilationc            
Yes 75 80 2.74 (1.80, 4.16) <0.001       
No 54 178  1        
            
c - In the three days prior to the censoring age 
d - ‘Other’ indicates that for the three days prior to the censoring age, the baby was outside the NICU. For example at another hospital or undergoing surgery. 
e - Babies with missing variables were few and represented few episodes of BSI. For this reason I considered it acceptable to remove them from the analyses. 
f - CS- Caesarean section 
g - For cases with higher ages (in days) at BSI, the number of controls available for selection became scarce. For control selection strategy 1 at NICU 1, two cases 
with ages at BSI of 111 and 132 days had to share controls with other cases.  
h - For control selection strategy 2 at NICU 1, one case with age at BSI of 132 days had to share controls with another case. 
 
Appendix to Chapter 8 
Table 8.2 Stratified BSI episodes and baby-days (BSI rate per 1000 baby-days) for 2001 b, c 
 
NICU 1    
Birth weight <700g 700g-<1200g ≥1200g 
 Inborn Outborn Inborn Outborn Inborn Outborn 
Level of care       
Special care 0/77 (0) 1/60 (16.67) 1/560 (1.79) 0/235 (0) 1/1074 (0.93) 0/113 (0) 
High dependency care 1/33 (30.30) 0/25 (0) 0/34 (0) 1/26 (38.46) 0/175 (0) 0/8 (0) 
Intensive care 1/113 (8.85) 8/414 (19.32) 1/307 (3.26) 3/397 (7.56) 1/126 (7.94) 1/20 (50.00) 
 
NICU 2    
Birth weight <700g 700g-<1200g ≥1200g 
 Inborn Outborn Inborn Outborn Inborn Outborn 
Level of care       
Special care 0/108 (0) 0/42 (0) 1/287 (3.48) 1/98 (10.20) 6/1346 (4.46) 0/217 (0) 
High dependency care 0/1 (0) 0/9 (0) 0/37 (0) 0/15 (0) 2/123 (16.26) 0/13 (0) 
Intensive care 7/699 (10.01) 2/94 (21.28) 3/395 (7.59) 1/324 (3.09) 3/224 (13.39) 0/18 (0) 
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Table 8.3 Stratified BSI episodes and baby-days (BSI rate per 1000 baby-days) for 2002 b, c 
NICU 1    
Birth weight <700g 700g-<1200g ≥1200g 
 Inborn Outborn Inborn Outborn Inborn Outborn 
Level of care       
Special care 0/165 (0) 0/101 (0) 0/613 (0) 1/268 (3.73) 5/1845 (2.71) 0/349 (0) 
High dependency care 2/42 (47.62) 0/9 (0) 1/78 (12.82) 5/170 (29.41) 8/361 (22.16) 5/85 (58.82) 
Intensive care 8/356 (22.47) 3/145 (20.69) 5/342 (14.62) 10/877 (11.40) 3/237 (12.66) 0/61 (0) 
 
NICU 2    
Birth weight <700g 700g-<1200g ≥1200g 
 Inborn Outborn Inborn Outborn Inborn Outborn 
Level of care       
Special care 0/151 (0) 0/7 (0) 1/371 (2.70) 1/184 (5.43) 11/2987 (3.68) 0/150 (0) 
High dependency care 1/28 (35.71) 0/0 (0) 0/77 (0) 1/20 (50.00) 3/215 (13.95) 1/54 (18.52) 
Intensive care 8/537 (14.90) 8/655 (12.21) 8/843 (9.49) 10/478 (20.92) 2/363 (5.51) 1/53 (18.87) 
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Table 8.4 Stratified BSI episodes and baby-days (BSI rate per 1000 baby-days) for 2003 b 
 
NICU 1    
Birth weight <700g 700g-<1200g ≥1200g 
 Inborn Outborn Inborn Outborn Inborn Outborn 
Level of care       
Special care 0/230 (0) 0/12 (0) 2/736 (2.72) 0/113 (0) 5/2333 (2.14) 1/129 (7.75) 
High dependency care 0/47 (0) 0/10 (0) 3/219 (13.70) 1/177 (5.65) 3/486 (6.17) 2/235 (8.51) 
Intensive care 2/162 (12.35) 2/193 (10.36) 5/433 (11.55) 9/689 (13.06) 1/289 (3.46) 3/139 (21.58) 
 
NICU 2    
Birth weight <700g 700g-<1200g ≥1200g 
 Inborn Outborn Inborn Outborn Inborn Outborn 
Level of care       
Special care 0/27 (0) 0/0 (0) 0/797 (0) 0/187 (0) 4/2959 (1.35) 0/187 (0) 
High dependency care 0/0 (0) 0/0 (0) 0/46 (0) 0/1 (0) 2/119 (16.81) 1/19 (52.63) 
Intensive care 12/737 (16.28) 5/424 (11.79) 12/1221 (9.83) 1/83 (12.05) 5/615 (8.13) 1/34 (29.41) 
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Table 8.5 Stratified BSI episodes and baby-days (BSI rate per 1000 baby-days) for 2004 b 
 
NICU 1    
Birth weight <700g 700g-<1200g ≥1200g 
 Inborn Outborn Inborn Outborn Inborn Outborn 
Level of care       
Special care 0/0 (0) 0/17 (0) 1/1156 (0.87) 0/92 (0) 2/1867 (1.07) 1/156 (6.41) 
High dependency care 0/0 (0) 3/127 (23.62) 1/158 (6.33) 0/15 (0) 3/424 (7.08) 0/35 (0) 
Intensive care 1/94 (10.64) 9/655 (13.74) 9/789 (11.41) 0/376 (0) 4/381 (10.50) 0/92 (0) 
 
NICU 2    
Birth weight <700g 700g-<1200g ≥1200g 
 Inborn Outborn Inborn Outborn Inborn Outborn 
Level of care       
Special care 0/54 (0) 0/114 (0) 0/437 (0) 0/160 (0) 9/2986 (3.01) 1/241 (4.15) 
High dependency care 0/5 (0) 0/0 (0) 1/48 (20.83) 0/6 (0) 4/365 (10.96) 0/7 (0) 
Intensive care 12/793 (15.13) 6/431 (13.92) 7/1135 (6.17) 2/306 (6.54) 4/552 (7.25) 0/32 (0) 
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Table 8.6 Stratified BSI episodes and baby-days (BSI rate per 1000 baby-days) for 2005 b, c 
 
NICU 1    
Birth weight <700g 700g-<1200g ≥1200g 
 Inborn Outborn Inborn Outborn Inborn Outborn 
Level of care       
Special care 0/0 (0) 0/0 (0) 0/56 (0) 0/0 (0) 0/205 (0) 0/0 (0) 
High dependency care 0/0 (0) 0/0 (0) 0/0 (0) 0/0 (0) 0/42 (0) 0/0 (0) 
Intensive care 0/0 (0) 1/80 (12.5) 0/10 (0) 0/9 (0) 0/5 (0) 0/0 (0) 
 
NICU 2    
Birth weight <700g 700g-<1200g ≥1200g 
 Inborn Outborn Inborn Outborn Inborn Outborn 
Level of care       
Special care 0/57 (0) 0/0 (0) 0/52 (0) 0/0 (0) 0/386 (0) 0/69 (0) 
High dependency care 0/0 (0) 0/0 (0) 0/3 (0) 0/0 (0) 0/2 (0) 0/0 (0) 
Intensive care 0/42 (0) 0/0 (0) 0/69 (0) 0/27 (0) 0/54 (0) 1/31 (32.26) 
b - Figures are not shown stratified for postnatal age, due to small numbers in some strata  
c - As the study period ran from May 2001 to February 2005 inclusive, 2001 and 2005 do not contain the full twelve months of data 
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Appendix to Chapter 9 
HAI surveillance criteria recommended by the ARHAI Surveillance 
Subgroup 
Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infection 
(ARHAI) Surveillance Subgroup (2010) Report on HCAI Surveillance Priorities – 
Recommendations for HCAI surveillance in England. Permission to reproduce this 
information was confirmed by the ARHAI in January 2011. 
http://www.dh.gov.uk/ab/ARHAI/index.htm. Accessed July 2010 
 
Criteria  Factors to be considered  
1. Clearly defined and agreed with outcome-related objectives  
 
 Involve infections where the outcome results in significant mortality 
and/or morbidity  
 The costs of the surveillance are justified by its potential impact  
 Involve conditions associated with a significant economic burden to the 
health service, to patients or to society  
 Link to relevant aspects of antimicrobial resistance  
 Provide performance measures for intra-organisational, national and, 
where relevant, international, extra-organisational comparisons  
 Resources are allocated to produce the optimal balance between local 
and others’ needs  
 Surveillance data informs regular audit cycles  
 Link with systems that ensure effective implementation of changes to 
practice that emerge from the surveillance/audit processes  
 Incorporate arrangements that allow assessment of organisational 
outcomes  
 
2. Accurate and timely data with reproducibility consistent with defined 
objectives  
 
 Data collection methodology provides accurate data  
 Takes account of lengths of patient stay  
 Takes account of variations over time  
 The methodology ensures appropriate sensitivity for the condition being 
surveyed  
 Effective validation systems are in place  
 Adequate post-discharge follow-up  
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3. Data collection utilises informatics systems effectively  
 
 Utilise routine patient management systems  
 Incorporate efficient, reliable and accurate IT systems (e.g. internet, 
intranet, personal digital assistants, scanned forms)  
 
4. Programme integrated with other data management systems  
 
 ’Piggy-backs’ onto existing data collection systems  
 Avoids duplication in relation to data collection  
 Utilises existing surveillance initiatives, e.g. National Vascular Database, 
ICNARC  
 
5. Data informs local services, commissioners, relevant government 
departments, Royal Colleges, professional organisations, general public and the 
media  
 
 Processes are in place to make results available early in formats that are 
informative and comprehensible to the target audience  
 The information is utilised for related professional issues e.g. consultant 
appraisal, revalidation  
 Processes exist to provide epidemiology and statistics training for 
relevant groups  
 
 
Publications Appendix 
Permission to reproduce the publications in this appendix was confirmed by Elsevier 
Ltd in January 2011. 
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Summary Comparisons of bacteraemia incidence between neonatal
intensive care units (NICUs) can identify centres with effective infec-
tion control, whose practices can be shared with other units. For fair
comparisons, infection incidence must be risk-adjusted to control for
differences between centres in the vulnerability of babies and the
intensity of invasive procedures which can introduce infection. We
reviewed risk adjustment methods for between-NICU comparisons of
bacteraemia incidence, both in the published literature and in regional
and national NICU infection monitoring systems. PubMed and Embase
were searched for studies reporting risk-adjusted bacteraemia inci-
dence in more than one NICU. An internet search found NICU infection
monitoring systems in Western industrialised countries. In all nine stud-
ies that met the inclusion criteria, risk adjustment reduced but did not
eliminate variation in bacteraemia incidence between NICUs. In both
the studies and the regional monitoring systems, adjustment for baby
susceptibility generally involved stratiﬁcation by factors measured at
birth. Adjustment for length of stay and invasive procedures involved
reporting incidence by days with a device, such as central venous
catheter days. Methods for NICU infection monitoring lack consistency.
Adjustment for factors measured at birth fails to capture changes in
susceptibility throughout admission and adjustment for device days
* Corresponding author. Address: MRC Centre of Epidemiology for Child Health, UCL Institute of Child Health, 30 Guilford Street,
London WC1N 1EH, UK. Tel.: þ0207 905 2764; fax: þ0207 905 2793.
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doi:10.1016/j.jhin.2008.06.014
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does not adequately reﬂect risk to babies not treated with the device.
Further research should address variation in risk for all babies through-
out their NICU stay.
ª 2008 The Hospital Infection Society. Published by Elsevier Ltd. All rights
reserved.
Introduction
Between 2% and 10% of babies admitted to neonatal
intensive care units (NICUs) experience at least one
episode of bacteraemia, which can lead to death
and other serious adverse outcomes.1e3 The major-
ity of bacteraemia episodes are hospital-acquired,
and often preventable through improvements in
hygiene practices and infection control.4e6
Suggestions that bacteraemia monitoring itself
might decrease infection rates7 are supported by
evidence from a systematic review of >100 ran-
domised controlled trials showing that audit and
feedback alone produce small to moderate
improvements in clinical practice.8,9 When compar-
ative monitoring has been used to trigger sharing of
improved practices between units, substantial
reductions in infection incidence appear to have
been achieved.10e12
Comparisons are complicated by the fact that
some of the variation observed between NICUs is
attributable to factors other than quality of care,
such as case mix, babies’ length of stay and the
invasivemedical procedures carried out, all ofwhich
can inﬂuence hospital-acquired infection.13 Tomake
fair and meaningful comparisons between hospitals,
a multicentre monitoring system must adjust for
these factors. Any residual variation may be ex-
plained, at least in part, by factors amenable to
change, such as hygiene practices. To formulate
a method for risk adjustment, factors must be iden-
tiﬁed which are both associated with infection and
reliably recorded. These factors can then be used
to stratify infection incidence, or can be included
in a statistical risk adjustment model.
We performed a systematic review to determine
methods used for risk adjustment in studies that
compared infection incidence between NICUs,
and to determine how much infection incidence
varied before and after risk adjustment. We also
determined the extent to which these approaches
for risk adjustment are being used by regional
surveillance systems for NICU-acquired infection
around the world. We discuss different approaches
for risk adjustment and suggest ways to improve
robustness of comparisons and consistency of
reporting.
Methods
Systematic review of studies reporting
risk adjustment
Studies were included if they reported any measure
of the frequency of bacteraemia at more than
one NICU and comparative results that were risk-
adjusted. We accepted any approach for risk
adjustment, including stratiﬁcation for risk factors,
for example reporting infections as rates per cath-
eter days, as well as the inclusion of risk factors in
a statistical risk adjustment model. We accepted
any deﬁnition for hospital-acquired bacteraemia,
but excluded studies concentrating on delivery-
associated bacteraemia in the ﬁrst few days of life.
We combined three sets of search synonyms re-
lating to NICU, bacteraemia, and monitoring or risk
adjustment to search PubMed and Embase databases
(with Embase thesaurus mapping) in any language
until October 2007 (search strategy available from
theauthors).Oneperson (P.P.) reviewedall titles and
abstracts for potentially eligible articles. Studies
meeting the inclusion criteria were reviewed by
two reviewers (P.P. and R.G.). We also searched
reference lists and ‘related articles’ of all included
studies (using PubMed). Abstracts from relevant
conferences were reviewed from 2005 to 2007.
Review of regional monitoring systems
As both infections and organisational structures
vary greatly among NICUs in developing countries,
we included only monitoring systems from Europe,
North America and Australasia to ensure general-
isability. The search was performed in Google using
short phrases and the region of interest.
Results
Systematic review of studies reporting
risk adjustment
Quality of literature
Nine studies met our inclusion criteria (Figure 1)
(Table I).1,14e21 Case deﬁnitions for bacteraemia
204 P. Phillips et al.
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varied in complexity from a ﬁrst positive blood cul-
ture,1,21 to hospital-acquired bacteraemia deﬁned
by US Centers for Disease Control and Prevention
(CDC) criteria.17,18,20,22 Two studies excluded
bacteraemia acquired before NICU admission by
including only diagnostic blood cultures taken at
least 48 h after admission.14,16 CDC criteria state
that ‘there must be no evidence that the infection
was present or incubating at the time of hospital
admission’, but give no time threshold.22 All but
two studies distinguished hospital-acquired from
delivery-associated bacteraemia, using thresholds
ranging from 48 to 72 h after birth.18,20
Risk adjustment
Table I shows that most studies took into account
the duration of exposure, by reporting incidence
per baby days of stay or per central venous cath-
eter (CVC) days, sometimes with Cox regression
or KaplaneMeier analyses of time to infection.16,17
Four studies did not take into account length of
stay, and reported only one or more infections
per baby.1,14,19,21
Adjustment for baby susceptibility and organ-
isational factors was performed by stratifying
bacteraemia incidence by birthweight, or by in-
cluding baby susceptibility factors in a risk ad-
justment model.14,18,20 Adjustment for medical
procedures was performed by reporting bacterae-
mia per days with a CVC. Other studies included
medical procedures in a risk adjustment model:
some factors were included as binary variables
(e.g. CVC: yes/no), some as durations censored
at the onset of bacteraemia or removal of the
CVC or ventilator, and others as time-dependent
variables updated continuously during a baby’s
stay.16,17
Two studies addressed the possibility that differ-
ences in blood sampling frequency between hos-
pitals could inﬂuence comparisons, as the more
samples taken the greater the risk of detecting
asymptomatic bacteraemia or a contaminated
4193 rejected after
scanning titles and
abstracts
79 rejected after full
text review
88 full papers reviewed
6020 studies found
PubMed: 2372
Embase: 3648
Total (minus overlap): 4281
9 studies included
0 from conference
proceedings
0 from PubMed
‘related articles’
searches
0 from bibliographies
9 studies
Figure 1 Flow diagram of the process and results of the systematic literature review.
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sample. The UK Neonatal Stafﬁng Study Group
(2005) found no association between the ratio of
positive to all blood cultures and the incidence of
bacteraemia or any of their risk adjustment vari-
ables. Brodie et al.measured a two-fold variation in
the frequency of blood sampling among NICUs, but
reported that differences in bacteraemia incidence
between NICUs remained signiﬁcant when results
for the commonest contaminant, coagulase-
negative staphylococcus, were removed from the
analysis.16
All nine studies showed residual variation in bac-
teraemia incidence between NICUs after risk adjust-
ment. Five studies reported a reduction in between-
NICU variation with risk adjustment (Table II).
Regional monitoring systems
Table III shows the seven regional monitoring
systems found.23e29 Case deﬁnitions varied in com-
plexity from a positive bacterial culture (excluding
cultures for coagulase-negative staphylococcus) to
CDC case deﬁnitions, while NEO-KISS (Krankenhaus
Infektions Surveillance System) modiﬁed the CDC
case deﬁnition for use in neonates.24,27,29,30 Four
systems exclude bacteraemia acquired before
NICU admission by including only diagnostic blood
cultures taken at least 48 h after admission, or
rejecting infections with evidence that they
were acquired elsewhere.23,24,26,29 Two systems
differentiate between delivery-associated and
hospital-acquired bacteraemia, using thresholds
of 48 or 72 h after birth.26,28
Risk adjustment
Five systems provide some adjustment for duration
of exposure, by reporting incidence by catheter
days, or catheter days and baby days of stay.23e26,29
All systems except NeonIN use some methods of
risk adjustment. Being based around the original
US CDC surveillance system, these are remarkably
similar; adjustment for baby susceptibility factors
by stratiﬁcation into birthweight groups, and
adjustment for medical procedure-related factors
by reporting incidence by catheter days. NEO-CAT
incorporates several factors in a multivariable risk
adjustment model.
Although most systems do not directly adjust for
differences in blood sampling frequency between
NICUs, their case deﬁnitions attempt to control for
differences in blood sample contamination by, for
example, requiring that a positive blood culture be
associated with clinical symptoms or a CVC.25
The Vermont Oxford Network goes further in rec-
ommending ‘potentially better practices’ to stan-
dardise sampling technique between participating
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NICUs, for example by recommending a minimum
blood sample of 1 mL.11
Most case deﬁnitions combine clinical evidence
of infection with blood culture results and conse-
quently require active reporting by clinicians. As
data storage generally differs between hospitals,
the methods for its collection are usually speciﬁc to
the NICU. We found no evidence that any system
exclusively uses electronic hospital administrative
data.
Discussion
Overall, risk adjustment attenuated but did not
remove differences in infection incidence between
Table II Variation in bacteraemia incidence between NICUs before and after risk adjustment
Authors Outcome measure Between-NICU
variation
reduced by risk
adjustment?
How much residual
variation between NICUs?
Canadian Neonatal
Network, 2002, 2005
(1) Incidence per
CVC days
(1) Yes (1) Statistically signiﬁcant variation
for all CVC strata
(2) Proportion of
babies with 1
bacteraemia
(2) Yes (2) Statistically signiﬁcant variation
for babies with birthweight <1500 g
Brodie et al., 2000 Time to
bacteraemia
after admission
Yes Statistically signiﬁcant
variation between 3/6 NICUs
Carrieri et al., 2003 (1) Time to
bacteraemia
after admission
(1) Unable
to determine:
no crude measures
provided
(1) Bacteraemia 3e10 days:
statistically signiﬁcant variation
(2) Time to
bacteraemia
after admission
(2) Unable to
determine: no crude
measures provided
(2) Bacteraemia 11e35 days:
statistically signiﬁcant variation
Gaynes et al., 1991 Incidence per
CVC days
Unable to determine:
no crude measures
provided
‘Signiﬁcant between-centre differences’,
but no risk-adjusted ﬁgures provided
NICHD, 2002 Proportion of
babies
1 bacteraemia
Unable to determine:
no risk-adjusted
ﬁgures provided
‘Statistically signiﬁcant variation’, but
no risk-adjusted ﬁgures provided
Stover et al., 2001 Incidence per
CVC days
Yes for babies
with birthweight
1501e2500 g
Variation remained, no information concerning
statistical signiﬁcance
UK Neonatal
Stafﬁng Study Group,
2002, 2005
(1) Proportion of
babies with 1
bacteraemia
(1) Yes (1) Statistically signiﬁcant variation in odds
ratios between NICUs with >1 level 1 cot
per handwash basin and NICUs with <1.
More handwash basins led to lower outcomes
Statistically signiﬁcant variation in odds
ratios between units with an infection
control nurse and units without. Presence
of an infection control nurse led to
lower outcomes.
(2) Proportion
of babies 1
bacteraemia
(2) Birth model: Yes (2) Statistically signiﬁcant variation for NICUs
allocated to different strata of consultant
provision. Lower consultant availability
led to lower odds ratios.
(3) Proportion of
babies 1
bacteraemia
(3) 12 h model: Yes (3) Statistically signiﬁcant variation for NICUs
allocated to different strata of consultant
provision. Lower consultant availability led to
lower odds ratios.
CVC, central venous catheter; NICU, neonatal intensive care unit.
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NICUs. Residual variation could indicate residual
confounding due to case mix or invasive medical
procedures, differences in data quality, or differ-
ences in the quality of care. The UK Neonatal
Stafﬁng Study Group suggests that residual varia-
tion is due to differences in quality of care:
measures of risk-adjusted bacteraemia showed
statistically signiﬁcant associations with NICU
organisational factors such as the provision of
neonatal consultants, hand washbasins and infec-
tion control nurses. There is general consensus
that risk adjustment is necessary, feasible and
effective, but there is no agreement as to the best
method for carrying it out.
Our review highlights the need for more consis-
tent outcome measures and risk adjustment
methods. AEurope-wide survey of hospital infection
control physicians revealed that their strongest
consensus research priority is standardisation of
surveillance systems for international comparison
of hospital-acquired infection incidence.31 Consis-
tency in the choice of denominator is the minimum
requirement; most studies and regional monitoring
systems reported incidence by baby or catheter
days, controlling for variations betweenNICUs indu-
ration of exposure to infections, which is recom-
mended in order to avoid bias in comparative
studies.32 Reporting rates also captures recurrent
infections within the same baby, which is not possi-
ble if reporting consists of a proportion of babies ex-
periencing one or more bacteraemias.
Meaningful international comparisons also require
consistency in the baby susceptibility factors and
medical procedures chosen for risk adjustment.Most
studies and regional monitoring systems adjust for
factors measured at birth, such as birthweight, but
this does not adjust for changes in a baby’s suscep-
tibility throughout his or her NICU stay. Days with
a CVC can provide such a continuous measure, but
they exclude the 80% of NICU babies not treatedwith
a CVC, who may have widely differing risks of
infection.15 Holmes et al. question the use of CVC
days for risk adjustment, as their multivariable anal-
ysis found parenteral nutrition to be a stronger pre-
dictor of bacteraemia than CVC use alone.33
Nevertheless, parenteral nutrition is used to treat
aminority (24%) of babies in theNICU.34 Furtheranal-
yses could investigate the attributable risk of differ-
entmedical procedures; if a procedure is responsible
for the burden of bacteraemia in a unit, it may be an
acceptable risk adjustment variable even if it is used
to treat a minority of babies. Current estimates sug-
gest that only w40% of bacteraemia are CVC-re-
lated.15 Otherwise continuous composite risk
adjustment variables may be preferable; capturing
multiple risk factors and all babies throughout their
NICU stay. An example is days of stay at each NICU
level of care, which in some countries is updated
daily and allocated to all babies according to clinical
status.35
The only regional monitoring system not perform-
ing risk adjustment is NeonIN, which aims to provide
simple, rapid determination of the patterns of
organisms in NICUs, with data entry by busy clini-
cians. NeonIN highlights dual requirements for NICU
monitoring: rapid data collection and feedback and
more time-consuming comparisons of risk-adjusted
rates. Both approaches are necessary; the former
can alert clinicians to sudden changes, the latter is
essential for quality of care benchmarking. For both
approaches, the use of routine electronic clinical
records would minimise staff workload and acceler-
ate the collection of data, but must be balanced
against the use of case deﬁnitions that include
clinical observations, which can require skilled data
collection and stand-alone data systems. It is possi-
ble that, with the standardisation of improved blood
sampling techniques such as those recommended by
the Vermont Oxford Network, blood sample contam-
ination could be reduced andwith it the requirement
for clinical symptoms to differentiate an episode of
bacteraemia from a contaminated sample. More
detailed data systems are being developed, such as
the Standardised Electronic Neonatal Database in
the UK and the Canadian NICU Network, which in the
future may support common deﬁnitions based on
routine electronic data.34,36
Risk adjustment is widely recognised as neces-
sary for meaningful comparisons of bacteraemia
rates between NICUs. However, there is a lack of
consistency in the case deﬁnitions, outcome mea-
sures and risk adjustment methods used. Case
deﬁnitions should be developed that allow data
extraction from routine electronic data, thereby
accelerating data collection and minimising staff
workload. Most regional monitoring systems agree
that adjustment for duration of exposure is
a minimum requirement; further research should
investigate the possibility of adjustment for rou-
tinely recorded, continuous, composite measures
of baby susceptibility and risk from medical pro-
cedures. The development of shared, detailed
routine electronic clinical record systems has the
potential to facilitate all of these improvements.
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Variation in infection incidence between
neonatal intensive care units can depend on
the measures used
Madam,
Bloodstream infection (BSI) incidence varies be-
tween neonatal intensive care units (NICUs).1 When
comparative BSI monitoring is used to trigger shar-
ing of improved practices between units, it can
reduce infection rates substantially.2 We compared
the incidence of BSI in two Inner London tertiary
NICUs, using two different measures: the propor-
tion of babies developing one or more BSIs; and
the rate of BSI per baby-days.
We analysed linked National Health Service
laboratory and patient administrative data for
admissions over a period of four years (admissions
per year: 260 in NICU 1 and 430 in NICU 2). An
episode of BSI was deﬁned by one or more blood
cultures for the same bacterial organism within
seven days. Because ~30% of blood cultures posi-
tive for coagulase-negative staphylococcus (CoNS)
may reﬂect blood sample contamination, we per-
formed separate analyses for CoNS and non-CoNS
BSI.3 For each NICU, we calculated the percentage
of babies (admissions) developing one or more
BSIs, and the rate of BSI by dividing total BSI
episodes by total baby-days of NICU stay. We also
calculated monthly rates of BSI, median lengths
of NICU stay, and percentages of BSI that were re-
current within babies. Differences between NICUs
were assessed for statistical signiﬁcance using
two-sample Z-tests for proportions, Poisson gener-
alised linear models for rates, and non-parametric
k-sample tests for medians.
A total of 58 196 baby-days were included in the
analyses. Of these, 10.9% of babies developed
CoNS BSI in NICU 1 compared with 8.5% in NICU 2
(P¼ 0.04). Rates of CoNS BSI per 1000 baby-days
were similar for both units: 5.3 for NICU 1 and
5.2 for NICU 2 [crude rate ratio: 1.0; 95% conﬁ-
dence interval (CI): 0.8e1.2]. The proportion of
babies developing non-CONS BSI was similar in
both units (3.4% NICU 1 vs 3.5% NICU 2; P¼ 0.86),
as were rates of non-CoNS BSI per 1000 baby-days
(2.2 NICU 1 vs 2.2 NICU 2; crude rate ratio: 1.0;
95% CI: 0.7e1.4). The median length of stay was
signiﬁcantly longer in NICU 1 (13 days versus
7 days, P< 0.001). Slightly more recurrent BSI oc-
curred in NICU 1 compared with NICU 2, but these
differences were not statistically signiﬁcant: 20.8%
of CoNS episodes were recurrences in NICU 1 ver-
sus 13.3% in NICU 2 (P¼ 0.07); non-CoNS recur-
rences comprised 1.7% in NICU 1 and 1.3% in NICU
2 (P¼ 0.82).
The ﬁndings highlight the importance of taking
into account length of stay. Median length of stay
in NICU 1 was nearly twice as long as for NICU 2, so
although NICU 1 may have had a higher proportion
of babies experiencing CoNS BSI, the two units had
similar numbers of CoNS BSI episodes per days of
stay. Differences in infection incidence must be
measured and interpreted with caution. Propor-
tions of babies experiencing one or more infections
are used in many studies reporting between-NICU
comparisons.2,4,5 Rates may be preferable as they
take into account differences in length of stay
and capture recurrent infections. An awareness
of length of NICU stay would allow clinicians to
investigate BSI in more detail, in order to target
infection control more effectively. An increased
length of stay may increase the risk of BSI, and
may be amenable to reduction. Conversely, it
could be the consequence of a higher incidence
of BSI, as babies with infections are kept in the
NICU for longer. As a minimum, comparisons of
BSI incidence between NICUs should be adjusted
for differences in length of NICU stay. Figure 1
demonstrates this adjusted comparison by month.
Using appropriate measures is but one element
of making fair and meaningful comparisons of
infection incidence between units. Analyses should
also adjust for differences in case mix and invasive
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medical procedures, which can also affect BSI
incidence regardless of quality of care.1 We previ-
ously reported a method of adjusting for these
confounding factors.6 If, as in our analyses, com-
parisons rely on routine hospital data, the effort
and cost involved in data collection is decreased.
However, a disadvantage of routine data is that
clinical symptoms required to differentiate be-
tween true BSI and blood sample contamination
are lacking. Reporting rates by organisms, as in
this analysis for CoNS and non-CoNS, offers a crude
but easy way to differentiate between infections
more or less likely to represent contamination. It
is also important to monitor CoNS BSI, as even
‘false positive’ blood cultures result in the in-
creased use of antibiotics and longer lengths of
hospital stay. Further research is needed to evalu-
ate appropriate methods of risk adjustment as the
availability of reliable data expands.
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Endemic carbapenem-resistant Acinetobacter
baumannii in a Brazilian intensive care unit
Madam,
In recent years, strains of multidrug-resistant
Acinetobacter baumannii have emerged as
important nosocomial pathogens, causing ventila-
tor-associated pneumonia, bacteraemia, and uri-
nary tract infection.1,2 Several outbreaks caused
by this micro-organism have been reported.3 How-
ever, the endemic situation of this hospital patho-
gen has been little investigated. In the present
study, we evaluated contamination in an intensive
care unit (ICU) caused by endemic carbapenem-
resistant Acinetobacter baumannii (CR-Ab) strains,
using environmental and patient cultures.
This prospective study was conducted from
January to July 2008, in an eight-bed adult ICU,
in a 120-bed Brazilian university hospital. All
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Risk stratiﬁcation by level of care for comparing
bloodstream infection rates in neonatal
intensive care units
Madam,
Comparisons of bloodstream infection (BSI) inci-
dence between neonatal intensive care units
(NICUs) can identify centres with potentially
better practices for infection control, which can
be shared with other units.1 To provide fair
comparisons, infection rates must take into
account differences between centres in the vul-
nerability of babies and the intensity of invasive
procedures that can introduce infection. Factors
associated with infection must be identiﬁed, which
can be used to stratify infection rates to give
meaningful comparisons between hospitals and
over time.2
To formulate a strategy for monitoring, we
examined gestational age at birth and daily Na-
tional Health Service (NHS) level of care, as factors
which could stratify BSI rates, to compare two
inner London tertiary NICUs with 260 and 430
admissions each year. Level of care has not pre-
viously been evaluated in risk-adjusted analyses; it
is a standardised measure of the intensity of care,
which is daily and routinely recorded for each baby
throughout NHS NICUs.3
We used linked NHS laboratory and patient
administrative data for admissions over four years,
producing daily counts of positive blood cultures
and babies at each level of care and gestational
age band. An episode of BSI was deﬁned as one or
more blood cultures in which the same bacterial
organism was isolated within a seven-day period.
This method of data collation was chosen to reﬂect
what could easily be carried out by hospital data
managers for routine monitoring.
We ﬁtted crude and adjusted Poisson generalised
linear models to investigate relationships between
the rate of BSI per baby-days of stay and level of
care, gestational age, NICU and blood sampling
frequency. We investigated blood sampling fre-
quency as this could inﬂuence comparisons; the
more samples taken the greater the risk of detecting
asymptomatic BSI or a contaminated sample.
NHS level of care and gestational age were
strongly associated with the rate of BSI, with level
of care being the strongest predictor. The best
adjusted model, in terms of minimising the Akaike
information criterion, included both factors.4 The
rate of BSI was 7.4 per 1000 baby-days and did
not differ between NICUs. The rate ratio for
BSI, adjusted for gestational age and sampling
frequency and relative to the baseline, special
care, was 3.37 [95% conﬁdence interval (CI):
2.38, 4.77] in intensive care and 4.40 (95%
CI: 3.15, 6.15) in high dependency care.
Level of care is itself a measure of vulnerability,
so its relationship with BSI is not surprising. The
key implication of this is that stratiﬁcation by level
of care could provide a simple risk adjustment tool
for meaningful comparisons of BSI between NICUs.
This is illustrated in Figure 1, which shows monthly
rates of BSI, by level of care for each NICU. Within
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levels of care different procedures may confer dif-
ferent risks, but this broad stratiﬁcation provides
a consistent approach across the NHS. Aggregation
of rates for high dependency and intensive care is
appropriate as they encompass similar invasive
procedures. However, if numbers allow, differenti-
ation into the three levels would provide more
discriminatory power.
A weakness of gestational age as a risk adjust-
ment measure is that it represents susceptibility to
infection at birth, without taking into account
changes in susceptibility throughout the NICU
stay. By contrast, level of care is updated daily,
so stratiﬁcation for level of care incorporates
changes in risk throughout the NICU stay. Risk
factors used in previous studies include days with
a central venous catheter (CVC),2 or days with
parenteral nutrition.5 Parenteral nutrition may be
a stronger predictor of BSI than CVC use alone.5
Both procedures provide a continuous measure of
risk, but are used to treat a minority of babies in
the NICU; 20% for CVCs and 24% for parenteral
nutrition.6,7 The remaining babies have widely
differing risks for infection. An advantage of level
of care is that it reﬂects risk status for all babies
for every day of stay.
In addition, stratiﬁcation by level of care de-
scribes rates by their location and clinical team,
which is relevant for targeting infection control
measures. Moreover, level of care data are stand-
ardised across the NHS, routinely recorded and
relatively complete and accurate because they are
used for costing purposes. Disadvantages include
the fact that clinical symptoms required to differ-
entiate between true BSI and contamination are
not routinely collected (although we found no
signiﬁcant association between blood sampling
rate and BSI rate in the adjusted analysis, which
would be expected if many positive blood cultures
represented contamination). In addition, we did
not differentiate between BSI which is hospital-
acquired and thew20% of BSI occurring in the ﬁrst
two days of life, which is likely to be maternally
transmitted. Such distinction by age at infection
is possible, but involves more intensive data
management. As the quality of routine neonatal
data improves, further research will be needed
to evaluate more complex methods of risk
adjustment.
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Survey of gut colonisation with
Stenotrophomonas maltophilia
among neonates
Madam,
Stenotrophomonas maltophilia is a nosocomial
pathogen with inherent and mutationally acquired
antibiotic resistance.1 Studies have implicated this
organism in bacteraemia and neonatal infections.1e3
Trimethoprim/sulfamethoxazole remains the ther-
apy of choice for infections with S. maltophilia
worldwide.1,4 However, this antibiotic is not
usually used in neonates as it increases risk of
hyperbilirubinaemia.5
In India w52% of all neonatal deaths are due to
sepsis.6 Sick neonates are admitted to a neonatal
intensive care unit (NICU) for treatment. However,
the ICU is a focal point for the emergence and
spread of antibiotic-resistant pathogens.7 Anti-
biotic resistance frequently poses more difﬁculty
in neonates where the options for therapy are
limited, especially for S. maltophilia, for example,
where the antibiotic of choice is generally not
empirically given to neonates. S. maltophilia is
thus a real threat in NICUs.
Surveillance of colonisation by S. maltophilia in
the NICU may be an effective way of monitoring
the carriage and antibiotic resistance pattern of the
organism. We therefore evaluated the carriage
of S. maltophilia as a part of a larger study to
understand the colonisation pattern of Gram-
negative organisms and their effect in neonates.
The gut of hospitalised patients is often colonised
with pathogens, and organisms from the gut may
be a predictor of nosocomial infections.
The study was carried out in a 20-bedded NICU
in a tertiary care centre in Kolkata. Samples were
collected over a one-year period. In all, 243 babies
were included in the study. Gastric aspirates were
collected from the neonates within 4 h of birth
(GA1) and also at any time if the babies were clin-
ically diagnosed with sepsis (GA2). An attempt was
also made to collect a faecal sample within 24 h of
the collection of GA2.
The gastric aspirates were stored at 4 C and the
faecal samples were kept at room temperature and
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